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Endoplasmic reticulum-plasma membrane (ER-PM) contact sites are specialized stable 
regions of the ER that are tightly apposed to the PM. These conserved organelle junctions are 
thought to function as rapid and direct avenues for inter-organelle communication between the 
ER and PM. However, a major obstacle in the study of ER-PM contacts has been the 
identification of the factors that form and stabilize these structures. By trying to understand how 
Sac1, an ER anchored phosphoinositide phosphatase, regulates the phosphoinositide lipid 
phosphatidylinositol-4-phosphate (PI4P) on the PM, we have gained critical insight into ER-PM 
contact site formation and function.  
Here I present work that demonstrates Sac1 functions at ER-PM contacts to 
dephosphorylate PI4P on the PM. In the first part of my thesis, I uncovered a role for the yeast 
oxysterol binding protein homolog (Osh) family as critical regulators of PI4P metabolism. The 
Osh proteins are known PI4P effectors that localize to ER-organelle contact sites, including ER-
PM. We found that the entire Osh family regulates PI4P metabolism in vivo, through Sac1, and 
the Osh proteins stimulate Sac1 phosphatase activity in vitro. We propose that the Osh proteins 
serve as sensors of PI4P and activators of Sac1 at ER-PM contacts. In the second part of my 
thesis, I identified the tricalbin proteins (orthologs of the extended synaptotagmins), Ist2 (a 
member of the TMEM16 family of ion channels), and the yeast VAP proteins, Scs2/22 as ER-
PM tethering proteins. Strikingly, cells lacking all three families of tethering proteins display a 
 dramatic retraction of the ER from the PM and an accumulation of cytoplasmic ER structures. 
These mutants also exhibit large accumulation of PI4P on the PM, consistent with a critical role 
for ER-PM contacts in regulating Sac1 function. Importantly, the generation of a strain lacking 
ER-PM junctions allowed us the opportunity to investigate novel functions for these structures. 
In addition to the defect in PI4P turnover, the unfolded protein response (UPR) was 
constitutively activated in cells lacking ER-PM junctions. This work provides a molecular 
mechanism for ER-PM contact site formation and identifies PI4P metabolism and ER 
homeostasis as new ER-PM contact site functions. 
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Chapter I 
Introduction 
 
Phosphoinositide signaling 
Lipids not only function as structural membrane barriers for the different compartments 
of the cell, they are also intimately involved in many aspects of cell physiology. Of the many 
lipid species found in eukaryotic cells, the phospholipid phosphatidylinositol (PI) and its 
phosphorylated derivatives, phosphoinositides (PIPs), are of particular importance in regulating 
an incredibly diverse array of critical cellular processes. These include cell signaling, 
cytoskeleton regulation, transcription, and membrane trafficking. Phosphoinositides are 
generated by phosphorylation of three accessible hydroxyl groups on the inositol sugar of 
phosphatidylinositol by PI-Kinases (Figure 1A). Phosphoinositides are turned over though 
dephosphorylation by PI-phosphatases. Through the interconversion of phosphoinositide 
isoforms by PI-kinases and phosphatases, phosphoinositides serve as highly versatile signaling 
molecules with 7 possible isoforms. Eukaryotes have evolved to use the versatile 
phosphoinositides to control a diverse array of membrane signaling events. Notably, mammals 
encode a large number of PI-Kinases (19) and phosphatases (at least 28)(Sasaki et al., 2009). 
Phosphoinositides mediate signaling though the membrane recruitment and activation of proteins 
with phosphoinositide binding domains, such as the pleckstrin homolog domain (PH), phox 
homology domain (PX), and FYVE domain (Fab1, YOTB, Vac1, and EEA1 domain)(Figure 1A; 
Harlan et al., 1994; Moravcevic et al., 2012; Vicinanza et al., 2008; Yu and Lemmon, 2001). In 
addition, there are several examples of phosphoinositide binding proteins that do not contain 
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established domains, interacting with phosphoinositides through basic patches or other motifs 
(Di Paolo and De Camilli, 2006; Dippold et al., 2009; Moravcevic et al., 2012). The number of 
proteins with phosphoinositide binding domains highlights the immensity of the 
phosphoinositide regulated signaling networks within eukaryotic cells. For example, in yeast at 
least 30 proteins contain PH domains (Yu et al. 2004). While in mammalian cells there are over 
250 PH domain containing proteins (Vicinanza et al., 2008) .  
Phosphoinositide recruitment and activation of proteins frequently occurs in concert with 
an additional protein component, such as a small GTPase, a small protein motif, or ubiquitin (Di 
Paolo and De Camilli, 2006). The coordinated recruitment and binding of a phosphoinositide and 
a protein by phosphoinositide effector proteins has been termed coincidence detection and allows 
for multiple signaling inputs to be integrated at a specific membrane in the cell (Figure 1B). For 
example, PI(4,5)P2 on the plasma membrane (PM) along with ubiquitinated PM cargo proteins or 
sorting signals on the cargo proteins themselves serve as coincidence detection for clathrin 
adaptors that initiate clathrin mediate endocytosis (Ford et al., 2001; Gaidarov and Keen, 1999; 
Honing et al., 2005; Itoh et al., 2001; Traub, 2003). Phosphoinositides can also signal as soluble 
secondary messengers and one of the earliest examples of phosphoinositide signaling studied 
was the soluble messenger inositol-(1,4,5)-triphosphate (InsP3). InsP3, generated by the triggered 
hydrolysis of PI(4,5)P2 by PLC, binds to the InsP3 receptor in the endoplasmic reticulum (ER) to 
trigger release calcium (Ca2+) stores (Berridge and Irvine, 1984; Clapham, 2007). Subsequently, 
additional soluble inositol phosphates are emerging as important signaling molecules in many 
systems (Tsui and York, 2010). 
While phosphoinositides are involved in numerous cellular signaling processes, one of 
the most important and extensively studied roles for phosphoinositides is in the regulation of  
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Figure 1.1. Phosphoinositide signaling 
(A) Phosphoinositide cycle. Phosphatidylinositol can be phosphorylated at the D3, D4, and D5 
position of the inositol sugar to generate phosphatidylinositol phosphates (PIP). 
Phosphoinositides can be dephosphorylated by phosphatases that interconvert different 
phosphoinositide isoforms or shut down signaling. Phosphoinositides mediate signaling by 
recruiting and activating effector proteins with phosphoinositide binding domain to the 
membrane, or through hydrolysis by lipases to generated soluble inositol phosphates and 
diacylglycerol (not shown).  
(B) Phosphoinositide signaling often requires an additional protein component on the membrane 
for effector recruitment. This type of dual targeting is called coincidence detection and adds an 
important layer of regulation to phosphoinositide signaling. Coincidence detection ensures the 
effector recruitment takes place at the right time and location. The protein or the 
phosphoinositide alone is not sufficient for recruitment of the effector, but when both are present, 
effector proteins are recruited and the effector is activated. 
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membrane trafficking between organelles. In addition to the example of endocytosis highlighted 
above, phosphoinositides are important for recruiting the machinery for nearly every trafficking 
step though the secretory and endocytic pathways (Vicinanza et al., 2008). Specific 
phosphoinositides are compartmentalized on organelles: PI4P and PI(4,5)P2 on the PM, PI4P at  
the Golgi, PI3P at endosomes, and PI(3,5)P2 on vacuoles/lysosomes (Di Paolo and De Camilli, 
2006). The compartmentalization of specific phosphoinositide species along with a similar 
partitioning of small GTPases plays an important role in determining organelle identity, as well 
as coordinating trafficking reactions between organelles (Audhya et al., 2000; Desrivieres et al., 
1998; Di Paolo and De Camilli, 2006; Hammond et al., 2012; Homma, 1998; Santiago-Tirado 
and Bretscher, 2011; Varnai et al., 2006; Vicinanza et al., 2008; Zoncu et al., 2007). This 
compartmentalization of phosphoinositides is tightly regulated to ensure that both 
phosphoinositides are generated and signaling takes place at the proper location and time. If 
phosphoinositides are misregulated, membrane trafficking events are either not initiated, when 
phosphoinositide generation is blocked, or potentially impaired when phosphoinositides are not 
turned over. Continuing with endocytosis as an example, PI(4,5)P2 is required for the initiation 
and maturation of clathrin coated endocytic events, and when not present, greatly disrupts 
endocytosis (Desrivieres et al., 1998; Homma, 1998; Varnai et al., 2006; Zoncu et al., 2007). 
Importantly, PI(4,5)P2 must also be hydrolyzed by PI-phosphatases during the completion of 
clathrin-mediated endocytosis to recycle the endocytic machinery that binds PI(4,5)P2 and allow 
for the maturation of the endocytic vesicle to a PI3P rich endosome (Clague et al., 2009; Zoncu 
et al., 2009). Without this turnover of PI(4,5)P2, the vesicle cannot progress to the endosome and 
the endocytic machinery remains trapped on the vesicle, unable  to participate in new rounds of 
endocytosis (Cremona et al., 1999; Kim et al., 2002; Stefan et al., 2005; 2002). Not surprisingly, 
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defects in phosphoinositide regulation, through mutations in PI-kinases and phosphatases, can 
lead to several diseases. These include cancer, through inappropriate accumulation of 
PI(3,4,5)P3, which drives proliferation signaling pathways, and several severe neurological 
diseases (Liu and Bankaitis, 2010). Therefore, studying the regulation and function of 
phosphoinositides is important to understanding and potentially intervening in human diseases.  
 
PI4P regulates essential Golgi and plasma membrane processes 
Of the many phosphoinositide isoforms, PI4P is unique in being found at relatively high 
abundance, relative to other phosphoinositide isoforms, at two distinct organelles in the cell. 
PI4P is a crucial regulator of essential and conserved processes at both the PM and Golgi (Figure 
2A). The Golgi pool of PI4P regulates trafficking from the Golgi and is important for the Golgi 
targeting of cytoplasmic proteins (D'Angelo et al., 2008; Santiago-Tirado and Bretscher, 2011). 
In yeast the type III PI4-kinase, Pik1, generates the Golgi pool of PI4P. Pik1 is essential and 
temperature sensitive alleles of Pik1 lead to trafficking defects of both vacuole and secretory 
cargo (Audhya et al., 2000; Hama et al., 1999; Walch-Solimena and Novick, 1999). The Golgi 
PI4P effectors that cause this lethal block in secretory trafficking in pik1 mutants are not 
completely clear, but it is at least in part due to the targeting of Myo2, a type 5 myosin that 
transports secretory vesicles to sites of growth (Santiago-Tirado et al., 2011). However Myo2 is 
not the only essential Golgi PI4P effector since pik1 mutant phenotypes are distinct from myo2 
mutants; pik1 mutants generate Berkeley bodies, which are seen in several secretory mutants, 
while myo2 alleles accumulate secretory vesicles (Govindan et al., 1995; Johnston et al., 1991; 
Novick et al., 1980; Walch-Solimena and Novick, 1999). Similar to yeast, in mammalian cells 
PI4P is a critical regulator of trafficking from the Golgi. Knock down or kinase dead mutants of 
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mammalian Golgi PI-4 Kinases result in trafficking defects and disrupted Golgi morphology, 
indicating a conserved role for PI4P in Golgi function (Balla et al., 2005; Bruns et al., 2002; 
Wang et al., 2003). Many Golgi targeted proteins also require PI4P for targeting in mammalian 
cells, including AP-1, GGAs, FAPPs, OSBP, and GOLPH3 (Balla et al., 2005; Dippold et al., 
2009; Levine and Munro, 2002; Wang et al., 2007; 2003).  
In yeast, the type III PI-4kinase, Stt4, localizes to the PM and generates a PM pool of 
PI4P (Audhya et al., 2000; Audhya and Emr, 2002; Baird et al., 2008). This PM pool of PI4P 
regulates vacuole morphology, the actin cytoskeleton, cell wall integrity, and is a precursor for 
PI(4,5)P2, which is critical regulator of many PM processes (Figure 2A; Audhya et al., 2000; 
Audhya and Emr, 2002; Clague et al., 2009; Desrivieres et al., 1998; Homma, 1998; Suh et al., 
2006; Varnai et al., 2006; Zoncu et al., 2007). Despite some specific phenotypes of PI-4kinase 
mutants, the PM pool PI4P was thought to serve only as a precursor for PI(4,5)P2 synthesis. 
However, recent work in mammalian cells using targeted PI-phosphatases demonstrated that 
many PM process thought to be regulated solely by PI(4,5)P2 can also be regulated by PI4P as 
well (Hammond et al., 2012). Knockout of the mammalian homolog of the Stt4, PI 4-kinase III 
alpha, in mice is lethal (Nakatsu et al., 2012). Embryonic fibroblasts from a conditional knockout 
mouse of PI 4-kinase III alpha display a substantial decrease of cellular PI4P levels and a loss of 
PI4P reporter specifically from the PM. In addition these conditional knock out cells had 
disruption of many PM PI4P and PI(4,5)P2 dependent cellular processes, including recruitment 
of STIM1 for store operated calcium entry and altered clathrin endocytic structure morphology 
and dynamics. Surprisingly only a small reduction of total PI(4,5)P2 levels was observed in the 
knockout cells, but the distribution of PI(4,5)P2 was greatly altered from the normal PM 
localization to aberrant internal structures within the cytoplasm. Taken together, this work has 
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demonstrated that PI4P generated at both at the Golgi and the PM control several conserved and 
essential membrane trafficking and signaling pathways within eukaryotic cells. 
 
PI4P regulation by the ER localized PI-Phosphatase Sac1 
PI4P levels within cells is tightly regulated by dephosphorylation mediated by the Sac1 
domain containing phosphatases: Sac1, and the synaptojanin homologs Sjl2/Inp52, and 
Sjl3/Inp53 (Foti et al., 2001; Guo et al., 1999). Yeast mutants of sac1 alone cause a large 
increase in cellular PI4P levels, while sjl2 and sjl3 single or double mutants have no change in 
PI4P. However sjl3/sac1 double mutants display a greater increase in PI4P over sac1 mutants 
alone and are inviable, indicating that although Sac1 is the primary phosphatase in PI4P turnover 
(Figure 2A), Sjl3 can compensate for loss of Sac1 (Foti et al., 2001).   
Sac1, Suppressor of ACtin 1, was initially discovered as a bypass suppressor of certain 
actin alleles (Novick et al., 1989). Shortly after, sac1 mutants were also found to be a suppressor 
of the yeast secretory mutant and phosphoinositide lipid transfer protein, Sec14 (Cleves et al., 
1989). Sec14 was subsequently determined to be required for PI4P production at the Golgi 
(Hama et al., 1999). How Sac1 impacts both the actin cytoskeleton and secretion remained 
unclear until it was uncovered that the Sac1 domain was a polyphosphoinositide phosphatase 
capable of dephosphorylating PI4P, PI3P, and PI(3,5)P2 and possessed a conserved CX5R motif 
found in several phosphoinositide phosphatases (Guo et al., 1999). As phosphoinositides regulate 
both membrane trafficking at the Golgi and the cytoskeleton, a role for Sac1 in these distinct 
processes is possible.  
Although Sac1 is genetically linked to PI4P turnover at the Golgi, labeling experiments in 
PI4-kinase/sac1 double mutants indicated that the major substrate of Sac1 is generated by the   
9 
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Figure 1.2. PI4P regulation 
(A) PI4P is generated by multiple PI-4Kinases, but primarily is regulated by the phosphatase 
Sac1. PI4P serves as essential regulators at both the Golgi and PM. Examples of the processes 
controlled by PI4P in yeast on each organelle are listed. 
(B) Yeast Sac1 domain organization. Sac1 is a 623 amino acid protein. TMDs = transmembrane 
domain.  
(C) Cartoon schematic of Sac1 in the ER membrane. Topology of domains relative to the 
cytoplasm and lumen of the ER are indicated. 
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PM localized PI4-Kinase Stt4, and not the Golgi PI4-kinase Pik1 (Audhya and Emr, 2002; Foti 
et al., 2001). In addition, deletion of sac1 can rescue the inviability of stt4 mutants, but not pik1 
(Foti et al., 2001). Consistent with this, the PI4P reporter, 2xPHOsh2, shifts it localization from 
primarily Golgi with weak PM signal that is enriched in the bud, to strong uniform localization at 
the PM in sac1 mutants (Roy and Levine, 2004). These results suggest that the major location of 
Sac1 PI4P turnover is the PM pool of PI4P, with a minor influence on Golgi pool of PI4P.  
Sac1 is an integral membrane protein with its N-terminal Sac1 phosphatase domain 
exposed to the cytoplasm and two transmembrane domains at the C-terminus (Figure 2B and 2C; 
Konrad et al., 2002; Whitters et al., 1993). Yeast Sac1 chiefly localizes to the endoplasmic 
reticulum with a small pool that traffics between the ER and the Golgi (Foti et al., 2001; Whitters 
et al., 1993). Sac1 requires ER localization and membrane anchorage for function as a truncation 
of Sac1 that removes the C-terminal transmembrane domains was not functional unless greatly 
overexpressed (Foti et al., 2001). Golgi trafficking of Sac1 is regulated by the nutrient condition 
in yeast, where in rich growth conditions Sac1 is retained in the ER by an interaction with Dpm1, 
a glycosylation enzyme in the ER. Upon starvation Sac1 traffics to and remains at the Golgi 
(Faulhammer et al., 2005). This regulated shuttling of Sac1 from the ER to the Golgi has been 
proposed to deplete PI4P at the Golgi, resulting in decreased Golgi trafficking in starvation 
conditions. However, the PI-Kinase at the Golgi, Pik1, also delocalizes from the Golgi in these 
conditions (Faulhammer et al., 2007). It has not yet been demonstrated that this nutrient triggered 
attenuation of PI4P signaling at the Golgi is important for yeast survival during starvation.  
In yeast, sac1 mutants display many phenotypes, highlighting the importance of 
maintaining proper PI4P levels and spatial distribution. Examples of sac1 mutant phenotypes 
include: inositol auxotrophy, constitutive unfolded protein signaling, disrupted protein 
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glycosylation, changes to vacuole morphology, and over 800 unique synthetic genetic 
relationships (Costanzo et al., 2010; Faulhammer et al., 2005; Foti et al., 2001; Jonikas et al., 
2009; Whitters et al., 1993). Though the mechanism of how Sac1 or increased PI4P levels are 
linked to sac1 mutant phenotypes is not known, it is likely that the overproduction of PI4P leads 
to improper targeting and activation of proteins to PI4P rich membranes. Interestingly, there is 
strong evidence that Sac1 has a potential direct role in sphingolipid regulation. Sac1 interacts 
with and is a stoichiometric member of the serine palymitoyltransferase, Orm1/2, Tsc3, and Sac1 
(SPOTS) complex, which regulates sphingolipid synthesis and includes the enzyme that 
catalyzes the first step in the sphingolipid biosynthetic pathway in the ER (Breslow et al., 2010). 
Sac1 is not required for SPOTS complex formation and its role in the SPOTS complex is 
unclear; however sac1 mutants do have altered sphingolipid levels (Breslow et al., 2010; Brice et 
al., 2009).  All of the phenotypes that we are aware of require Sac1 catalytic activity, however it 
is possible that some phenotypes may not be linked to PI4P turnover and may require Sac1 in 
additional roles. 
Although Sac1 has been primarily studied in yeast, Sac1 is conserved in higher 
eukaryotes. Throughout evolution Sac1 retains the same domain architecture, a cytoplasmic N-
terminal Sac1 domain linked to two transmembrane domains in the C-terminus, and like in yeast, 
primarily localizes to the ER with a pool that traffics to the Golgi (Nemoto et al., 2000; Rohde et 
al., 2003). Although sac1 mutants in yeast are viable, mutants in higher eukaryotes display more 
severe phenotypes. Sac1 mutants in Drosophila exhibit accumulation of cellular PI4P levels, 
critical development defects, and embryonic lethality (Wei et al., 2003; Yavari et al., 2010). 
These developmental detriments are caused by the improper activation of key and conserved 
developmental signaling processes, including JNK MAPK signaling, and Hedgehog signaling 
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(Wei et al., 2003; Yavari et al., 2010).  Sac1 has critical roles in mammals as Sac1 knockout 
mice are preimplantation lethal and siRNA knock down of Sac1 in cell culture results in loss of 
cell viability (Liu et al., 2008). siRNA knock down of Sac1 in mammalian cells also has 
pleiotropic effects including altered PI4P distribution, mitotic spindle defects, and Golgi 
fragmentation (Liu et al., 2008; Rohde et al., 2003). These studies highlight the important role of 
Sac1 in maintain proper PI4P levels to ensure normal developmental signaling and also 
demonstrate a key role for PI4P signaling in development in higher eukaryotes. 
 
How does the ER localized phosphatase, Sac1, regulate PI4P on the PM? 
Due to Sac1’s ER localization and its primary substrate, PI4P, residing on the PM, the 
mechanism of how Sac1 hydrolyzes PI4P on the PM has remained a paradox. There are three 
major hypotheses or models to explain this conundrum. First Sac1 traffics through the secretory 
pathway to the PM where Sac1 would easily have access to PI4P in cis (Figure 3). Second, PI4P 
is transferred from the PM to the ER for hydrolysis by Sac1. Lastly, Sac1 reaches from the ER to 
the PI4P on the PM in trans at regions where the ER and PM are close together. Additional 
hypotheses, or a combination of the three above cannot be ruled out. There have been several 
studies that have either directly or indirectly tested these models and they are discussed below. 
Sac1 trafficking to the PM may be simplest solution for how Sac1 reaches its substrate. 
Indeed Sac1 is found to traffic to the Golgi during certain starvation conditions in both yeast and 
metazoans (Blagoveshchenskaya et al., 2008; Faulhammer et al., 2005) However several lines of 
evidence discount this model. Critically, Sac1 has not been observed on the PM and its 
localization has been demonstrated by fluorescence microscopy to be primarily in the ER in both 
yeast (Faulhammer et al., 2005; Foti et al., 2001) and mammalian cells (Nemoto et al., 2000). In 
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addition, Sac1 has been shown to co-sediment with ER markers by sucrose gradient 
sedimentation (Faulhammer et al., 2005). Yeast Sac1 also doesn't accumulate on the PM in a 
strong endocytosis mutant (Tahirovic et al., 2004), ruling out small pools of Sac1 trafficking 
through the secretory system past the Golgi.  Furthermore, mammalian Sac1 has a putative COP1 
recognition signal and was found to bind COP1 coat components, providing a mechanism for 
retrieval of Sac1 from the Golgi back to the ER (Rohde et al., 2003). This study also found that 
Sac1 lacking this retrieval signal accumulates in the Golgi and does not progress to the PM. 
Finally, yeast strains expressing Sac1 fused to an ER retention signal have lower PI4P levels than 
wild type Sac1 cells, indicating normal PI4P metabolism does not require Sac1 to leave the ER 
(Konrad et al., 2002). Taken together, these results strongly favor a mechanism for Sac1 
mediated PI4P turnover in which Sac1 resides in the ER. 
The second model for the mechanism of Sac1 turnover is the transport of PI4P from the 
PM to the ER. There are two possible routes for the transport of PM PI4P to the ER: retrograde 
vesicular trafficking or non-vesicular lipid transport. Retrograde transport of PI4P from the PM 
to the ER is an unlikely mechanism of PI4P turnover due to the tight spatial regulation of 
phosphoinositides along the trafficking steps from the PM back to the ER. PI4P that is 
endocytosed would likely be turned over by the synaptojanin phosphatases that are recruited to 
endocytic sites to turn over PI(4,5)P2 and PI4P through their 5-phosphatase and Sac1 domains 
(Stefan et al., 2002). The non-vesicular transport of PI4P from the PM to the ER is an intriguing 
alternative possibility. A growing amount of research has uncovered several families of lipid 
transfer proteins that are thought to transfer lipids between organelles (Lev, 2010; Toulmay and 
Prinz, 2011). One of the best studied examples is the phosphatidylinositol/phosphatidylcholine 
transfer protein Sec14, which is thought to be essential for the lipid composition of the Golgi and 
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by transferring PI to the Golgi for PI4P synthesis (Mousley et al., 2012). However recent work 
has argued that Sec14 function is not merely to transfer PI to the Golgi, but to present PI to Pik1 
for efficient phosphorylation for the generation of PI4P (Mousley et al., 2012; Schaaf et al., 
2008). In addition, while several proteins have been shown to transfer lipids between membranes 
in vitro, it is still contended whether some of these proteins do so in vivo (Georgiev et al., 2011). 
Nonetheless, for both the vesicular and non-vesicular transport, PI4P would be predicted to 
greatly accumulate on the ER in the absence of Sac1 due to PI4P’s continual transfer to the ER 
without turnover. However as mentioned above, sac1 mutants accumulate the PI4P reporter, 
2xPHOSH2, on the plasma membrane and not in the ER (Roy and Levine, 2004; Stefan et al., 
2011). Although some PI4P binding domains with a bias for the Golgi pool of PI4P (PH domains 
of FAPP1, Osh1, and OSBP all bind the small Golgi GTPase Arf1 in addition to PI4P) do show 
some weak ER localization in sac1 mutants, they are still primarily Golgi localized (Godi et al., 
2004; Levine and Munro, 2002; Roy and Levine, 2004). This small increase in PI4P detected at 
the ER is likely due to the PI4P generated at the Golgi trafficking back to the ER during normal 
retrograde transport, and not from the PM. 
The third model for Sac1 hydrolysis of PM PI4P proposes that Sac1 regulate PM PI4P in 
trans from regions of the ER that are in close proximity to the PM.  Based on the published 
research discussed above this is the favored model for Sac1 PI4P regulation. Sites where the ER 
is associated with the PM are termed ER-PM contact sites and will be the focus of the rest of the 
introduction. 
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Figure 1.3. Three potential models for ER localized Sac1 regulation of PM PI4P. 
Model 1. Sac1 traffics to the PM to turn over PI4P in cis. 
Model 2. PI4P traffics back to the ER from the PM either through retrograde vesicular trafficking 
or through non-vesicular transport (Not shown). 
Model 3. Sac1 regulated PI4P in trans at sites where the ER and PM are close together. 
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ER-PM membrane contact sites 
Organelle contact sites, also known as membrane contact sites or organelle junctions, are 
ubiquitous structures in eukaryotes that are frequently seen in electron microscopy studies on 
various organisms and tissues (Elbaz and Schuldiner, 2011; Toulmay and Prinz, 2011). 
Organelle contacts sites have been defined as regions where two organelles come in very close 
proximity (10-30nm) and appear to be physically interacting, but do not fuse. Although overlap 
between organelles by fluorescence microscopy is relatively common, membrane contacts are 
generally characterized and quantitated by electron microscopy, due to the small dimensions that 
define these contacts. Despite being first described many decades ago (Copeland and Dalton, 
1959; Porter and Palade, 1957), there is still a lot that is not known about organelle contacts. 
With some exceptions, the factors that mediate many of these contacts are undiscovered. In 
addition, the functions for several organelle contacts are poorly characterized or unknown. 
However, organelle contacts are intriguing structures as potential platforms for direct 
communication between organelles. Inter-organelle communication at organelle contacts would 
allow a more direct and rapid route for the transfer of signals and coordination between 
organelles than membrane trafficking. Indeed most of the known and proposed functions for 
these sites involve signaling and metabolite transport processes (Toulmay and Prinz, 2011).  
The ER is the most frequent organelle that participates in organelle contacts and has been 
observed to form junctions with virtually all organelles in the cell, including the PM, 
mitochondria, and every compartment along the endocytic and secretory pathway (Friedman and 
Voeltz, 2011). The morphology of the ER in mammalian cells could explain this promiscuous 
association with many organelles, as the ER in most cells types consists of a continual network 
that emanates from the nucleus to every region of the cell (Friedman and Voeltz, 2011; Shibata 
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et al., 2006). However even in yeast, where the ER network is predominately sequestered to the 
cortex of the cell, contacts are still frequently seen with all organelles (West et al., 2011). One of 
the most striking examples of this has been observed between the ER and the mitochondria. By 
serial electron microscopy tomography studies with yeast, ER tubules emanating from the 
normal peripheral network appear to reach out and grasp tubules of the mitochondria in a process 
that is likely important for mitochondrial fission (Friedman et al., 2011). These observations, 
along with several others, indicate that organelle contacts are indeed directed and regulated 
structures, and are not formed as a result of spontaneous contact between organelles.  
Of the ER-organelle contacts identified, ER-PM contacts are perhaps the most intriguing 
because they link the major biosynthetic organelle in the cell, the ER, with one of the primary 
destinations of the biosynthetic products, the PM. This potentially allows for a tight coordination 
of ER processes with the PM and vice versa. In addition the PM is the major signaling platform 
in the cell and direct cooperation between the ER and PM in response to extracellular signaling is 
an exciting possibility. Junctions between the ER and the PM were first described by electron 
microscopy of muscle cells during the 1950s (Porter and Palade, 1957). In the subsequent 
decades, ER-PM contacts have been observed by electron microscopy in various cell types and 
organisms. Like the diversity of ER morphologies that are seen in different organisms and cell 
types, ER-PM contacts very greatly in abundance and magnitude. The budding yeast 
Saccharomyces cerevisiae has served as an excellent model system for studying ER morphology, 
ER-organelle contacts, and in particular ER-PM contacts. In yeast the ER makes extensive 
contact with the PM; a large percentage of the non-nuclear ER is tethered to the PM at an 
average distance of 30nm, ranging from 10-50nm (Pichler et al., 2001; West et al., 2011). This 
ER associated with the PM has been termed cortical ER (cER) and forms a network of sheets and 
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tubules similar to the ER morphology of mammalian cells, except instead of spanning the 
cytoplasm, the network is adhered to the PM (Figure 4A). This network of both ER tubules and 
sheets can be easily seen by fluorescence microscopy by focusing on a focal plane at the 
periphery of yeast cells (Figure 4B; Prinz et al., 2000). This cortical ER network is tethered to 
about 40% of the PM surface, representing a significant domain on the plasma membrane of 
yeast cells (Pichler et al., 2001; West et al., 2011). The side of the cER facing the PM is 
completely devoid of ribosomes, indicating either a close enough connection that ribosomes are 
excluded or the enrichment of proteins between these organelles that preclude ribosome binding. 
The absence of ribosomes is a common feature of ER-organelle contacts and these ER regions 
likely have specialized functions distinct from protein synthesis and translocation (Figure 4C). 
In most cultured mammalian cells, ER-PM contacts have not been extensively studied 
beyond their role in calcium signaling, which will be discussed below. This is primarily due to 
the very small percentage of the PM that is occupied by the ER. In Hela cells, less than .5% of 
PM has associated ER (Orci et al., 2009; Wu et al., 2006) and unlike yeast, the ER is evenly 
distributed throughout the entire cell, with only small contacts with the PM (Figure 4D). 
However close association between the ER and PM in cultured cells can be observed by total 
internal fluorescence microscopy despite the very small percentage of the PM in contact with the 
ER under normal conditions (Wu, 2006). However, in certain cell types ER-PM contacts are 
more prevalent. In muscle cells, where ER-PM associations were first observed, there are 
extensive ER-PM connections that are important for calcium release during muscle contraction 
(Porter and Palade, 1957). In addition, neuronal cells have more substantial ER-PM contacts, 
some greater than 5µm, in the cell body and several smaller sized contacts have been observed in 
the synapse (Hayashi et al., 2008; Rosenbluth, 1962). In plants the ER forms a cortical network  
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Figure 1.4. ER morphology and ER-PM contacts. 
(A) Cartoon of the ER network in a midsection view of a yeast cell. The majority of the non-
nuclear ER is associated with the PM. 
(B) Cartoon of the ER network at the yeast periphery, the network sheets and tubules adhered to 
the PM is similar to the mammalian ER, but the network is only seen from this peripheral 
viewpoint. 
 (C) Diagram of an ER-PM contact site the spacing between the organelles range from 10-30nm 
and ribosomes (Blue dots) are excluded from this surface.  
(D) Cartoon representation of the ER in a mammalian cell. Green represents the PM and black, 
the ER. ER forms of network of sheets and tubules through out the cell. Very little of the total 
ER is in contact with the PM, but stable structures are present. 
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tightly apposed to the PM, similar to the ER morphology seen in yeast (Staehelin, 1997). The 
cER network in plant cells is very tightly associated with the PM and can still be observed 
attached to the PM when cells are lysed and the cytoplasm is washed away (Hepler et al., 1990). 
In addition to the general association of the cER with the PM in plants, the ER is a component of 
more specialized PM structures. These include cER juxtaposed to large PM invaginations, that 
may play a role in membrane trafficking, and the plasmodesmata, a specialized ER, PM, and cell 
wall structure that connects two adjacent cells (Maule et al., 2011; Staehelin, 1997). 
Plasmodesmata are especially interesting ER-PM contacts as they are the major routes of 
intercellular communication and transport in plants and important hubs for several signaling 
pathways.  
 
Functions for ER-PM contacts 
 Although ER-PM contacts are ubiquitous and conserved structures, they have mostly 
been appreciated for their roles in Ca2+ signaling in muscle cells and lipid transport in the fly 
photoreceptor cells.  However in recent years, a renewed interest in ER-PM contacts has 
uncovered additional functions for ER-PM contacts. Interestingly, for several of the functions 
that will be described in the following sections, ER-PM contacts have provided an important 
mechanistic insight for previously unclear observations. In addition, as research of ER-PM 
contacts has expanded, an intimate link between PM phosphoinositide signaling and ER-PM 
contacts has been uncovered and will be highlighted in the following sections on ER-PM 
contacts. 
 
Calcium signaling 
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 The best-characterized function of ER-PM contacts is Ca2+ signaling in higher 
eukaryotes. In muscle cells there are abundant specialized ER-PM junctions critical for 
mobilizing calcium to induce muscle contractions. These muscle specific ER-PM structures are 
formed by the sarcoplasmic reticulum (muscle ER) engaging closely with the transverse tubules 
or T-tubule, a specialized invagination of the sarcolemma (muscle PM) (Rossi and Dirksen, 
2006). These contacts form two types of junctions: a diad or triad. If a T-tubule is in contact with 
only one sarcoplasmic reticulum terminal cisterna, the structure is termed a diad (found in 
cardiac muscles) and if two on each side of the tubule, a triad (abundant in skeletal muscle) 
(Bootman, 2006; Carrasco and Meyer, 2011). At triad and diad junctions, the voltage gated Ca2+ 
channel is enriched on the PM and the Ryanodine receptors (Ryr), a Ca2+ channel, is enriched on 
the closely apposed sarcoplasmic reticulum. During depolarization of skeletal muscle cells, the 
voltage gated calcium channels (VGCC) on the PM open, causing an influx of extracellular Ca2+ 
and triggering the closely apposed Ryr to open and release the store of calcium from the 
sarcoplasmic reticulum (Endo, 2009). This large increase in cytoplasmic Ca2+ levels induces 
muscle contraction. Although the VGCC and Ryr receptors are major components of muscle ER-
PM junctions, in cells lacking Ryr receptor, triads structures still persist (Franzini-Armstrong et 
al., 1991; Ikemoto et al., 1997). One family of proteins implicated in tethering these membranes 
together are the junctophilins, proteins that were found to be enriched in muscle cells and 
localize to triad and diad junctions (Takeshima et al., 2000). Exogenous expression of 
Junctophilin induces ER-PM contacts in non-muscle cells and loss of a junctophilin-2 results in a 
decrease in tight contacts at heart muscle diads in the mouse cardiomyocytes, suggesting a role 
for maintaining these ER-PM contacts in heart muscle (Takeshima et al., 2000). Junctophilin is 
anchored in the ER by a single transmembrane domain and contains several tandem cytoplasmic 
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MORN (membrane occupation and recognition nexus) motifs. MORN motifs have been shown 
to bind phosphoinositides (Ma et al., 2006) and full length junctophilin 2 can bind acidic 
phospholipids including phosphatidylserine and the phosphoinositide PI(3,4,5)P3 (Bennett et al., 
2013). Thus the junctophilins likely mediate sarcoplasmic reticulum tethering to the PM by 
binding to PM phosphoinositides.  
 Beyond the highly dedicated function in muscles, ER-PM contacts are also a central 
component in calcium signaling and transport in other cell types. Upon activation of 
phospholipase C (PLC) isoforms by several signaling pathways, PLC hydrolyzes the 
phosphoinositide PI(4,5)P2 to generate two important signaling molecules (Kadamur and Ross, 
2013). The lipid product of hydrolysis is diacylglycerol, which has important signaling functions 
at the PM. The released head group is inositol-(1,4,5)-trisphosphate InsP3, a soluble inositol 
secondary messenger that binds to the InsP3 receptor (a calcium channel in the ER) causing the 
release of the Ca2+ stores in the ER and triggering calcium regulated signaling (Clapham, 2007). 
When the ER stores of Ca2+ are depleted, the influx of extracellular Ca2+ from the PM through 
calcium release activated channels (CRAC) is induced to refill Ca2+ stores in the ER and to 
maintain a high cytoplasmic Ca2+ concentrations for continued signaling (Carrasco and Meyer, 
2011). The mechanism of this ER store regulated entry of extracellular Ca2+ has been termed 
store operated calcium entry (SOCE) and had remained a mystery until the identification of 
stromal interacting molecule 1 and 2 (STIM). The STIM proteins were discovered to be ER 
integral membrane proteins that are the ER components required for SOCE and shortly after, 
ORAI1 was identified as the PM CRAC channel (Feske et al., 2006; Liou et al., 2005; Roos et 
al., 2005; Vig et al., 2006; Zhang et al., 2006; 2005). Subsequent work has revealed an elegant 
mechanism of how STIM and ORAI1 mediate SOCE at ER-PM contacts. STIM proteins contain 
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a luminal EF-hand and SAM calcium-binding motif that serves as the calcium sensor for the 
luminal concentration of Ca2+, a single transmembrane domain, a CRAC activation domain 
(CAD), and a polybasic domain that can bind PI(4,5)P2. Upon store depletion and the loss of 
Ca2+ binding, the EF-hand motif triggers a conformational change that induces oligomerization 
of STIM proteins resulting in translocation to existing ER-PM junctions (Figure 5A; Liou et al., 
2005; 2007; Wu et al., 2006). This recruitment to ER-PM contacts depends on the polybasic 
domain interacting with PI(4,5)P2 on the PM (Korzeniowski et al., 2009; Liou et al., 2007).  
Once at these sites the STIM protein binds to, oligomerizes, and activates ORAI by direct 
interaction of the CRAC activation domain of the STIMs to ORAI (Park et al., 2009; Yuan et al., 
2009). Interestingly, phosphoinositides play important roles in both the initial signaling response 
to generate IP3 and in the later step for recruitment of the STIM proteins to ER-PM contacts sites 
for ORAI activation.  
 
Lipid transfer  
In addition to Ca2+ signaling, lipid transfer has been a major focus of research for 
organelle contacts. The ER is the major site of synthesis for the three types of lipids found in 
eukaryotic cells: sphingolipids, phospholipids, and sterols. Although vesicular trafficking is the 
most obvious route to move lipids from the ER to other organelles, non-vesicular lipid transfer is 
required for several organelles. For example, non-vesicular transport must occur from the ER to 
the mitochondria, since there is no vesicular trafficking between these organelles (Voelker, 
2003). In addition to the mitochondria, there is evidence that non-vesicular lipid transfer occurs 
between many other organelles and the ER, including between the ER and PM (Kaplan and 
Simoni, 1985; Vance et al., 1991). Due to the observed association of the ER with many 
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organelles, non-vesicular transport has been suggested to take place at organelle contact sites. 
Transfer of lipids between organelles is likely to be energetically unfavorable, even if the two 
membranes are in close proximity. Thus, protein factors are needed to mediate lipid transfer. 
Consistent with this, several families of lipid transfer proteins have been identified that can bind 
and transfer a wide variety of lipid substrates, including all three lipid classes (Holthuis and 
Levine, 2005).  
One of the first and best-characterized lipid transfer protein that functions at ER-PM 
contacts is the Drosophila phosphatidylinositol transfer protein, retinal degeneration B (rdgB). 
As the name implies, rdgB mutants have retinal degeneration phenotypes caused by the loss of 
microvilli in the photoreceptor cells. rdgB was found by sequence homology to be related to the 
phosphatidylinositol transfer protein Sec14 and facilitated the transfer phosphatidylinositol in 
vitro (Bankaitis et al., 1989; Hotta and Benzer, 1970; Rubinstein et al., 1989; Vihtelic et al., 
1993). rdgB is highly enriched at specialized ER-PM contacts near the microvilli of 
photoreceptors and its likely function is to transfer phosphatidylinositol from the ER to the PM at 
these contacts (Suzuki and Hirosawa, 1994; Vihtelic et al., 1993). This is an important process 
for Drosophila photoreceptor cells since a large amount of PI is lost by the hydrolysis of 
PI(4,5)P2  to DAG and InsP3 by PLC during light induced signaling (Hardie, 2001). 
Replenishment of PI on the PM from its site of synthesis in the ER by rdgB is needed to 
regenerate PI(4,5)P2  for additional rounds of signaling. This process highlights another 
important function for ER-PM contact sites, as well as provides another link between PM 
phosphoinositides and the function of ER-PM contact sites. In addition, this particular example 
punctuates why an organelle contact site is a more direct and rapid route of transfer than 
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vesicular trafficking, which would require transport progression through the secretory pathway to 
reach the PM. 
In addition to rdgB, the yeast oxysterol-binding homology (OSH) family of lipid transfer 
proteins is thought to function at ER-PM contacts. The Osh proteins are a seven-member family 
that all contain a conserved oxysterol binding protein related domain (ORD). The domain 
architecture of the Osh proteins divides the family into short Osh proteins (Osh4, Osh5, Osh6, 
and Osh7) that consist of only an ORD domain, and the long Osh proteins, that in addition to the 
ORD domain contain an extended N-terminal region with protein and lipid interaction domains 
(Osh1, Osh2, Osh3). These long Osh proteins all contain a Pleckstrin homology (PH) domain 
and an FFAT ER-targeting motif (diphenylalanine in an acidic tract, consensus EFFDAxE) that 
is recognized by the ER vesicle associated membrane protein (VAMP) associated protein (VAP) 
(Scs2 and Scs22 in yeast) (Loewen et al., 2003). The PH domain of the long Osh proteins can 
bind to phosphoinositides, including PI4P (Yu et al., 2004). A tandem PH domain of Osh2 is 
used as a PI4P reporter in yeast and the PH domain of Osh1 is used as a Golgi specific PI4P 
reporter since this PH domain also interacts with the small Golgi GTPase Arf1 (Levine and 
Munro, 2002; Roy and Levine, 2004). Four of the Osh proteins (Osh2, Osh3, Osh6, and Osh7) 
are enriched at ER-PM contacts, while Osh1 localizes to the Golgi and another ER-organelle 
contact, the nuclear vacuole junction (Levine and Munro, 2001; Schulz et al., 2009). 
Interestingly, nearly all (9/12) of the mammalian oxysterol-binding protein (OSBP)–related 
proteins (ORPs) contain the extended N-terminus with an ER targeting FFAT motif and a PH 
domain. Many of the mammalian ORP proteins localize to various ER-organelle contacts 
(reviewed in (Olkkonen and Li, 2013; Yan and Olkkonen, 2008)). Interestingly, other lipid 
protein families contain a similar domain architecture. The ceramide transfer protein (CERT) 
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also shares the same architecture of a PH domain and an FFAT motif in its long N-terminus that 
precedes the lipid transfer domain and Nir2, the mammalian ortholog of rdgB, contains an FFAT 
motif (Hanada et al., 2003; Kawano et al, 2006). Moreover, both Nir2 and CERT require these 
targeting motifs to localize to ER-Golgi contacts for efficient lipid transfer (Kawano, 2006; 
Perreti et al., 2008). This shared architecture of lipid transfer proteins likely serves as a 
coincidence detection mechanism for ER-organelle contacts, where the FFAT motif localizes the 
protein to the ER, and the PH domain specifies the other organelle by binding to a specific 
phosphoinositide (Figure 5B).  
 The yeast Osh family share a common redundant function, as deletion of all seven genes 
is inviable, with only one is required to maintain viability (Beh et al., 2001). The function for the 
Osh proteins has been assumed to involve sterol binding and transport as they are related to the 
mammalian oxysterol binding protein. In strong support of this, the Osh4 protein crystal 
structure has been solved bound to a variety of sterol molecules in a conserved pocket of the 
ORD that all of the Osh proteins contain (Im et al., 2005). However, when assayed in vitro only 
the ORD domain of Osh2, Osh4, and Osh5 can extract and transfer sterols in vitro, while the 
other Osh proteins had weak or no sterol transfer activity (Schulz et al., 2009). Despite both the 
in vitro and structural data, the in vivo function for these proteins is unclear and the shared 
essential function has yet to be identified. Specifically testing for sterol transport in vivo, osh 
mutants display PM to ER transport defects (Raychaudhuri et al., 2006), but when tested by 
different approaches, osh mutants are near wild type in non vesicular sterol transport either to or 
from the ER (Georgiev et al., 2011). In addition, the Osh proteins have been linked to many 
other phenotypes, including the regulation of cell polarity (Kozminski et al., 2006) and Osh4 in 
Golgi PI4P regulation (Fairn et al., 2007).  
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Figure 1.5. Functions for ER-PM contacts 
(A) Store operated Calcium entry. CC=coiled coil, CAD CRAC activation domain, PB=Poly 
Basic domain, EF-hand calcium binding domain. 
When ER lumen Ca2+ levels are high the EF-hand of STIM1 binds calcium and is monomeric 
(1). Upon release of Ca2+ stores in the ER, the EF hand confirmation changes resulting in 
oligomerization of the STIM proteins (2). STIM oligomerization increases its affinity for PM 
PI4,5P2, resulting in translocation of STIM to existing ER-PM contacts. At ER-PM contacts the 
STIM proteins cluster and activate the Orai1 channels, inducing Calcium influx for sustained 
signaling and reloading of ER stores (3).  
(B) The long Osh proteins in yeast and the mammalian Orp family contain a protein architecture 
that serves as a coincidence detector for ER-PM (or other ER-organelle contacts). The PH 
domain specifies binding to phosphoinositides on the target organelle and the FFAT motif binds 
the ER protein VAP proteins (Scs2/22 in yeast). The ORD domain is proposed to transfer sterols 
between organelles. Similar architectures are found in other lipid transfer protein families (see 
text).  
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In mammalian cells, the functions ascribed to the ORP proteins are even more varied and include 
sterol transport between the ER and various organelles, membrane trafficking, microtubule 
motor regulation, and cell signaling (Jansen et al., 2010; Lev, 2010; Peretti et al., 2008; Rocha et 
al., 2009; Wang et al., 2005). Although diverse in function, and unclear in their shared essential 
function in yeast, nearly all the ORP protein family localize to, and likely function at various ER-
organelle contacts, including ER-PM.  
 
PM signaling regulation 
Another proposed function for ER-PM contacts is the regulation of receptor tyrosine 
kinase signaling. Ptp1b is a tyrosine phosphatase that dephosphorylates many signaling proteins 
that reside on the PM (Tonks, 2003). However Ptp1b, in a situation similar to Sac1, is an ER 
resident protein that regulates substrates on a different organelle. Ptp1b doesn’t contain a 
transmembrane domain, but associates with the ER via its hydrophobic C-terminus (Anderie et 
al., 2007a; Frangioni et al., 1992; Woodford-Thomas et al., 1992). Ptp1b dephosphorylation of 
proteins has been proposed to take place at ER-PM structures, and interactions between Ptp1b 
and its substrates have been observed at the cell periphery (Anderie et al., 2007b). These trans 
interactions have been detected with PKCδ, insulin receptor, epidermal growth factor receptor, 
and EphA3 receptor (Anderie et al., 2007b; Nievergall et al., 2010). Alternatively, it has also 
been suggested that ER-endosome contacts are a platform for Ptp1b dephosphorylation for 
receptors that have been endocytosed (Eden et al., 2010; Haj et al., 2002). It is possible that 
Ptp1b can function at both ER-PM and ER-endosome contacts, but in the case for insulin 
receptor signaling, Ptp1b has been shown not to require endocytosis (Shi et al., 2004).  In 
addition, ER associated Ptp1b is enriched at specialized ER-PM structures at cell-matrix 
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adhesions and cell-cell contacts, indicating that at least for some substrates, ER-PM contacts are 
the likely site for Ptp1b regulation (Haj et al., 2012; Hernández et al., 2006). Thus, the ER-
resident Ptp1b likely acts in trans from the ER to dephosphorylate signaling proteins on the PM. 
 
PI4P regulation by Sac1 and ER-PM contacts 
Sac1 functioning at ER-PM contacts is an attractive mechanism for PM PI4P turnover. 
Are ER-PM junctions required for Sac1 function and if so, is Sac1 regulated at these sites? In 
addition to these specific questions related to Sac1, little is known on how ER-PM contacts are 
formed and maintained. Not knowing the identity of the factors that hold or tether the ER and 
PM together has proved a major hurdle in the study of ER-PM contacts. In addition, as these 
structures are conserved, and in some systems incredibly extensive, there are likely additional 
important functions for ER-PM contact that have not yet been discovered.  
In the following chapters, my work (in addition to the exceptional work of my colleagues 
and collaborators) on understanding the mechanism of Sac1 function has led to many important 
insights into PI4P regulation and ER-PM contacts. We have found that Sac1 contains a long 
flexible linker that can span the distance of membrane contact sites found at ER-PM junctions, 
suggesting that an in trans mechanism for Sac1 function is possible. In addition, we discovered 
that PI4P regulation in yeast requires a family of lipid transfer proteins, the yeast oxysterol 
binding protein homologs. Osh proteins, as mentioned above, localize to ER-PM contacts sites, 
and osh mutants display sac1 mutant phenotypes, including large accumulations of PI4P. In 
addition, Osh proteins can stimulate Sac1 activity in vitro. Finally, we uncover the mechanism 
for ER-PM tethering in yeast and importantly demonstrate that Sac1 requires these contacts for 
function. This work has provided others with the foundation to study these contacts in other 
33 
systems and has identified exciting additional functions for these structures that were not 
previously known. Some of this recent work from the field will be highlighted in the conclusion 
and future directions chapter. 
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Abstract 
Sac1 phosphoinositide (PI) phosphatases are essential regulators of PI signaling 
networks. Yeast Sac1, an integral endoplasmic reticulum (ER) membrane protein, controls PI4P 
levels at the ER, Golgi, and plasma membrane (PM). Whether Sac1 can act in trans and turnover 
PI4P at the Golgi and PM from the ER remains a paradox. We find that Sac1-mediated PI4P 
metabolism requires the oxysterol-binding homology (Osh) proteins. The PH domain-containing 
family member, Osh3, localizes to PM/ER membrane contact sites dependent upon PM PI4P 
levels. We reconstitute Osh protein-stimulated Sac1 PI phosphatase activity in vitro. We also 
show that the ER membrane VAP proteins, Scs2/Scs22, control PM PI4P levels and Sac1 
activity in vitro. We propose that Osh3 functions at ER/PM contact sites as both a sensor of PM 
PI4P and an activator of the ER Sac1 phosphatase. Our findings further suggest that the 
conserved Osh proteins control PI metabolism at additional membrane contact sites. 
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Introduction 
Phosphatidylinositol 4-phosphate, PI4P, serves as an essential signaling molecule at the 
plasma membrane and Golgi in the control of membrane trafficking, cytoskeletal organization, 
lipid metabolism, and signal transduction pathways (D'Angelo et al., 2008). Maintaining the 
proper balance of PI4P levels through the regulation of phosphoinositide (PI) kinases and 
phosphatases is critical. Sac1-like PI phosphatases are important regulators of PI4P turnover and 
are implicated in disease (Liu and Bankaitis, 2010). Yeast cells lacking Sac1 display elevated 
PI4P levels resulting in impaired membrane trafficking, abnormal vacuolar morphology, altered 
lipid metabolism, and growth defects (Foti et al., 2001; Guo et al., 1999; Rivas et al., 1999). 
Inactivation of Sac1 PI phosphatase activity provided by Sac1 and the synaptojanin-like proteins, 
Sjl2 and Sjl3, results in massive PI4P accumulation, secretory defects, and lethality (Foti et al., 
2001). In mammalian cells, depletion of Sac1 leads to elevated cellular PI4P levels, Golgi 
fragmentation, and defects in mitotic spindle organization (Liu et al., 2008). Loss of Sac1 in the 
mouse and Drosophila results in embryonic lethality (Liu et al., 2008; Wei et al., 2003). Thus, 
Sac1 PI phosphatases are essential for multiple, conserved cellular functions. 
While Sac1 PI phosphatases are key modulators of PI4P metabolism, little is known 
about their regulation. Both yeast and mammalian Sac1 are integral membrane proteins localized 
to the endoplasmic reticulum (ER) and Golgi (Faulhammer et al., 2007; Foti et al., 2001; Nemoto 
et al., 2000). Upon starvation in yeast, or in the absence of growth factors in mammalian cells, 
Sac1 traffics from the ER to the Golgi where it antagonizes PI4P synthesis and Golgi function 
(Blagoveshchenskaya et al., 2008; Faulhammer et al., 2007). While roles for Sac1 in the control 
of PI4P at the ER and Golgi PI4P are known, less is understood about how Sac1 regulates PI4P 
levels at the plasma membrane (PM). Previous studies indicate that sac1Δ mutant yeast cells 
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accumulate PI4P at the PM generated by the PI 4-kinase Stt4 (Baird et al., 2008; Foti et al., 2001; 
Roy and Levine, 2004). Yet, Sac1 is not known to traffic to the PM, nor is it known if Sac1 
regulates PM PI4P pools from the ER. A recent study describing the molecular structure of the 
Sac1 catalytic domain suggests that Sac1 may act in trans from the ER to turnover PI4P at the 
PM (Manford et al., 2010). However, factors that link Sac1 PI phosphatase activity to PI4P at the 
PM are unknown. 
We find that PI4P metabolism and Sac1 function require the oxysterol-binding homology 
(Osh) protein family. In particular, Osh3 assembles at cortical ER structures in response to PM 
PI4P levels. We reconstitute Osh protein-stimulated Sac1 PI phosphatase activity against PI4P-
containing liposomes in vitro. In addition, the ER membrane VAP proteins, Scs2 and Scs22, 
control PM PI4P levels in vivo and Sac1 activity in vitro. We propose that the Osh and VAP 
proteins regulate Sac1 PI phosphatase activity at PM/ER membrane contact sites. We also 
discuss potential roles for these proteins in the control of PI metabolism at additional membrane 
contact sites. Membrane junctions between the ER and other organelles are sites for lipid transfer 
and metabolism, Ca2+ transport and signaling, and the down-regulation of insulin and growth 
factor receptors (reviewed in Lev, 2010). Thus, modulation of PI levels at membrane contact 
sites may provide a fundamental mechanism for signaling between cellular membrane 
compartments. 
 
Materials and Methods 
Yeast Strains, Plasmids, and Media 
Descriptions of strains and plasmids used in this study are in Tables 2.1 and 2.2. Gene 
deletions and epitope tags were introduced into yeast by homologous recombination (Longtine et 
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al., 1998). The pGO-GFP expression vectors were used to create GFP-Sac1 and GFP-2xPHOsh2 
fusion constructs. The pRS vector series have been described previously (Christianson et al., 
1992; Sikorski and Hieter, 1989). Coding sequences were amplified by PCR using ExTaq 
(Takara Mirus Bio). Plasmids were sequenced to ensure that no mutations were introduced due 
to manipulations. Mutant constructs were generated by site directed mutagenesis (Quickchange, 
Stratagene) and confirmed by sequencing. Standard techniques and media were used for yeast 
and bacterial growth. 
 
Fluorescence Microscopy 
Fluorescence microscopy experiments were performed on mid-log yeast cultures in 
synthetic media at the indicated temperatures. To visualize the plasma membrane, cells were 
stained with filipin (10 mg/ml) that binds ergosterol. Images were obtained using a DeltaVision 
RT microscopy system (Applied Precision) equipped with an IX71 Olympus microscope, a 
PlanApo 100X objective (1.35 NA, Olympus), DAPI, FITC, and rhodamine filters, and a Cool 
Snap HQ digital camera (Photometrics). Images were deconvolved using soft-WoRx 3.5.0 
software (Applied Precision, LLC).  All results are based on observations of > 100 cells. 
 
Electron Microscopy 
For ultrastructural analysis, 50 OD600 units of log-phase cells incubated at the appropriate 
temperature were harvested from YPD medium and fixed in 3% glutaraldehyde, 0.1 M Na 
cacodylate (pH 7.4), 5 mM CaCl2, 5 mM MgCl2, and 2.5% sucrose for 1 h. Cells were further 
processed for electron microscopy as described previously (Rieder et al., 1996). 
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Phosphoinositide Analysis 
Cellular phosphoinositide levels were measured as described (Baird et al., 2008; Stefan et 
al., 2002). Briefly, yeast were grown to mid-log phase (OD600=0.5-0.8), harvested, washed in 
media lacking inositol, preshifted to the indicated temperature for 10 minutes, and labeled with 
myo-[2-3H]inositol for 1 hour. Cells were precipitated in 4.5% perchloric acid (PCA) and 
mechanically lysed using glass beads. Lysates were washed in 100 mM EDTA, phospholipids 
were deacylated, and the resulting gro-PI species were separated by HPLC (Shimadzu) using a 
Partisphere SAX column (GE Healthcare) and detected with a 610TR radiomatic detector 
(PerkinElmer). 
 
Protein Expression Levels 
5 OD600 equivalents of mid-log cells pretreated at the indicated temperatures were 
harvested by precipitation in 10% trichloroacidic acid (TCA).  Precipitates were washed in 
acetone, aspirated, resuspended in lysis buffer (150 mM NaCl, 50mM Tris pH 7.5, 1mM EDTA, 
1% SDS), and mechanically lysed with glass beads. Sample buffer (150 mM Tris pH 6.8, 6M 
Urea, 6%SDS, 10% b-mercaptoethanol, 20% Glycerol) was added and extracts were analyzed by 
SDS PAGE and immunoblotting with the following antibodies: α-Myc (9E10, Abcam), α-HA 
(12CA5, Roche), α-Pep12 (Invitrogen), α-Dpm1 (Invitrogen), and α-GFP (Santa Cruz 
Biotechnology). 
 
Protein Binding Assays 
For Scs2-3xHA and GST-Osh1-613 binding, GST alone or GST-Osh1-613 was immobilized 
on glutathione sepharose 4B (GE Healthcare) and incubated with Scs2-3xHA yeast cell lysates 
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solubilized in PBS containing 0.5% Tween 20, 0.1 mM EDTA, 0.1 mM AEBSF, 1 µM pepstatin 
A, and a protease inhibitor cocktail (Complete EDTA-free; Roche). Beads were extensively 
washed with lysis buffer and bound material was subsequently analyzed by SDS-PAGE and 
immunoblotting. 
For Sac1-13xmyc crosslinking to 3xHA-Osh3 and Osh7-3xHA, 30 OD600 cell equivalents 
were spheroplasted, and disrupted in a dounce homogenizer in lysis buffer (20 mM HEPES pH 
7.4, 50 mM potassium acetate, 2mM EDTA, 0.2M sorbitol, 0.1 mM AEBSF, 1 µM pepstatin A, 
and a protease inhibitor cocktail, Complete EDTA-free). Lysates were precleared for 5 min at 
500 x g and were then centrifuged at 13,000 x g for 10 min at 4°C to generate pellet (P13) 
fractions. P13 fractions were incubated with 2mM DSP and 2mM DTBP in crosslinking buffer 
(same as lysis buffer, but no AEBSF) and prepared for denaturing immunoprecipitation 
conditions as previously described (Seaman et al., 1998). 3xHA-Osh3 and Osh7-3xHA 
complexes were immunoisolated with EzviewTM Red anti-HA affinity gel (Sigma), incubated in 
sample buffer containing 10% b-mercaptoethanol to cleave crosslinkers, and analyzed by SDS-
PAGE and immunoblotting. 
 
Recombinant Protein Expression and Purification 
The bacterial expression vectors pGEX6P-1 (GE healthcare) and pRSET-B (Invitrogen) 
were used to generate recombinant fusion proteins. BL21 (DE3)pLys cells (EMD) transformed 
with protein expression plasmids were grown at 37 °C to an OD600 of 0.4. The bacteria were then 
shifted to 25°C for 1 h and protein expression was induced by the addition of 0.1 mM IPTG for 
16 hours. GST and his6 fusion proteins were purified from BL21 cells with glutathione sepharose 
4B (GE Healthcare) and Ni-NTA agarose (Qiagen) respectively according to the manufactures 
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instructions. Protein concentrations were determined by the Bradford assay (BioRad). Purified 
proteins were stored at -20oC in storage buffer (50mM Tris pH 6.8, 150mM NaCl, 2mM DTT, 
50% glycerol) until use. The GST-Osh1-613 fusion was stored at -80oC in phosphate buffered 
saline (PBS) until further use. 
 
In vitro Sac1 Phosphatase Assays 
For the microsome phosphatase assays, P13 fractions were isolated from mechanically 
disrupted spheroplasts in lysis buffer (50mM Tris pH 6.8, 150mM NaCl, 2mM DTT, 1 mM 
EDTA) lacking protease inhibitors. P13 pellets were extensively washed in lysis buffer and 
sonicated to form microsomes. Protein concentrations were determined with Pierce® protein 
assay reagent (Thermo) and adjusted to 0.8 mg/ml and aliquots were stored at -80oC until further 
use. High salt washed microsomes were prepared by incubation on ice in RB containing 2 M 
NaCl for 30 minutes. Salt treated microsomes were recovered by centrifugation at 13,000 x g and 
the resulting P13 membrane pellets were resuspended by sonication to reform microsomes. 
Phospholipids (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, POPC; 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoserine, POPS; bovine brain phosphatidylinositol, PtdIns; and 
cholesterol) were purchased from Avanti and stock solutions were stored in chloroform at -20oC. 
Both diC16 PI4P and soluble diC8 PI4P were purchased from Echelon or Cell Signals. PI4P-
containing liposomes (0.6 mM POPC:0.2 mM POPS:0.2 mM diC16 PI4P, 1mM total lipid) were 
prepared by hydrating dried lipid pellets in reaction buffer (50mM Tris pH 6.8, 150mM NaCl, 
2mM DTT) and subsequent sonication. PtdIns-containing liposomes (0.6 mM POPC:0.2 mM 
POPS:0.2 mM PtdIns, 1mM total lipid) were prepared similarly. Microsomes were incubated 
with liposomes of indicated composition or soluble diC8 PI4P (60 mM) at 37oC and reaction 
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aliquots (50 ml) were stopped at indicated time points reactions with 50 mM N-ethylmaleimide 
(NEM). Phosphate release was measured by the addition of Biomol GreenTM (Enzo) and 
measured at OD620, as described previously (Maehama et al., 2000) 
For in vitro phosphatase assays using recombinant Sac11-522 and Osh proteins, purified 
proteins were added at indicated concentrations to liposomes or soluble diC8 PI4P in reaction 
buffer at the indicated temperatures. Cholesterol-containing liposomes (0.6 mM POPC:0.2 mM 
POPS:0.2 mM PI4P: 0.2 mM cholesterol) were prepared as described above.  Reactions (50 ml) 
were stopped at the indicated times with NEM and detection of phosphate release was assayed as 
described above. 
 
Preparation of 3H-PI Liposomes and Lipid Transfer/Fusion Assays 
 Liposomes containing 3H-PI isoforms were initially prepared as described above, except 
consisting of 0.6 mM POPC, 0.2 mM POPS, and 15 Ci/mmol 3H-PI(4,5)P2 (American 
Radiolabeled Chemicals). The resulting liposomes containing 3H-PI(4,5)P2 were incubated with 
recombinant SHIP2 PI 5-phosphatase (Echelon) to dephorylate 3H-PI(4,5)P2 and thus generate 
liposomes containing 3H-PI4P. The presence of both 3H-PI(4,5)P2 and 3H-PI4P was confirmed 
by HPLC analysis. 
 Liposomes containing 3H-PI(4,5)P2 and 3H-PI4P (3H-PI) were mixed with Sac1-GFP 
microsomes in RB buffer and incubated at 37oC for 30 minutes either in the absence or presence 
of 0.2 mM GST-Osh3588-996. Following this incubation, anti-GFP antibodies were added and 
Sac1-GFP microsomes were immuno-isolated using protein A-coupled magnetic Dynabeads. 
Liposomes in the unbound fraction were then sedimented by centrifugation at 100,000 x g. The 
amount of 3H-PI present in the resulting immuno-isolated microsome fraction, sedimented 
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liposome pellet fraction, and supernatant fraction was determined by liquid scintillation 
counting. 
Lipid Overlay and Sedimentation Assays 
The lipid overlay assays were performed essentially as described (Audhya and Emr, 
2002). Briefly, two-fold dilutions of lipids solubilized in chloroform were spotted onto 
reinforced nitrocellulose (Whatman) as indicated. Membranes were blocked with 5% non-fat 
milk in PBS containing 0.1 % Tween 20 and incubated overnight with 4 mg/ml his6-Osh4 
constructs in PBS containing 0.1 % Tween 20 and 2% fatty acid-free albumin. Membranes were 
extensively washed with PBS containing 0.1 % Tween 20 and bound protein was detected by 
immunoblotting using α-T7-Tag (Novagen) against the T7 tag in the fusion proteins. 
For the liposome sedimentation assays in Figure 2.10A, PI4P and PI-containing 
liposomes were prepared as described above, incubated with 2 mM recombinant his6-Osh4, 
GST-Osh3588-996, or his6-Sac1C392S,C395S for 30min at 25°C, and centrifuged at 100,000 x g for 15 
minutes at 4oC. Liposomes consisted of PC:PS:PI4P (3:1:1, 1 mM total lipid). The resulting 
supernatant and pellet fractions were prepared for SDS-PAGE analysis and Coomassie-stained to 
detect recombinant proteins. For the experiments in Figure 2.14D, liposomes consisted of 
PC:PS:PI4P (3:1:1, 0.1 mM total lipid) and were incubated with 0.4 mM his6-Osh4 and 0.4 mM 
his6-Sac1C341NBD for 30min at 25°C, and centrifuged at 100,000 x g for 15 minutes at 4oC. The 
resulting supernatant and pellet fractions were prepared for SDS-PAGE analysis and proteins 
were detected by immunoblotting using α-T7-Tag (Novagen) against the T7 tag in the fusion 
proteins. The relative amounts of his6-Sac1C341NBD  in supernatant and pellet fractions were 
determined using ImageJ analysis software. 
NBD Protein Labeling and Fluorescence Spectroscopy 
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 Purified his6-Sac1C392S,C395S protein was labeled with IANBD [N,N’-dimethyl-N-
(iodoacetyl)-N’-(7-nitrobenz-2-oxa-1,3-diazolyl)ethylenediamine] (GE Healthcare) essentially 
using the same technique as described earlier (Saksena et al., 2009). The labeled protein was 
extensively dialyzed in 150 mM NaCl, 50 mM Tris pH 7.5, 0.1% b-mercaptoethanol to quench 
and remove excess IANBD. The concentration of NBD-labeled Sac1 was determined by the 
Bradford assay (BioRad). All intensity measurements were carried out in RB buffer at 22°C. 
Emission spectra for NBD-labeled his6-Sac1C341NBD were recorded in quartz cuvettes in 150 ml 
final volume, either in the absence or presence of liposomes (PC:PS:PI4P, 3:1:1, 0.1 mM lipid 
total). NBD was excited at 468 nm, and emission was scanned at 500-590 nm. 
 
Results 
The Oxysterol-Binding Homology Proteins Regulate PI4P Metabolism 
Yeast Sac1 is an integral membrane protein that localizes to nuclear and peripheral ER 
compartments (Figure 2.1A; Foti et al., 2001). Yet, PI4P is generated by the PI 4-kinases Stt4 
and Pik1 at the PM and the Golgi, respectively (Figure 2.1E; Audhya et al., 2000). It is not 
known how ER-embedded Sac1 turns over these distinct PI4P pools. Sac1 traffics between the 
ER and Golgi to regulate PI4P levels at these membrane compartments (Faulhammer et al., 
2007). However, Sac1 has not been found at the PM. We reasoned that ER-localized Sac1 might 
control PM PI4P pools at PM/ER membrane contact sites where the peripheral ER closely 
apposes the PM (within 10 nm; Figure 2.1B). While Sac1 localizes to the peripheral ER (Figure 
2.1A), no proteins that regulate Sac1 activity at PM/ER membrane contact sites are known.  
We hypothesized that a PI4P effector might link PI4P at the PM to Sac1 at the ER 
(Figure 2.1B). For this, we focused on the PI4P-binding proteins Osh1, Osh2, and Osh3,  
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Figure 2.1. The yeast oxysterol-binding proteins control PI4P metabolism. 
(A) Sac1-GFP localizes to the ER (marked by DsRed-HDEL). Peripheral ER and nuclear ER 
(nER) compartments are labeled. Scale bar = 4µm. See also Figure 2.2B.  
(B) Electron microscopy of a region of a yeast spheroplast showing proximity between cortical 
ER and the PM (top, scale bar = 100nm). Model for PI4P metabolism at PM/ER membrane 
contact sites (bottom). 
(C) Diagram of the oxysterol binding homology (Osh) proteins and OSBP. ORD, OSBP-related 
sterol binding domain; FFAT, di-phenalanines within an acidic track; PH, pleckstrin homology 
domain; GOLD, Golgi localization domain; Ank, ankyrin repeats 
(D) Cellular PI4P levels measured by 3H-inositol labeling and HPLC analysis for wild type, oshΔ 
[CEN OSH4], oshΔ [CEN osh4ts], and sac1Δ cells at 26oC (grey) and 38oC (black). Error bars are 
the SD of three experiments. See also Figure 2.2C and Table 2.3. 
(E) PI4P localization in wild type, oshΔ [CEN OSH4], oshΔ [CEN osh4ts], and sac1Δ cells. Wild 
type, oshΔ [CEN OSH4], and oshΔ [CEN osh4ts] cells carrying GFP-2xPHOsh2 were shifted to 
38°C for 1 hour; sac1Δ cells were observed at 26oC. Scale bar = 4µm. 
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Figure 2.2. Sac1 expression, localization, and function in cells lacking Osh protein function. 
(A) Steady-state Sac1-GFP expression levels in osh1-7Δ osh4ts cells at 26°C, wild type cells at 
38°C, and osh1-7Δ osh4ts cells at 38°C. Pep12 was followed as a loading control. Cultures were 
incubated at the indicated temperature for 90 minutes. 
(B) GFP-Sac1 localizes to the ER (marked with DsRed-HDEL) in wild type and osh1-7Δ osh4ts 
cells at 38°C. Peripheral ER and nuclear ER are labeled.  Pearson correlation coefficients (PCC) 
between GFP-Sac1 and DsRed-HDEL are shown for each cell. Scale bar = 4µm. 
(C) Sac1 and the Osh proteins function in a common pathway. Cellular PI4P levels were 
measured by 3H-inositol labeling and HPLC analysis for wild type, sac1ts, osh1-osh7Δ [CEN 
osh4ts], and osh1-osh7Δ sac1Δ [CEN osh4ts sac1ts] cells. Cells were pre-shifted 38°C for 10 
minutes and prior to labeling for 1 hour at 38oC. Error bars represent SD of four independent 
experiments. 
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members of the oxysterol-binding protein homology family (Figure 2.1C). Osh2 and Osh3 
possess PH domains that bind PI4P and localize to cortical, punctate structures (Figures 2.1C, 
2.3A, 2.4; Levine and Munro, 2001; Roy and Levine, 2004). Osh1 also contains a PH domain, 
but localizes to the Golgi and nuclear-vacuolar membrane junction sites (Levine and Munro, 
2001). Osh1, Osh2, and Osh3 are similar to mammalian oxysterol-binding protein (OSBP) that 
contains a PI4P-binding PH domain (Figure 2.1C). These proteins are members of the OSBP-
related protein (ORP) family that contain sterol-binding OSBP-related domains (ORD; Figure 
2.1C). Among the ORP family, Osh4/Kes1 does not possess a PH domain, but also binds PI 
lipids (Figure 2.1C; Li et al., 2002). Osh4/Kes1 is also known to regulate PI4P levels at the Golgi 
(Fairn et al., 2007; Li et al., 2002). Given the properties of the Osh protein family to bind PI4P, 
regulate PI4P (in the case of Osh4/Kes1), and to localize to membrane contact sites, we further 
examined the role of the Osh proteins in PI4P metabolism. 
First, we measured PI4P levels in cells lacking Osh protein function. For this, we utilized 
strains that lack the OSH1-OSH7 genes and carry wild type OSH4 or a temperature sensitive 
allele, osh4-1, on a plasmid, as loss of all Osh proteins is lethal (oshΔ:CEN OSH4 or oshΔ:CEN 
osh4ts cells; Beh and Rine, 2004). In 3H-inositol labeling experiments, PI4P levels were 6 to 7-
fold higher than wild type cells in oshΔ:CEN OSH4 and oshΔ:CEN osh4ts cells at the permissive 
temperature (26oC, Figure 2.1D), suggesting that Osh proteins (other than Osh4) control PI4P 
levels in vivo. At the restrictive temperature for oshΔ:CEN osh4ts cells, PI4P levels were elevated 
18-fold above wild type levels (38oC, Figure 2.1D) and were greater than PI4P levels in sac1Δ 
mutant cells (13-fold above wild type; Figure 2.1D). Expression levels of a Sac1-GFP fusion 
were slightly reduced in oshΔ:CEN osh4ts mutant cells at 38oC (approximately three-fold; Figure 
2.2A). This did not account for the 18-fold increase in PI4P in oshΔ:CEN osh4ts cells, as 
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complete loss of Sac1 resulted in only a 13-fold increase in PI4P (sac1Δ cells; Figure 2.1D). 
Moreover, GFP-Sac1 localized to both nuclear and peripheral ER compartments in wild type and 
oshΔ:CEN osh4ts cells at 38oC (Figure 2.2B). The 18-fold increase in PI4P levels in oshΔ:CEN 
osh4ts mutant cells resembled levels previously reported for triple mutant sac1ts sjl2Δ sjl3Δ cells 
(Foti et al., 2001), suggesting that the Osh proteins may regulate multiple Sac1-like PI 
phosphatase activities. We also examined PI4P levels in cells lacking both Sac1 and Osh protein 
function to test for additive effects. PI4P levels were not further elevated in sac1ts oshΔ:CEN 
osh4ts cells compared to oshΔ:CEN osh4ts cells at 38oC (Figure 2.2C, Table 2.3) suggesting that 
Sac1 and the Osh proteins act in a common pathway. Together, these results implicate the Osh 
proteins in PI4P metabolism and Sac1 phosphatase function. 
Using the PI4P FLARE (fluorescent lipid-associated reporter) GFP-2xPHOsh2, PI4P is 
found, in wild type cells, at Golgi compartments and the PM via Pik1 and Stt4 PI 4-kinase 
activities, respectively (Figure 2.1E; Roy and Levine, 2004). In contrast, the PI4P FLARE was 
stabilized at the PM in oshΔ:CEN OSH4 and oshΔ:CEN osh4ts cells, although weak fluorescence 
at intracellular puncta was detected (Figure 2.1E). The PI4P FLARE was also increased at the 
PM in sac1Δ cells, consistent with elevated levels of Stt4-generated PI4P at the PM (Figure 
2.1E; Baird et al., 2008; Foti et al., 2001; Roy and Levine, 2004). While previous studies have 
implicated one Osh family member, Osh4/Kes, in PI4P regulation at the Golgi (Fairn et al., 
2007; Li et al., 2002), our results suggested that additional Osh proteins control PI4P metabolism 
at the PM.  
 
Osh2 and Osh3 Localize to PM/ER Contact Sites in a PI4P-Dependent Manner 
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Several lines implicated Osh2 and Osh3 in the control of PI4P metabolism at the PM. 
First, both bind PI4P and localize to cortical structures (Figures 2.1C, 2.3A, 2.4A; Levine and 
Munro, 2001; Roy and Levine, 2004; Schulz et al., 2009).  Second, expression of OSH2 or OSH3 
from a plasmid partially rescued the increased PI4P levels in oshΔ:CEN osh4ts mutant cells at 
38oC (from 18-fold above wild type to 5 and 8-fold, respectively; Table 2.3). Third, osh2Δ 
osh3Δ double mutant cells displayed elevated PI4P levels as measured by 3H-inositol labeling 
experiments (2.7-fold above wild type; Figure 2.3B, Table 2.3). Lastly, the PI4P FLARE was 
stabilized at the PM in osh2Δ osh3Δ double mutant cells (particularly in mother cells), compared 
to wild type cells (Figure 2.3B).  
We examined if Osh3 localized to PM/ER membrane contact sites in order to regulate 
PI4P at the PM. Osh3-GFP localized to cortical patches often associated with cortical ER (cER) 
compartments marked with DsRed-HDEL (Figure 2.3A, arrows), as well as the PM stained with 
filipin (Figure 2.4A). To confirm that Osh3 patches associated with cER, we examined Osh3-
GFP localization in cells lacking the reticulons Rtn1, Rtn2, and Yop1, as the cER displays 
expanded sheet-like structures in these mutant cells (Voeltz et al., 2006). Osh3-GFP patches 
clustered at cER compartments (marked with DsRed-HDEL) adjacent to the PM (stained with 
filipin) in rtn1Δ rtn2Δ yop1Δ triple mutant cells and was absent from regions lacking cER 
structures (Figure 2.4A). Together, our results suggested that Osh3 localizes to PM/ER 
membrane contact sites and modulates PM PI4P levels, possibly by regulation of cER-localized 
Sac1. 
Osh3 localization did not always coincide with cER compartments (Figure 2.3A, 
asterisk), suggesting that its assembly at PM/ER membrane contact sites may be dynamic and 
progress in regulated stages. Thus, we tested if Osh3 localization and function required PM PI4P.  
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Figure 2.3. Osh2 and Osh3 localize to PM/ER contact sites and control PM PI4P. 
(A) Osh3-GFP localization in wild type cells coexpressing the DsRed-HDEL ER marker. Arrows 
show Osh3-GFP puncta associated with cortical ER. The asterisk shows an Osh3-GFP patch not 
associated with the cortical ER. See also Figure 2.4A. 
(B) Cellular PI4P levels in wild type and osh2Δ osh3Δ mutant cells measured by 3H-inositol 
labeling and HPLC analysis (left). Error bars are the SD of three experiments. See also Table 2.3. 
GFP-2xPHOsh2 (PI4P) localization in wild type or osh2Δ osh3Δ mutant cells (right). Mother cells 
are indicated (m). 
(C) Osh3-GFP localization in wild type or stt4ts cells at 38°C. Levels were enhanced using 
Adobe Photoshop in the DIC overlay image for stt4 mutant cells (lower left). See also Figure 
2.4B. 
(D) Growth of oshΔ [CEN osh4ts] cells coexpressing OSH3 alleles. Serial dilutions of cells 
carrying empty vector or Osh3-GFP constructs were incubated at 26°C and 38°C. Osh3-GFP 
mutant constructs: AAAT, substitution of phenylalanines in the FFAT motif with alanine, DPH, 
deletion of the PH domain. See also Figure 2.4C. 
Scale bars = 4µm. 
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Figure 2.4. Osh3 localizes to PM/ER contact sites. 
(A) Osh3-GFP localization in wild type cells co-expressing the DsRed-HDEL ER marker (top). 
Arrows show Osh3-GFP puncta associated with cortical ER structures. The PM was stained with 
the sterol-binding dye filipin. Osh3-GFP and DsRed-HDEL localization in cells lacking the 
reticulons Rtn1, Rtn2, and Yop1 (bottom). Arrows indicate overlap between Osh3-GFP, DsRed-
HDEL, and the PM stained with filipin. Peripheral regions devoid of cortical ER and Osh3-GFP 
are highlighted by dashed lines. 
(B) Osh3 localization to cortical patches is independent of PI(4,5)P2 and Golgi PI4P pools. Osh3-
GFP in wild-type, pik1ts, or mss4ts cells at 38°C. Cells were shifted to 38°C for one hour prior to 
being observed. 
(C) Osh3 localization depends on its PH domain and FFAT motif. Localization of wild type 
Osh3-GFP and various Osh3-GFP mutants expressed from a plasmid in osh3∆ cells is shown. 
Scale bars = 4µm. 
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Osh3-GFP localized diffusely in the cytoplasm in cells with impaired Stt4 PI 4-kinase activity 
(stt4ts cells; Figure 2.3C), showing that Osh3 localization required PM PI4P synthesis. In 
contrast, Osh3-GFP was present at the PM in pik1ts mutant cells impaired in PI4P synthesis at the 
Golgi, although Osh3 was observed at intracellular structures in these cells (Figure 2.4B). 
Likewise, Osh3-GFP localized to cortical patches in cells with reduced PI(4,5)P2 levels (mss4ts 
cells; Figure 2.4B). A form of Osh3 lacking its PH domain (Osh3	  ΔPH-GFP) did not rescue the 
growth defects of oshΔ:CEN osh4ts mutant cells at 38oC (Figure 2.3D).  In addition, Osh3	  ΔPH-
GFP displayed increased cytoplasmic localization, compared to wild type Osh3-GFP (Figure 
2.4C).  Thus, the assembly of Osh3 at cortical patches required PM PI4P synthesis, consistent 
with its ability to bind PI4P and control PM PI4P levels.  
Next we asked if other regions in Osh3 play a role in its function. Osh3 contains an FFAT 
motif (di-phenyalanines within an acidic track; Figures 2.1C, 2.3D, 2.5A). FFAT motifs bind the 
MSP domains of the yeast ER membrane proteins Scs2 and Scs22, orthologs of the mammalian 
ER membrane VAP proteins (Figure 2.5A; Kaiser et al., 2005; Loewen et al., 2003). A form of 
Osh3 bearing substitutions in the FFAT motif (Osh3AAAT-GFP) partially rescued the growth 
defects of oshΔ:CEN osh4ts cells at 38oC (Figure 2.3D) and assembled at cortical patches (Figure 
2.4C). A previous study reported that a mutant form of Osh3 with substitutions in the FFAT 
motif was mislocalized from the cortical ER (Loewen et al., 2003). However, this study used a 
GFP-Osh3 fusion that required Scs2 overexpression to target to the cortical ER. Consistent with 
this previous study, we found that Osh3-GFP targeting to the cortical ER was impaired in scs2Δ 
scs22Δ double mutant cells (see Figure 2.6D). As expected, substitution of the FFAT motif in 
combination with deletion of the PH domain (GFP-Osh3	  ΔPH, AAAT; Figure 2.3D) resulted in 
inactivation of Osh3, as this mutant protein did not rescue the growth defect of oshΔ:CEN osh4ts  
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Figure 2.5. The VAP proteins Scs2 and Scs22 control PM PI4P metabolism. 
(A) Diagrams of mammalian VAP, yeast Scs2/Scs22, OSBP, and Osh3. VAP proteins possess a 
major sperm protein domain (MSP), a coiled-coil, and a transmembrane domain (TMD). 
(B) The GST-Osh31-613 fusion binds Scs2-3xHA from solubilized yeast lysates.  GST alone does 
not bind Scs2-3xHA. Total input and bound fractions are shown. 
(C) Cellular PI4P levels in wild type and scs2Δ scs22Δ cells measured by 3H-inositol labeling 
and HPLC analysis. Error bars show SD of three independent experiments. See also Table 2.3.  
(D) Localization of GFP-2xPHOsh2 (PI4P) in wild type and scs2Δscs22Δ cells. Mother cells are 
indicated (m). Scale bar = 4µm. See also Figure 2.6. 
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Figure 2.6. Sac1 and Osh3 expression and localization in cells lacking the VAP proteins. 
(A) Sac1-GFP localizes to the ER (marked with DsRed-HDEL) in wild type and scs2Δ scs22Δ 
cells. Peripheral ER and nuclear ER are labeled.  Pearson correlation coefficients (PCC) between 
GFP-Sac1 and DsRed-HDEL are shown for each cell. 
(B) Sac1-GFP expression levels are similar in lysates from wild type and scs2∆ scs22∆ cells as 
analyzed by immunoblotting using GFP antibodies. Pep12 is used as a loading control. 
(C) Osh3-GFP expression levels are similar in lysates from wild type and scs2∆ scs22∆ cells as 
analyzed by immunoblotting using GFP antibodies. Pep12 is used as a loading control. 
(D) Osh3-GFP localizes to cortical patches in wild type and scs2∆ scs22∆ cells. Osh3-GFP 
localization in wild type cells co-expressing the DsRed-HDEL ER marker (left). Arrows show 
Osh3-GFP puncta associated with cortical ER structures. Osh3-GFP and DsRed-HDEL 
localization in cells lacking the VAP proteins Scs2 and Scs22 (right). Osh3-GFP cortical puncta 
not localized with the cortical ER are indicated by asterisks. Peripheral regions devoid of cortical 
ER are highlighted by dashed lines. 
Scale bars = 4µm.  
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cells (Figure 2.3D). Moreover, Osh3	  ΔPH,AAAT-GFP localized diffusely in the cytoplasm, and not 
at cortical patches (Figure 2.4C). Thus, Osh3 undergoes multiple interactions involving at least 
PI4P and the Scs2/Scs22 VAP proteins to assemble and function at PM/ER membrane contact 
sites.  
 
The VAP Proteins Scs2 and Scs22 Regulate PI4P Metabolism 
We then addressed if the ER membrane VAP proteins Scs2/Scs22 control Osh3 function 
and PI4P metabolism. As FFAT motifs from OSBP and Osh proteins bind VAP proteins (Figure 
2.5A; Kaiser et al., 2005; Loewen et al., 2003), we specifically confirmed interactions for Osh3 
and Scs2. A GST-Osh3 N-terminal fragment containing the FFAT motif (GST-Osh31-613; Figure 
2.5A) bound to glutathione-sepharose beads efficiently isolated an Scs2-3xHA fusion from 
solubilized cell extracts (Figure 2.5B).  GST alone was unable to bind Scs2-3xHA (Figure 2.5B). 
We then tested if the VAP proteins Scs2/Scs22 impact PI4P metabolism. PI4P levels were 
elevated 2.9-fold above wild type in scs2Δ scs22Δ double mutant cells, as assessed by 3H-
inositol labeling (Figure 2.5C; Table 2.3). The PI4P FLARE was also stabilized at the PM in 
scs2Δ scs22Δ double mutant cells, particularly in mother cells (the PI4P FLARE was also 
weakly observed at intracellular puncta; Figure 2.5D). Thus, Osh3 and Scs2 interact and the 
VAP proteins Scs2/Scs22 control PI4P levels at the PM. 
We performed additional tests to address how the VAP proteins Scs2/Scs22 might control 
PI4P metabolism. Sac1-GFP localized to nuclear and cortical ER membrane compartments in 
scs2Δ scs22Δ double mutant cells (Figure 2.6A). Steady-state expression of Sac1-GFP and 
Osh3-GFP were unaffected in scs2Δ scs22Δ mutant cells, compared to wild type cells (Figures 
2.6B, 2.6C). Thus while Sac1, Osh3, and the VAP proteins Scs2/Scs22 act in common to control 
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PI4P metabolism, the VAP proteins are not required for Sac1 or Osh3 stability. Similar to the 
cortical localization of Osh3AAAT-GFP (Figure 2.4C), Osh3-GFP localized to cortical structures 
in scs2Δ scs22Δ mutant cells (Figure 2.6D). However, Osh3-GFP cortical patches did not appear 
to be associated with the peripheral ER in scs2Δ scs22Δ mutant cells (Figure 2.6D), consistent 
with a previous study (Loewen et al., 2003). These findings suggest that PI4P metabolism at 
PM/ER junctions may occur in regulated stages. Osh3 may initially assemble at the PM, possibly 
as a PI4P sensor via its PH domain. Subsequent interactions between Osh3 and the VAP proteins 
may lead to stimulation of Sac1 PI phosphatase activity at PM/ER junctions. 
 
The Osh and VAP Proteins Control Sac1 Phosphatase Activity 
To test if the VAP and Osh proteins regulate Sac1 activity, we set up an in vitro 
phosphatase assay using PI4P-containing liposomes (PC:PS:PI4P) and microsomes containing 
integral Sac1-GFP prepared from cellular membranes (Figures 2.7A, 2.8A).  PI4P phosphatase 
activity was readily detected with wild type microsomes (145 pmol/mg total protein/min, at 10 
min, Figure 2.7A) and was specifically due to Sac1-GFP, as microsomes prepared from sac1Δ 
cells lacked activity (Figure 2.7A). We also did not detect significant phosphatase activity using 
Sac1-GFP microsomal preps against liposomes lacking PI4P (PC:PS:PtdIns liposomes; Figure 
2.8B). Thus, this in vitro assay followed microsome-embedded Sac1 activity against PI4P 
presented on liposomes, rather than PI species that might be present in the microsomes.   
To confirm that liposomes did not fuse with Sac1-GFP microsomes or that PI4P did not 
transfer from liposomes to microsomes, we incubated Sac1-GFP microsomes with liposomes 
containing 3H-labeled PI4P and PI(4,5)P2 (Figure 2.8C). Following a 30-minute incubation at 
37oC (the course of the phosphatase assays; Figures 2.7A, 2.8B), Sac1-GFP microsomes were  
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Figure 2.7. The VAP proteins Scs2/Scs22 control Sac1 PI phosphatase activity in vitro. 
(A) PI4P-containing liposomes were incubated with wild-type (circles), scs2∆ scs22∆ (squares), 
or sac1∆ (triangles) microsomes for the indicated times. Phosphate release was measured by a 
malachite green assay. Error bars show the SD of two experiments measured in duplicate. See 
also Figure 2.8. 
(B) Short acyl chain diC8 PI4P was incubated with wild-type (circles), scs2∆ scs22∆ (squares), 
or sac1∆ (triangles) microsomes for the indicated times. Error bars show the SD of two 
experiments measured in duplicate. 
(C) Short acyl chain diC8 PI4P was incubated with untreated (circles), NaCl-washed (triangles), 
or NaCl-washed microsomes in the presence of GST-Osh3588-996 (diamonds) for the indicated 
times. Error bars show the SD of two experiments measured in duplicate. See also Figure 2.10A. 
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Figure 2.8. The Osh3 ORD domain does not stimulate PI4P extraction or transfer in vitro. 
(A) Sac1-GFP levels in P13 microsomes isolated from wild type, osh1-osh7∆ [CEN osh4ts],  
scs2∆ scs22∆, and sac1∆ cells. Samples were incubated at 37˚C for 30 minutes (phosphatase 
reaction conditions) prior to immunoblotting. The ER membrane protein Dpm1 is used as a 
loading control. 
(B) Liposomes containing PI4P (PC:PS:PI4P, circles) or liposomes without PI4P (PC:PS:PtdIns, 
diamonds) were incubated with P13 membrane fraction microsomes from wild type cells. 
Phosphate release was measure by a malachite green assay (Maehama et al., 2000). Liposomes 
lacking PI4P (PC:PS:PtdIns) show background phosphatase activity (diamonds). Error bars show 
SD of two independent experiments each performed in duplicate. 
(C) Schematic diagram of the Sac1-GFP microsome/liposome fusion and lipid transfer control 
assay. Liposomes containing 3H-PI4P and 3H-PI(4,5)P2 (PC:PS:3H-PIP liposome) were 
incubated with P13 membrane fraction microsomes from wild type cells. Samples were 
incubated at 37˚C for 30 minutes (phosphatase reaction conditions) prior to immuno-isolation of 
Sac1-GFP microsomes using GFP antibodies and protein A-coupled magnetic Dynabeads. 
(D) Examination of Sac1-GFP microsome immuno-isolation. Fractions shown are the total input, 
the fraction bound to magnetic Dynabeads, and the unbound fraction depleted of Sac1-GFP 
microsomes. 
(E) Measurements of 3H-PI4P and 3H-PI(4,5)P2 present in isolated Sac1-GFP microsome 
fractions and the fractions unbound to Dynabeads by scintillation counting. Sac1-GFP 
microsomes were incubated with PC:PS:3H-PIP liposomes either in the absence (grey bars) or 
presence of 0.2 mM GST-Osh3588-996 (black bars). 
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(F) Measurements of 3H-PI4P and 3H-PI(4,5)P2 from the ubound fraction present in liposome 
pellet (P100), and supernatant fractions (S100) by liquid scintillation counting. Sac1-GFP 
microsomes were incubated with PC:PS:3H-PIP liposomes either in the absence (grey bars) or 
presence of 0.2 mM GST-Osh3588-996 (black bars). 
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immuno-isolated using anti-GFP antibodies and protein A-coupled magnetic Dynabeads (Figure 
2.8D). Unbound liposomes (and microsomes not containing Sac1-GFP) were subsequently 
sedimented by high-speed centrifugation. The amount of 3H-PI species in isolated Sac1-GFP 
microsomes, sedimented liposomes, and the resulting supernatant fraction was determined by 
liquid scintillation counting. Only a minor portion, 3.1±0.9% of the total 3H-PI, associated with 
isolated Sac1-GFP microsomes (Figure 2.8E, bound fraction). The bulk of 3H-PI, 93.1±6.2%, 
remained in the unbound fraction (Figure 2.8E). 88.5±1.3% of 3H-PI in the unbound fraction 
sedimented upon high-speed centrifugation (Figure 2.8F, P100 fraction), indicating that the 
majority of 3H-PI in the unbound fraction remained in a membrane bilayer. A small amount of 
the unbound fraction, 11.5±1.2%, was found in the supernatant fraction, perhaps due to micelles 
that did not sediment (Figure 2.8F, S100 fraction). Thus, liposomes did not fuse with Sac1-GFP 
microsomes and 3H-PI species were not efficiently transferred from liposomes to Sac1-GFP 
microsomes, under conditions that resulted in efficient dephosphorylation of PI4P in liposomes 
(Figures 2.7A, 2.8B). We also performed experiments in the presence of recombinant Osh3 
(GST-Osh3588-996 including the FFAT and ORD domain, see Figure 2.9A).  However, the 
distribution of 3H-PI species was not significantly affected by the addition of GST-Osh3588-996 
(Figures 2.8E and 2.8F). Similarly, purified his6-Osh4 (see Figure 2.9A) did not significantly 
alter the distribution of 3H-PI species in analogous experiments (our unpublished results). Thus, 
Osh3 and Osh4 did not enhance membrane fusion or 3H-PI transfer between liposomes and Sac1-
GFP microsomes.  
Following these control experiments, we addressed whether the VAP proteins controlled 
Sac1 PI phosphatase activity. Microsomes lacking Scs2 and Scs22 were impaired in the initial 
rate of PI4P turnover (more than two-fold: 66 pmol/mg total protein/min, at 10 min; as compared 
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to wild type, Figure 2.7A). In addition, scs2Δ scs22Δ microsomes were impaired in maximal 
Sac1 phosphatase activity as compared to wild type microsomes (1232±159 pmol PO4 released 
versus 2543±274 pmol, respectively; Figure 2.7A). Levels of Sac1-GFP and the ER protein 
Dpm1 were similar in both wild type and scs2Δ scs22Δ microsomal preparations (Figure 2.8A).  
Thus, while Sac1-GFP levels were similar, Sac1 activity was impaired in scs2Δ scs22Δ 
microsomes. Importantly, these experiments provide the first in vitro demonstration of Sac1 
activity in trans and indicate that the yeast VAP proteins promote this activity. 
Wild type and scs2Δ scs22Δ microsomes demonstrated similar activity against a soluble 
substrate, short acyl chain diC8 PI4P (in the absence of other lipids; Figure 2.7B), indicating that 
both microsomal preps contained similar intrinsic Sac1 activity. As in the PI4P liposome assay, 
microsomes isolated from sac1Δ cells did not display activity against diC8 PI4P (Figure 2.7B). 
Notably, both wild type and scs2Δ scs22Δ microsomes displayed increased activity for the 
soluble diC8 PI4P substrate (approximately 1500 pmol PO4 released/mg total protein/min, after 1 
minute; Figure 2.7B).  At later time points both preps continued to display similar turnover rates, 
although slower likely due to reduced substrate concentrations. Thus, the VAP proteins 
Scs2/Scs22 may act to link Sac1 to substrates on opposing membranes, possibly through the 
FFAT-containing Osh proteins, Osh2 and Osh3. 
We then tested if the Osh proteins stimulate Sac1 activity in vitro. As Sac1 levels were 
reduced in oshΔ:CEN osh4ts cell lysates (Figures 2.2B, 2.8A), we did not use microsomes 
prepared from these mutant cells. However, we found that Osh3 was depleted from membrane 
fractions by incubation in high salt (our unpublished results). Sac1-GFP microsomes were then 
subjected to a high salt wash to deplete peripherally associated membrane proteins, such as 
Osh3. Sac1-containing microsomes were not active against PI4P-containing liposomes following  
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Figure 2.9. The ORD domains stimulate Sac1 activity in vitro. 
(A) Schematic of the reconstituted Sac1 phosphatase assay. PI4P-containing liposomes were 
incubated with his6-Sac11-522, GST-Osh3588-996 or his6-Osh4. Phosphate release was measured by 
a malachite green assay. The Coomassie-stained gel shows the recombinant proteins used in the 
in vitro assays. The dot indicates a GST-Osh3588-996 degradation product. 
(B) GST-Osh3588-996 stimulates Sac1 in vitro. Results from in vitro phosphatase assays including 
0.33 mM his6-Sac11-522 (squares), 0.1 mM his6-Sac11-522 (diamonds), 1 mM GST-Osh3588-996 and 
0.1 mM Sac11-522 (circles), and background levels in the presence of 1 mM GST-Osh3588-996 
alone (triangles). Error bars show SD of two experiments measured in duplicate. See also Figure 
2.10B. 
(C) Osh4 stimulates Sac1 in vitro. Results from in vitro phosphatase assays with 0.33 mM his6-
Sac11-522 (squares), 0.03 mM his6-Sac11-522 (diamonds), 0.03 mM his6-Sac11-522 and 12 mM his6-
Osh4 (circles), and 12 mM his6-Osh4 alone (triangles). Error bars show SD of two experiments 
measured in duplicate. 
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Figure 2.10. The ORD domain stimulates Sac1 activity in vitro. 
(A) The Osh3 ORD domain activates Sac1 independently of the VAP proteins. Short acyl chain 
diC8 PI4P (60 mM) was incubated with untreated scs2∆ scs22∆ microsomes (squares), NaCl-
washed scs2∆ scs22∆ microsomes (triangles), or NaCl-washed scs2∆ scs22∆ microsomes in the 
presence of 0.2 mM GST-Osh3588-996 (diamonds) for the indicated times. Phosphate release was 
measured by the malachite green assay. Error bars show the SD of two experiments measured in 
duplicate. 
(B) Scheme for the reconstituted Sac1 phosphatase assay. PI4P-containing liposomes were 
incubated with his6-Sac11-522, his6-Sac1C392S,C395S, GST-Osh3588-996 or GST. Phosphate release 
was measured by a malachite green assay.  
(C) The Coomassie-stained gel shows purified, recombinant his6-Sac11-522 and catalytically 
inactive his6-Sac11-522, C392S, C395 proteins. 
(D) GST does not stimulate his6-Sac11-522 activity in vitro and GST-Osh3588-996 does not activate 
his6-Sac1C392S, C395S. The results of control in vitro phosphatase assay experiments are shown: 0.1 
mM inactive his6-Sac1C392S,C395S  (triangles), 0.1 mM inactive his6-Sac1C392S, C395S and 1 mM 
GST-Osh3588-996 (diamonds), 0.1 mM his6-Sac11-522 (squares), and 0.1 mM his6-Sac11-522  and 1 
mM GST (circles). 
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the high salt wash. Thus, we were not able to test whether recombinant Osh3 stimulated Sac1 in 
trans activity (our unpublished results). However, NaCl-washed microsomes displayed a reduced 
rate of diC8 PI4P turnover (more than two-fold: 600±115 pmol/mg total protein/min, after 1 min, 
as compared to untreated microsomes at 1600±206 pmol/mg total protein/min, after 1 min, 
Figure 2.7C) and maximal Sac1 phosphatase activity compared to untreated microsomes 
(1746±213 pmol PO4 released versus 2789±211 pmol, respectively after 30 min; Figure 2.7C). 
To test if impaired Sac1 activity in NaCl-washed microsomes was due to the loss of Osh 
proteins, purified GST-Osh3588-996 (see Figure 2.9B) was added back to the reaction. Strikingly, 
0.2 mM GST-Osh3588-996 restored activity in salt-washed microsomes to levels nearly identical to 
untreated Sac1-GFP microsomes (1450±155 pmol/mg total protein/min after 1 min, and 
3000±176 pmol PO4 released after 30 min, Figure 2.7C). Thus, recombinant Osh3 stimulated 
full-length Sac1 in microsomes, providing the first evidence that ORP proteins control Sac1 PI 
phosphatase activity in vitro. 
 To test if GST-Osh3588-996 required the VAP proteins to stimulate Sac1, Sac1-GFP 
microsomes prepared from scs2Δ scs22Δ mutant cells were washed with high salt to deplete 
peripheral membrane proteins. As expected, NaCl-washed scs2Δ scs22Δ microsomes displayed 
impaired rates of diC8 PI4P turnover, compared to untreated scs2Δ scs22Δ microsomes (more 
than two-fold: 577±151 pmol/mg total protein/min, after 1 min, as compared to untreated scs2Δ 
scs22Δ microsomes at 1315±186 pmol/mg total protein/min, after 1 min, Figure 2.10A). Salt-
washed scs2Δ scs22Δ microsomes also displayed reduced maximal Sac1 phosphatase activity, 
compared to untreated scs2Δ scs22Δ microsomes (1364±223 pmol PO4 released versus 
2652±206 pmol, respectively after 30 min; Figure 2.10A). Interestingly, 0.2 mM GST-Osh3588-
996 restored full activity in salt-washed scs2Δ scs22Δ microsomes (1489±145 pmol/mg total 
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protein/min after 1 min, and 2994±176 pmol PO4 released after 30 min, Figure 2.10A). Thus, the 
Osh3 ORD domain stimulated Sac1 activity against diC8 PI4P independently of the VAP 
proteins Scs2 and Scs22. 
 
Reconstitution of Sac1 Phosphatase Activation by ORD Domains 
Since the Osh3 ORD domain stimulated Sac1 activity in microsomes, we tested whether 
Osh proteins directly stimulate Sac1. We reconstituted Sac1 phosphatase activity in vitro using 
purified components at known concentrations. Sac1 lacking its transmembrane domains was 
expressed and purified from bacteria (his6-Sac11-522) and incubated with PI4P-containing 
liposomes (Figure 2.9A). Purified his6-Sac11-522 dephosphorylated PI4P in a dose and time-
dependent manner (400 pmol/min/mg protein for 0.33 mM his6-Sac11-522 after 5 minutes; Figure 
2.9B). At 0.1 mM his6-Sac11-522, the turnover rate was reduced to approximately 250 pmol PO4 
released/min/mg protein after 5 minutes (Figures 2.9B, 2.10D). A mutant form of Sac1 bearing 
substitutions in both cysteine residues in the CX5R active site (his6-Sac1C392S, C395S, Figure 
2.10C) did not display phosphatase activity against PI4P-containing liposomes (Figure 2.10D).  
Importantly, addition of the Osh3 ORD domain (GST-Osh3588-996; Figure 2.9B) stimulated Sac1 
phosphatase activity three-fold against PI4P-containing liposomes, as 0.1 mM his6-Sac11-522 in 
the presence of 1 mM GST-Osh3600-996 displayed a turnover rate similar to 0.33 mM his6-Sac11-
522 (Figure 2.9B).  As a control, 1 mM GST alone did not increase Sac1 activity (Figure 2.10D). 
GST-Osh3588-996 did not catalyze PI4P turnover in the absence of his6-Sac11-522 (Figure 2.9B) or 
in the presence of inactive his6-Sac1C392S, C395S (Figure 2.10D).  
As the ORD domain is common to all ORP proteins, we addressed if Sac1 activation is a 
conserved function for the Osh proteins. We then tested if full-length Osh4/Kes1 stimulated Sac1  
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Figure 2.11. PI binding regulates Osh4 function. 
(A) The structure of Osh4/Kes1 (Im et al., 2005) is shown with mutants used in this study. 
Osh4∆1-29 (orange) and Osh4L111D (green) are defective in sterol binding (Im et al., 2005). Osh43E 
(R236E, R242E, R243E; blue) is impaired in PI binding  (see Figures 2.12A and B; Li et al., 
2002). Cholesterol bound within the structure is shown in yellow. 
(B) Coomassie-stained gel showing recombinant, purified his6-Sac11-522 and wild type and 
mutant his6-Osh4 proteins.  
(C) In vitro phosphatase assays using 0.1 mM his6-Sac11-522 and wild type and mutant Osh43E 
proteins (1.2 mM). PI4P liposomes (PC:PS:PI, 3:1:1) were tested. Error bars show the SD of two 
experiments each measured in duplicate. 
(D) In vitro phosphatase assays using 0.1 mM his6-Sac11-522 and wild type and mutant Osh43E 
proteins (1.2 mM) against short acyl chain diC8 PI4P. Error bars show the SD of two 
experiments each measured in duplicate. See also Figure 2.12C. 
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Figure 2.12. The ORD domains of Osh3 and Osh4 bind phosphoinositides. 
(A) The Osh3 and Osh4 ORD domains bind PI4P in liposome sedimentation assays.  PI4P-
containing liposomes (PC:PS:PI4P, 3:1:1, 1 mM total lipid) or PtdIns-containing liposomes 
(PC:PS:PI, 3:1:1, 1 mM total lipid) were incubated with recombinant his6-Osh4 or GST-Osh3588-
996 proteins. Liposomes and bound proteins were sedimented by centrifugation at 100,000 x g 
and proteins were detected in Coomassie-stained SDS-PAGE gels. 
(B) his6-Osh4 binds phosphoinositides. PI lipid overlay binding assays (FAT blots) using his6-
Osh4 and the PI binding mutant his6-Osh43E. Bound proteins were detected with antibodies 
against the T7 tag in the fusion proteins. 
(C) Osh4 stimulates Sac11-522 activity in vitro: 0.1 mM his6-Sac11-522 in vitro phosphatase activity 
against increasing concentrations of diC8 PI4P (circles), activity in the presence of 0.1 mM his6-
Sac11-522 and 1.2 mM his6-Osh4 (squares). Osh4 stimulates Sac11-522 activity in vitro 
independently of cholesterol: activity in the presence of 0.1 mM his6-Sac11-522,1.2 mM his6-
Osh4, and 250 mM cholesterol (triangles). Errors bars show the SD of two independent 
experiments measured in duplicate. 
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phosphatase activity in vitro. In these assays, we lowered the his6-Sac11-522 concentration (to 
0.033 mM with activity near background levels; Figure 2.9C). In the presence of 12 mM his6-
Osh4, 0.033 mM his6-Sac11-522 activity increased ten-fold over the course of the experiment, 
reaching that of 0.33 mM his6-Sac11-522 (Figure 2.9C). In addition, at high concentrations (300 
mM) of short acyl chain diC8 PI4P, 1.2 mM his6-Osh4 stimulated 0.1 mM his6-Sac11-522 activity 
greater than six-fold (Figures 2.11D, 2.12C). Thus, the ORD domains from Osh3 and Osh4 
directly activated Sac1 in vitro. 
 
PI and Sterol Binding Control Osh4 Function 
Osh4/Kes1 binds PI lipids in vitro (Li et al., 2002). Consistent with this, his6-Osh4 
sedimented more efficiently with PI4P-containing liposomes, compared to PtdIns-containing 
liposomes (Figure 2.12A). GST-Osh3588-996 also sedimented more readily with PI4P-containing 
liposomes than it did with PtdIns-containing liposomes (Figure 2.12A). We tested if PI binding 
was necessary for Osh4 function in vitro and in vivo. Substitution of three basic residues (R236E, 
K242E, K243E; termed 3E, Figure 2.11A) impairs Osh4 PI binding (Li et al., 2002). The mutant 
his6-Osh43E protein was stably expressed and purified (Figure 2.11B). We confirmed that his6-
Osh43E was defective in PI binding using an overlay assay (Figure 2.12B). In contrast, wild type 
his6-Osh4 bound PI3P, PI4P, and PI(4,5)P2 (in order of binding affinity; Figure 2.12B). Notably, 
his6-Osh43E did not stimulate Sac1 activity against PI4P in liposomes (Figure 2.11C). In 
addition, his6-Osh43E was impaired in Sac1 activation against short acyl chain diC8 PI4P, as 
compared to wild type his6-Osh4  (two-fold vs. six-fold stimulation respectively, Figure 2.11D). 
Consistent with these in vitro results, cellular PI4P levels were 17-fold above wild type in 
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oshΔ:CEN osh4ts cells co-expressing Osh43E at 38oC (Table 2.3), indicating that PI binding is 
essential for Osh4 function. 
As the Osh proteins bind sterol lipids in vitro (Im et al., 2005; Raychaudhuri et al., 2006), 
we tested if sterol lipids regulate Osh-stimulated Sac1 activity. Addition of 250 mM cholesterol 
(>800-fold above the Kd of Osh4 for cholesterol; Im et al., 2005) did not significantly affect Osh4-
stimulated Sac1 activity against diC8 PI4P (Figure 2.12C). We also measured in vivo PI levels in 
oshΔ:CEN osh4ts cells expressing wild type OSH4 or the sterol-binding defective mutants, osh4Δ 
1-29 or osh4L111D (see Figure 2.11A; Im et al., 2005). In oshΔ:CEN osh4ts cells co-expressing 
either Osh4	  Δ1-29 or Osh4L111D, PI4P levels were 21- and 19-fold above wild type levels (Table 2.3). 
Thus, while cholesterol did not alter Sac1 activity in vitro, sterol binding was essential for Osh4-
mediated PI4P metabolism in vivo.  
 
The Osh Proteins Interact with the Sac1 Catalytic Domain 
As the Osh3 and Osh4 ORD domains activated Sac1 in vitro, we examined if Osh 
proteins interact with Sac1. We initially used Osh7 for these experiments as it is expressed at 
higher levels than Osh3 (2350 Osh7 molecules/cell vs. 600 Osh3 molecules/cell; 
Ghaemmaghami et al., 2003). Osh7 localizes to the cortical ER even though it lacks a PH 
domain and FFAT motif (Schulz et al., 2009; Figure 2.1C). A membrane pellet fraction 
containing Osh7-3xHA and Sac1-13xmyc was incubated with crosslinkers, solubilized, and 
processed for co-immunoprecipiation against the 3xHA tag on Osh7. A small fraction of Sac1-
13xmyc specifically isolated with Osh7-3xHA (Figure 2.13A), suggesting that this interaction 
was transient or possibly indirect since it required crosslinking. However, Sac1 is far more 
abundant in cells than Osh7 (48, 000 Sac1 molecules/cell; Ghaemmaghami et al., 2003); thus  
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Figure 2.13. The ORD domain interacts with Sac1 and model for regulation of PI4P 
metabolism by Osh3, Scs2/Scs22, and Sac1 at PM/ER Membrane Contact Sites. 
(A) Sac1-13xmyc specifically interacts with Osh7-3xHA. Membrane fractions from cells 
expressing Osh7-3xHA and Sac1-13xmyc or Sec61-13xmyc were incubated with crosslinkers, 
solubilized, immunoprecipitated with anti-HA beads and analyzed by immunoblotting to detect 
Osh7-Sac1 complexes. See also Figure 2.14A. 
(B) GST-Osh3588-996 induces a conformational shift in the Sac1 catalytic domain. Emission scans 
of 0.06 mM Sac1C341NBD in buffer (red), in the presence of liposomes (PC:PS:PI4P, 3:1:1, 0.1 
mM lipid total; dark grey), liposomes and 0.8 mM GST-Osh3588-996 (blue), liposomes with 0.8 
mM GST-PHFAPP1 (green), and buffer alone (light grey). See also Figure 2.14. 
(C) Model for PI4P turnover at PM/ER membrane contact sites. High PM PI4P levels recruit and 
activate Osh3 at ER/PM contact sites. Interactions between Osh3 and the VAP proteins 
Scs2/Sc22 activate ER-localized Sac1.  
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Figure 2.14. Osh3 and Osh4 interact with Sac1. 
(A) Sac1-13xmyc interacts with 3xHA-Osh3. P13 membrane fractions from cells expressing 
3xHA-Osh3 and Sac1-13xmyc or Sac1-13xmyc alone were incubated with crosslinkers, 
solubilized, immunoprecipitated with anti-HA beads and analyzed by SDS-PAGE and western 
analysis to detect Osh3-Sac1 complexes.  
(B) The structure of the Sac1 domain (Manford et al., 2010) is shown. The purified his6-
Sac1C392,C395S protein was labeled with NBD at the only remaining cysteine residue, C341 
(orange), residing in L4 of the loops (L1-L4, green) that surround the catalytic cysteine residues 
(C392 and C395, red). 
(C) PI binding is required for the Osh-induced conformational shift in the Sac1 catalytic domain. 
Emission scans of 0.06 mM Sac1C341NBD in buffer (red), in the presence of liposomes 
(PC:PS:PI4P, 3:1:1, 0.1 mM lipid total; dark grey), liposomes and 0.4 mM his6-Osh4 (blue), and 
liposomes with 0.4 mM PI binding-defective mutant his6-Osh43E (green). The control emission 
scans of liposomes in buffer and buffer alone are shown in grey and light grey, respectively. 
(D) Osh4 increases membrane association of the Sac1 domain.  PI4P-containing liposomes 
(PC:PS:PI4P, 3:1:1, 0.1 mM total lipid) were incubated with 0.4 mM his6-Osh4 and 0.06 mM 
his6-Sac1C392S,C395S proteins. Liposomes and bound proteins were sedimented by centrifugation at 
100,000 x g and proteins were detected by immunoblotting against the T7 tag in the fusion 
proteins. Quantification of his6-Sac1C341NBD for each fraction is shown underneath. 
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only a small fraction of Sac1 is expected to co-isolate with Osh7. Importantly, Osh7-3xHA did 
not crosslink to another abundant ER membrane protein, Sec61-13xmyc (Figure 2.13A). We also 
observed cross-linking between 3xHA-Osh3 and Sac1-13xmyc (Figure 2.14A). As a control, the 
ER transmembrane protein Wbp1 was not isolated with 3xHA-Osh3 (our unpublished 
observations). Together, these results suggested that multiple Osh proteins interact with Sac1 and 
that the ORD domain is responsible. 
Next, we tested if the ORD and Sac1 domains physically interact in vitro. We were 
unable to detect a stable complex between the purified Sac1 domain and Osh3 or Osh4 ORD 
domains in solution (our unpublished results). For this reason, we developed assays to monitor 
Sac1 and ORD domain interactions on a membrane bilayer. The Sac11-522 domain contains three 
cysteine residues: C392 and C395 in the catalytic site and C341 in loop 4 (L4) that resides on the 
same surface as the catalytic site (Figure 2.14B; Manford et al., 2010). Purified his6-Sac1C392S, 
C395S was covalently labeled with the fluorescent dye NBD at C341 (Sac1C341NBD, Figure 2.14B). 
Movement of NBD from an aqueous environment to a more hydrophobic environment is 
accompanied by changes in its spectral properties (e.g. emission wavelength maximum, termed 
“blue shift”, and intensity) and thus can be used as an indicator for conformational changes in a 
protein as well as membrane association. Sac1C341NBD underwent a significant increase in NBD 
fluorescence signal (6.6-fold) and a shift in the maximum emission wavelength (blue shift) upon 
addition of liposomes (Figure 2.13B), reflecting a membrane-induced change in the local 
environment of L4 in the Sac1 catalytic domain. Interestingly, addition of GST-Osh3588-996 
reduced Sac1C341NBD signal intensity in the presence of liposomes (1.7-fold), consistent with an 
Osh3-induced shift in L4 of Sac1 to a less hydrophobic environment (Figure 2.13B). As a 
control, GST fused to the PI4P-binding PH domain from FAPP1 did not alter the Sac1C341NBD 
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fluorescence signal in the presence of liposomes (Figure 2.13B). Thus, the Osh3 ORD domain-
induced reduction in Sac1C341NBD signal intensity was not simply due to competition for PI4P 
binding. 
To address whether these effects were conferred by another ORD domain, we incubated 
Sac1C341NBD with liposomes either in the absence or presence of his6-Osh4. Addition of his6-
Osh4 reduced Sac1C341NBD signal intensity in the presence of liposomes (1.7-fold, Figure 2.14C), 
similar to GST-Osh3588-996. Interestingly, the Osh43E mutant protein that is defective in PI 
binding and Sac1 stimulation did not affect Sac1C341NBD fluorescence intensity in the presence of 
liposomes (Figure 2.14C). As a change in NBD fluorescence can be due to effects in membrane 
association as well as protein conformational states, we examined the membrane binding status 
of Sac1C341NBD in the absence and presence of Osh4. Surprisingly, the ability of his6-Sac1C341NBD 
to sediment with liposomes was increased in the presence of his6-Osh4 (> two-fold; Figure 
2.14D). Thus, the reduction in Sac1C341NBD fluorescence intensity by Osh4 was not due to 
decreased Sac1 domain membrane binding. Accordingly, the Osh-induced shift in Sac1C341NBD 
fluorescence intensity may reflect an Osh-induced conformational change in the Sac1 catalytic 
domain, consistent with Osh-stimulated Sac1 phosphatase activity in vitro. Moreover, an Osh-
induced increase in membrane association may contribute to Sac1 activation.  
 
Discussion 
Sac1-like phosphatases are essential regulators of PI signaling networks. We show that 
the oxysterol binding homology (Osh) proteins control Sac1 activity. Members of the ORP 
family are known to bind sterol and PI lipids and are implicated in disease (Ngo et al., 2010). We 
demonstrate a new role for this family: control of PI4P metabolism through Sac1 PI 
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phosphatases. Our results also explain how ER-localized Sac1 can regulate PM PI4P levels in 
trans: via the function of Osh proteins at PM/ER membrane contact sites as sensors of PI4P at 
the PM and activators of the Sac1 phosphatase in the ER. 
 
PM PI4P Metabolism Occurs at PM/ER Membrane Contact Sites 
 Recent studies have proposed that Sac1 regulates PI4P in cis at the ER and Golgi, as well 
as in trans at the PM from the ER (Baird et al., 2008; Manford et al., 2010). In accord, Sac1 has 
been shown to regulate PI4P levels at the ER and Golgi (Faulhammer et al., 2007; Foti et al., 
2001). Our findings and additional evidence indicate that ER-localized Sac1 controls PM PI4P 
pools. First, PI4P accumulates at the PM in cells lacking Sac1 (Figure 2.1E; Roy and Levine, 
2004).  Second, Sac1 does not traffic to the PM and was not stabilized at the PM in an 
endocytosis mutant (Tahirovic et al., 2005). Likewise, cells expressing a form of Sac1 that is 
retained in the ER do not display elevated PI4P levels (Konrad et al., 2002). Last, we 
demonstrate that full-length Sac1 in microsomes dephosphorylates PI4P in trans on distinct 
liposomes (Figure 2.7). 
We propose that the Osh and VAP proteins function as regulators of Sac1 activity at 
membrane contact sites. Notably, Osh3 localization to PM/ER membrane sites was dependent on 
PI4P synthesis (Figure 2.3C) and a mutant form lacking the PH domain was destabilized from 
cortical patches (Figure 2.4C). We suggest that the PH domain-containing protein Osh3 acts as a 
sensor of PI4P levels at the PM and subsequently activates the Sac1 PI phosphatase at the ER 
(Figure 2.13C). Our study also highlights a role for Scs2 and Scs22 in PI4P metabolism. Cells 
lacking Scs2 and Scs22 display elevated PM PI4P levels (Figure 2.5). Moreover, Scs2 and Scs22 
stimulate Sac1 activity against PI4P in liposomes (Figure 2.7A). Scs2 and Scs22 may activate 
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Osh3 at PM/ER membrane contact sites to control PM PI4P levels (Figure 2.13C). The yeast 
VAP proteins may also aid in the formation of membrane junctions. Scs2 and Scs22 have been 
implicated in PM/ER membrane contact site formation (Loewen et al., 2007). In addition, Scs2 
binds anionic phospholipids, including PI4P, in vitro (Kagiwada and Hashimoto, 2007). 
 
Mechanisms for Regulation of Sac1 Activity by the Osh Proteins 
Multiple inputs control Osh protein function. We propose that PI4P binding to the Osh3 
PH domain and Scs2 interactions via the FFAT motif activate Osh3 at PM/ER membrane contact 
sites (Figure 2.13C). These interactions may then facilitate interactions between the Osh3 ORD 
domain and downstream target proteins such as Sac1 (Figure 2.13C). Thus, Osh3 may serve as a 
‘co-incidence detector’ of PI4P, the VAP proteins, and Sac1. We also found that PI and sterol 
binding control Osh4/Kes1 function (Figure 2.11, Table 2.3). The Osh proteins control sterol 
localization in vivo (Beh and Rine, 2004) and transfer sterol lipids in vitro (Raychaudhuri et al., 
2006). Osh4/Kes1 function required sterol binding in vivo (Table 2.3), but was not affected by 
the addition of cholesterol in vitro (Figure 2.12C). The concentrations of Osh4 or PI4P in our in 
vitro studies may have bypassed a requirement for sterol binding. In vivo, the ability of the Osh 
proteins to extract sterol lipids may control membrane bilayer rigidity and curvature, and thus 
formation of membrane contact sites (Figure 2.13C). Notably, the Osh proteins can tether 
liposomes in vitro (Schulz et al., 2009). Alternatively, sterol binding may control Osh protein 
localization in vivo. Consistent with this idea, OSBP localizes to the ER when bound to 
cholesterol and to the Golgi when bound to 25-hydroxycholesterol (Peretti et al., 2008).  
Osh4/Kes1 also binds PI lipids in vitro (Figure 2.12; Li et al., 2002). This may be a 
general feature of ORD domains, as Osh3 showed increased affinity for PI4P liposomes (Figure 
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2.12). A form of Osh4 impaired in PI binding (Figure 2.12) did not stimulate Sac1 activity in 
vitro (Figure 2.11). While our results did not indicate that Osh3 transfers PI lipids (Figure 2.8), 
the Osh proteins may bind PI lipids and present substrates to Sac1 at the membrane interface. 
Alternatively, PI binding may be necessary for productive interactions with Sac1.  This idea is 
supported by our findings that Osh3 and Osh4 induced changes in Sac1C341NBD spectral 
properties in the presence of liposomes, but PI binding-defective Osh43E was incapable of 
interacting with Sac1 (Figures 2.13, 2.14). The Osh-induced effects on Sac1C341NBD signal 
intensity may reflect a conformational change in Sac1 or a shift in the orientation of Sac1 with 
respect to the membrane bilayer. In addition PI binding may be necessary for Osh-stimulated 
Sac1 membrane association (Figure 2.14D). 
 
Conserved Functions for the Osh/ORP and VAP Proteins in PI Metabolism  
ORP and VAP proteins may share conserved roles in PI homeostasis. Each of the Osh 
proteins partially rescues the PI4P metabolism defects in oshΔ:CEN osh4ts cells (our unpublished 
observations). Both Osh3 and Osh4 stimulate Sac1 PI phosphatase activity in vitro (Figures 2.7, 
2.9, 2.11). Osh6 and Osh7 localize to the peripheral ER (Schulz et al., 2009), and Osh7 interacts 
with Sac1 in crosslinking experiments (Figure 2.13A). Osh1 localizes to nuclear-vacuole 
junctions to participate in lipid metabolism (Levine and Munro, 2001). Osh4 regulates PI4P at 
the Golgi (Fairn et al., 2007; Li et al., 2002) where it may regulate Sac1 activity. Likewise, 
mammalian ORP and VAP proteins have been implicated at membrane contact sites. A recent 
study found ORP1L and VAP at ER/endosome membrane contact sites (Rocha et al., 2009). 
Mammalian VAP proteins control PI4P metabolism at ER/Golgi membrane contact sites (Peretti 
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et al., 2008). In addition, bound to 25-hydroxycholesterol, OSBP localizes to the Golgi and 
ER/Golgi contact sites (Peretti et al., 2008).  
ORP and VAP proteins may then regulate additional PI signaling networks. Osh7 and 
Scs2 overexpression rescued the growth defects of mutant yeast cells with toxic levels of PI3P 
due to loss of the Sac1-like PI phosphatases Ymr1 and Sjl3, myotubularin and synaptojanin 
orthologs (Parrish et al., 2005). Cells lacking Osh or VAP protein function also display increased 
cellular PI3P levels (Table 2.3). It is unclear which Osh proteins regulate PI3P metabolism and if 
Osh and VAP proteins regulate other Sac1-like PI phosphatases, such as synaptojanins or 
myotubularin. Yet, cells lacking Osh function accumulate PI4P levels similar to sac1 sjl2 sjl3 
triple mutant cells (Figure1; Foti et al., 2001), suggesting they may control Sac1-like activity 
encoded by the yeast synaptojanins. 
We propose that the Osh proteins act as sensors of PI levels and regulate the Sac1 PI 
phosphatase at membrane contact sites. By retaining Sac1 at the ER, cells can recruit Sac1 to 
distinct organelle contact sites as needed (e.g. ER/PM, ER/Golgi, ER/endosome, ER/lysosome). 
This would allow the cell to maintain a wide range of Sac1 phosphatase activity and permit use 
of a common phosphatase (Sac1) to regulate PI lipids at multiple sites in the cell. Membrane 
contact sites facilitate communication between organelles through lipid transfer and metabolism 
(Lev, 2010). This elegant system may allow cells to balance not only PI levels but also other 
lipids at ER membrane contact sites, as the ER is a major site of lipid synthesis. Thus, 
modulation of PI levels by Sac1, the Osh proteins, and VAP proteins may allow signaling 
between the ER and compartments along the secretory and endocytic systems, thus linking ER 
lipid biosynthesis to multiple membrane compartments in the cell. Interestingly, both Sac1 and 
the yeast VAP protein Scs2 are implicated in phospholipid metabolism (Loewen et al., 2004; 
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Rivas et al., 1999). In addition, Sac1 has recently been identified as a component of a protein 
complex at the ER involved in sphingolipid metabolism (Breslow et al., 2010). Thus, future 
studies on Sac1 may reveal new insights into the links between membrane homeostasis and PI 
signaling pathways. 
 
Acknowledgements 
We thank C. Beh for strains and plasmids. We are grateful to S. Weys for technical assistance. 
We thank members of the Emr lab, C. McMaster, and S. Henry for discussions and A. Bretscher, 
C. Fromme, and D. Teis for comments on the manuscript. This work was supported by funds 
from the Weill Institute for Cell and Molecular Biology (S.D.E.). 
 
Tables 
Table 2.1. Strains used in this study 
Strain Genotype Reference 
SEY6210 MATa leu2-3,112 ura3-52 his3D200 trp1-D901 lys2-801 suc2D9 (Robinson et al., 1988) 
SEY6210.1 MATa leu2-3,112 ura3-52 his3D200 trp1-D901 lys2-801 suc2D9 (Robinson et al., 1988) 
AAY102 SEY6210 except stt4Δ::HIS3 and harboring pRS415stt4-4  (Audhya et al., 2000) 
AAY104 SEY6210 except pik1Δ::HIS3 and harboring pRS314pik1-83  (Audhya et al., 2000) 
AAY202 SEY6210 mss4Δ::HIS3 and harboring YCplac111mss4ts-102  (Stefan et al., 2002) 
MFY55 SEY6210 sac1Δ::TRP1 (Foti et al., 2001) 
JRY6203 SEY6210 osh2Δ::URA3 (Beh et al., 2001) 
JRY6202 SEY6210 osh3Δ::LYS2 (Beh et al., 2001) 
ANDY25 SEY6210 osh2Δ::URA3 osh3Δ::LYS2  This study 
CBY926 SEY6210 osh1Δ::KanMX4 osh2Δ::KanMX4 osh3Δ::LYS2 
osh4Δ::HIS3 osh5D::LEU2 osh6D::LEU2 osh7D::HIS3 [TRP1 
CEN osh4-1] 
(Beh and Rine, 2004) 
CBY924 SEY6210 osh1D::KanMX4 osh2D::KanMX4 osh3D::LYS2 
osh4D::HIS3 osh5Δ::LEU2 osh6Δ::LEU2 osh7Δ::HIS3 [TRP1 
CEN OSH4] 
(Beh and Rine, 2004) 
CBY886 SEY6210 osh1D::KanMX4 osh2D::KanMX4 osh3D::LYS2 
osh4D::HIS3 osh5Δ::LEU2 osh6Δ::LEU2 osh7Δ::HIS3 [URA3 
CEN osh4-1] 
(Beh and Rine, 2004) 
ANDY14 SEY6210 SCS2-mCherry::HISMX6 This study 
ANDY17 SEY6210 OSH3-GFP::HISMX6 This study 
ANDY34 SEY6210 OSH2-GFP::TRP1 This study 
YCS471 CBY886 except SAC1-GFP::TRP1 This study 
DBY355 SEY6210 scs2Δ::TRP1 scs22Δ::HIS3MX6 This study 
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DBY337 SEY6210 SCS2-3xHA::HISMX6 This study 
DBY407 SEY6210 scs2Δ::TRP1 scs22Δ::HIS3MX6 SAC1-GFP::TRP1 This study 
DBY408 SEY6210.1 scs2Δ::TRP1 scs22Δ::HIS3MX6 sac1Δ::TRP1 This study 
DBY336 SEY6210 SCS2-GFP::HISMX6 This study 
MFY110 SEY6210.1 SAC1-GFP::TRP1 (Foti et al., 2001) 
ANDY57 AAY102 except OSH3-GFP::TRP1 This study 
ANDY70 AAY202 except OSH3-GFP::TRP1 This study 
ANDY144 AAY104 except OSH3-GFP:: KANMX6 This study 
ANDY89 SEY6210 SAC1-13xMYC::TRP1 This study 
ANDY90 SEY6210 SAC1-13xMYC::TRP1 osh3Δ::LYS2 and harboring 
(URA3 CEN 3xHA-OSH3) 
This study 
ANDY101 MFY55 except harboring [URA3  CEN sac1ts osh4ts] This study 
ANDY102 CBY886 except harboring [URA3  CEN sac1ts osh4ts] This study 
ANDY104 CBY886 sac1Δ::TRP1 and harboring [URA3 CEN sac1ts osh4ts] This study 
ANDY105 SEY6210 rtn1Δ::TRP1 rtn2Δ::HISMX6 yop1Δ::TRP1 OSH3-
GFP::KANMX6 
This study 
ANDY145 SEY6210 SEC61-13xMYC::TRP1 This study 
ANDY142 SEY6210 OSH7-3xHA::HISMX6 SAC1-13xMYC::TRP1 This study 
ANDY146 
 
SEY6210 OSH7-3xHA::HISMX6 SEC61-13xMYC::TRP1 This study 
 
Table 2.2. Plasmids used in this study 
Plasmid Description Source 
pCS276 pRS426-pPRC1-GFP-2xPHOsh2 This study 
pCS357 pRS424-pPRC1-GFP-2xPHOsh2 This study 
 pRS416-DsRed-HDEL (Audhya and Emr, 2002) 
pRH1585 pKar2-DsRed-HDEL (Bevis et al., 2002) 
pCS355 pRS424-pPRC1-GFP-SAC1 This study 
pAM5 pRS414-OSH2 This study 
pAM6 pRS414-OSH3 This study 
pAM7 pRS414-OSH3-GFP This study 
pAM8 pRS414-osh3 AAAT-GFP This study 
pAM9 pRS414-osh3 PH∆-GFP This study 
pAM10 pRS414-osh3AAAT, PH∆-GFP This study 
pAM12 pRS416- pPRC1-3xHA-OSH3 This study 
pCB254 pRS314-OSH4 (Beh and Rine, 2004) 
pCS388 pRS314-osh41-29Δ This study 
pCS381 pRS314-osh4L111D This study 
pCS384 pRS314-osh43E, R236E K242E k243E This study 
pCB255 pRS314-osh4 ts-1 (Beh and Rine, 2004) 
pCB231 pRS316-OSH4 (Beh and Rine, 2004) 
 pRS316-osh4 ts-1 (Beh and Rine, 2004) 
MFB65 pRS416-sac1ts-23 (Foti et al., 2001) 
pAM11 pRS416-sac1 ts-23 osh4 ts-1 This study 
pAM13 pGEX6P-1-OSH3588-996 This study 
pAM14 pGEX6P-1-OSH31-613 This study 
pCS389 pRSET-B-his6-OSH4 This study 
pCS397 pRSET-B-his6-osh41-29Δ This study 
pCS390 pRSET-B-his6-osh4L111D This study 
pCS393 pRSET-B-his6-osh43E, R236E K242E k243E This study 
pCS398 pRSET-B-his6-SAC11-522 This study 
pCS399 pRSET-B-his6-sac1C392S C395S This study 
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 pRS415-stt4-4 (Audhya et al., 2000) 
 YCplac111-mss4ts-102 (Stefan et al., 2002) 
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Table 2.3. Phosphoinositide levels in wild type and mutant cells examined in this study 
 
Strain 
PI levels (% of total 3H-labeled PtdIns & PIPs) 
PtdIns PI3P PI4P PI(3,5)P2 PI(4,5)P2 
wild type 26°C 95.7±1.81 1.24±0.37 1.24±0.36 0.13±0.07 1.06±0.38 
wild type 38°C  93.1±2.21 1.15±0.58 1.61±0.35 0.13±0.02 1.66±0.24 
      
osh1-osh7Δ [OSH4] 26°C  88.5±2.34 1.38±0.19 7.64±1.31 0.18±0.05 1.04±0.32 
osh1-osh7Δ  [OSH4] 38°C 90.3±3.74 1.27±0.87 5.63±3.51 0.10±0.11 1.29±0.57 
      
osh1-osh7Δ [osh4ts] 26°C  85.8±1.44 1.75±0.22 9.54±0.24 0.13±0.03 0.92±0.08 
osh1-osh7Δ  [osh4ts] 38°C 72.5±0.61 2.01±0.16 22.8±0.72 0.30±0.16 0.44±0.12 
      
sac1Δ  26°C 81.6±0.56 1.56±0.32 16.4±0.79 0.16±0.02 0.30±0.10 
      
sac1ts 38°C   88.2±4.21 2.21±0.80 7.85±2.86 0.13±0.08 1.58±0.55 
sac1ts osh1-7Δ  [osh4ts] 
38°C 
76.3±8.43 1.74±0.50 21.2±7.71 0.13±0.06 0.62±0.30 
      
osh2Δ  osh3Δ  26°C  90.9±3.77 1.41±0.12 3.38±0.40 0.13±0.03 1.19±0.55 
      
scs2Δ scs22Δ  26°C  92.8±2.32 2.18±0.73 3.60±0.80 0.23±0.07 1.61±0.59 
      
osh1-osh7Δ  [osh4ts] 38°C      
+ [CEN OSH2] 84.5±5.88 0.88±0.44 6.36±3.05 0.09±0.01 0.65±0.36 
+ [CEN OSH3] 86.5±4.95 1.67±1.36 9.82±3.30 0.14±0.10 0.62±0.38 
+ [CEN OSH4] 83.0±3.91 2.22±0.71 9.92±2.19 0.16±0.03 1.05±0.52 
+ [CEN osh4	  Δ1-29] 67.9±7.86 2.21±0.64 26.3±6.72 0.29±0.11 0.36±0.28 
+ [CEN osh4L111D] 79.9±4.38 1.63±0.12 24.3±2.08 0.18±0.06 0.22±0.10 
+ [CEN osh4R236E, K242E, K243E] 81.1±4.44 1.58±0.10 21.7±1.92 0.30±0.03 0.28±0.06 
+ [empty vector]  71.0±3.91 1.69±0.31 24.3±3.56 0.26±0.06 0.22±0.09 
 
Yeast strains incubated at the indicated temperatures were labeled with 3H-myo-inositol. Lipids 
were extracted and deacylated for analysis by HPLC as described. The mean peak area (cpm) of 
PtdIns and each PI species is reported as a percentage of the total 3H-labeled lipids. The values 
reported are the mean (± standard deviation) of at least two independent experiments. 
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Abstract 
 ER-PM junctions are conserved structures defined as regions of the ER that tightly 
associate with the PM. However, little is known about the mechanisms that tether these 
organelles together and why such connections are maintained. Using a quantitative proteomic 
approach, we identified three families of ER-PM tethering proteins in yeast: Ist2 (related to 
mammalian TMEM16 ion channels), the tricalbins (Tcb1/2/3, orthologs of the Extended 
Synaptogmins), and Scs2 and Scs22 (VAP proteins). Loss of all six tethering proteins results in 
the separation of the ER from the PM and the accumulation cytoplasmic ER. Importantly, we 
find that phosphoinositide signaling is mis-regulated at the PM and the unfolded protein response 
is constitutively activated in the ER in cells lacking ER-PM tether proteins. These results reveal 
critical roles for ER-PM contacts in cell signaling, organelle morphology, and ER function. 
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Introduction 
The endoplasmic reticulum (ER) is a vast membrane network of sheets and tubules with 
essential roles in protein modification and secretion, lipid synthesis, and calcium signaling. To 
execute its various functions, the ER is organized into distinct compartments, such as rough ER 
membranes studded with ribosomes and smooth ER enriched in lipid biosynthetic enzymes. In 
addition, the ER adopts diverse shapes and architectures in different organisms and specialized 
cell types (Shibata et al., 2006). For example, in cells dedicated to protein secretion such as 
pancreatic acinar cells, the ER is an expansive system compactly arranged into stacks of 
membrane sheets.  In contrast, in excitable cells such as muscle cells, ER tubules form close 
associations with the plasma membrane (PM) that are important for calcium-inducible 
contractions (Carrasco and Meyer, 2011). Thus, cells have evolved multiple mechanisms for ER 
shape and architecture that support specialized functions performed in the ER. 
The ER must coordinate each of its specialized functions with other organelles in the cell 
(e.g. the PM, Golgi, endosomes, lysosomes, and mitochondria). Vesicular trafficking between 
organelles has long been appreciated as a major mechanism for intracellular signaling and 
communication. However, recent studies have highlighted roles for membrane junctions between 
organelles– where two organelles are closely apposed without undergoing membrane fusion– as 
important sites for intracellular signaling (Carrasco and Meyer, 2011; Toulmay and Prinz, 2011). 
Although the ER is known to contact numerous organelles, ER-PM junctions are some of the 
most prominent. Since their initial discovery (Porter & Palade, 1957), ER-PM junctions have 
been observed in numerous organisms and cell types. One of the best-studied examples is the 
association of ER-localized STIM proteins with the PM calcium channel Orai at ER-PM 
junctions in the store-operated calcium entry pathway (Liou et al., 2005; Park et al., 2009). 
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Additional PM-ER junctions have been described in neurons, insect photoreceptor cells, and in 
plants (Hayashi et al., 2008; Hepler et al., 1990; Suzuki and Hirosawa, 1994). 
In yeast cells, large regions of the plasma membrane have an underlying network of 
cortical ER (cER; Pichler et al., 2001; West et al., 2011). This network is associated with 20-
45% of the PM, with an average distance of 33nm between the organelles (Pichler et al., 2001; 
West et al., 2011). Due to the close association of the PM and cER, ribosomes are excluded from 
the face of the cER adjacent to the PM (West et al., 2011), suggesting these structures have roles 
distinct from protein translocation into the ER. Consistent with this, a pathway has been 
described for the regulation of phosphoinositide (PI) lipid turnover at the PM by an ER-localized 
PI phosphatase (Stefan et al., 2011). In addition, the yeast oxysterol-binding protein homologs 
(Osh proteins) have been suggested to mediate sterol lipid transport at ER-PM contact sites 
(Schulz et al., 2009). Thus, junctions between the ER and the PM appear to be important sites for 
lipid metabolism and transport.  
 While ER-PM junctions have been known for several decades, our understanding of the 
mechanisms that tether the cortical ER to the PM and why such connections are established 
remains limited. The VAP orthologs Scs2 and Scs22 have been implicated in PM-ER contact 
formation and cortical ER inheritance in yeast (Loewen et al., 2007).  However, we know 
relatively little about the architecture and the structural components of ER-PM junctions. In this 
study, we have uncovered the mechanism of ER-PM tethering in yeast. Using quantitative 
proteomics approaches, we identified additional ER-PM tethering factors: Ist2 (a member of the 
TMEM16 ion channel family) and the tricalbin proteins (Tcb1, Tcb2, and Tcb3–orthologs of the 
extended synaptotagmin family). These proteins have been suggested to localize to the cortical 
ER, but functions for these proteins have remained unknown (Fischer et al., 2009; Toulmay and 
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Prinz, 2011). We demonstrate that Ist2, the tricalbins, and the VAP orthologs Scs2/22 tether the 
cortical ER to the plasma membrane. Deletion of all six genes leads to a retraction of the ER 
away from the PM, and redistribution of ER into internal structures. This collapse of cortical ER 
leads to elevated levels of a phosphoinositide lipid at the PM and an unexpected induction of the 
unfolded protein response (UPR) in the ER. Moreover, cells lacking cER have impaired growth 
under cellular stress conditions and require an intact UPR for viability.  
 
Materials and Methods  
Yeast Strains, Plasmids, and Growth Assays 
Chromosmal taggings and knock outs were performed as previously described (Longtine et al., 
1998). To generate the ire1/Δtether double mutant, Δtether cells harboring a pRS416-IRE1 
(pAM36) plasmid were transformed with a NATMX knock out PCR for IRE1 containing 500bp 
of 5’ and 3’ UTR. Transformants were screened by PCR and 3 positive candidates were struck 
on 5FOA 2x to select for loss of pAM36. A similar plasmid shuffle was performed for the 
hac1/Δtether double mutant. For all plating assays, cells were grown to mid-log, adjusted to 1 
OD600/ml and serial dilutions were plated on the indicated media. For liquid growth assays, cells 
were grown to midlog, adjusted to 0.1 OD600/ml, and grown at 26°C. OD600 measurements were 
taken at the indicated time points. 
 
Fluorescence Microscopy 
All fluorescent microscopy was performed on mid-log cells. Images were aquired with a CSU-X 
spinning disk microscope (Yokogawa), with a 63x 1.4NA objective on an inverted microscope 
(DM16000B; Leica), a QuantEM EMCCD camera (Photometrics), and controlled by Slidebook 
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5.0 (Intelligent Imaging Innovations). The brightness and contrast of images were adjusted in 
Slidebook 5.0 and cropped in Photoshop (Adobe). 
 
Electron Microscopy 
Yeast cells were fixed with 2.5% (v/v) glutaradye for 1 hour and incubated in 1% potassium 
permanganate for 1 hour. Cells were dehydrated with 50%, 70%, 95%, and 100% ethanol. 
Samples were transitioned into 100% propylene oxide and embedded in Spurr’s resin. Electron 
microscopy was performed on a Morgnani 268 transmission electron microscope (FEI) with a 
AMT digital camera and 80eV beam. The cER/PM ratios were measured using ImageJ. The 
brightness of EM images was adjusted with Photoshop (Adobe). 
 
Phosphoinositide Analysis 
To measuere cellular phosphoinositide levels, 5OD600 equivalents of mid-log cell grown in 
minimal media were harvested, washed in inositol free media, incubated for 10min in inositol 
free media at 26°C unless indicated, and labeled with myo-[2-3H] inositol for 1 hour. Cells were 
then precipitated in 4.5% perchloric acid and lysed by vortexing with glass beads. Lysates were 
than washed in 100mM EDTA, phospholipids were deacylated, and head groups were isolated 
by extraction. Samples were dryed and resuspened in H2O. 5million counts of each sample were 
were seperated by HPLC (Shimadzu) using a partisphere SAX column (GE healthcare) and 
measured by a 610TR radiomatic detector (PerkinElmer). 
 
Subcellular Fractionation 
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Sucrose gradients were performed as described (Estrata et al., 2003) with modification. 75OD600 
equivalents of mid-log cells were harvested, washed in TE (10mM Tris-HCl pH 7.5, 1mM 
EDTA) and resuspened in STE10 buffer (10%[wt/wt] sucrose, 10mM EDTA, 10mM Tris-HCl 
pH7.5, Complete EDTA-free protease inhibitor cocktail [Roche], .1mM AEBSF, 1µM pepstatin 
A). Beads were added to the meniscus and vortexed for 2 min. 1ml of additional STE 10 buffer 
was added and lysates were cleared by 500g spin for 5min. .5mls of lysate (25OD600 equivalents) 
were loaded on top of a 10ml 20-60% linear sucrose gradient and spun at 100000g’s for 18 hours 
in a SW41TI rotor (Beckman). Twelve .875ul fractions were collected form the top and TCA 
precipitated. The fractions were washed 2x in Acetone, dryed, and resuspened in 6M urea sample 
buffer (150 mM Tris pH 6.8, 6 M Urea, 6% SDS, 10% β-mercaptoethanol, 20% Glycerol). All 
samples were heated at 42°C 20min and then analzyed by western blot. 
 
β-galactosidase assay 
Harvested cells were washed 1x in Z buffer (60mM Na2HPO4, 40mM NaH2PO4 10mM KCl, 
1mM MgSO4) and OD600 were measured. Samples were adjusted to 500ul in Z buffer, 50ul 
of .1% SDS was added, and samples were vortexed for 15 seconds. 50ul of chloroform was then 
added and samples were vortexed for 15 seconds. Reactions were started by the addion of 100ul 
of ONPG (4mg/ml). 500ul of 1M Na2CO3 was added to quench the reaction and samples were 
spun for 13000gs for 2min. Abs420  of the supernatent was measured and the units of activity 
were calculated (1000 x Abs420)/(time (min) x OD600 equivelents). 
 
CPY sorting 
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CPY sorting was performed as described (Foti et al.) Briefly mid-log cells were harvested, 
washed in synthetic media, and Easytag Express 35S protein labeling mix(Perkin Elmer) was 
added for 10 min. Chase solution of cold Methionine and Cysteine was added, and samples were 
TCA precipitated at indicated time points. After 30 min of precipitation, extracts were generated, 
and carboxypeptidase Y (CPY) was immunopecipitated.  
 
SILAC experiment and quantitative mass spectrometry 
Cells were grown in the presence of heavy or light lysine and arginine isotopes, harvested at 
mid-log, washed in TE, and frozen. Cells were resupended in lysis buffer (50 mM Tris pH 7.5, 
1% Tween20, 150 mM NaCl, 5 mM EDTA, 2X Complete EDTA-Free protease inhibitor tablets 
[Roche], 1X PhosStop [Roche]) and disrupted with glass beads for 30min. Cell lysates were 
cleared by 2x 16000g spin and incubated with M2 flag beads (Sigma) for 2 hours at 4°C. Beads 
were then washed 3 times and the protein was eluted with 100 mM Tris (pH 8.0), 1% SDS at 
95°C for 5 min. Samples were processed for mass spectrometry as described (MacGurn et al., 
2011). 
 
Cellular protien expression levels and antibodies 
5OD600 equivelents of mid-log cells were harvested and precipitated with tricholoroacidic acid 
(TCA). Samples were washed 2x in acetone, dryed, and lysed by bead beating. Extracts were 
analyzed by Western blot using an Odyssey infared imaging system (LI-COR Biosciences). The 
following antibodies were used in this study: α-HA (12CA5, Roche), α-G6PDH (Sigma), α-
Dpm1 (Invitrogen), and α-GFP (Santa Cruz Biotechnology), α-FLAG (M2, Sigma), α-CPY, and 
α-Pma1 (gift from Amy Chang, University of Michigan-Ann Arbor). 
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Results 
Identification of candidate PM-ER tether proteins 
The cortical ER (cER) and PM make extensive contacts, as observed in yeast cells by the 
close apposition of the ER protein Sec61-GFP and a PM marker (mCherry-2xPHPLCδ; Figure 
3.1A). At these sites, levels of the lipid phosphatidylinositol-4-phosphate (PI4P) in the PM are 
regulated in trans by the ER-localized PI phosphatase Sac1 (Stefan et al., 2011). However, the 
mechanisms that link the cER and PM (within 15 nm) and allow Sac1 to catalyze PI4P turnover 
at the PM are not well understood. The VAP orthologs Scs2/Scs22 have been implicated in PM-
ER membrane tethering and Sac1-mediated PI4P turnover (Loewen et al., 2007; Stefan et al., 
2011). Scs2 and its homolog Scs22 contain a single transmembrane domain and a major sperm 
protein (MSP) domain that binds FFAT motifs (two phenylalanines in an acidic tract) in lipid 
transfer proteins (Figure1C; Loewen et al., 2003). However, cells lacking both Scs2 and Scs22 
only accumulate a 2-fold increase in PI4P, while loss of Sac1 results in a nearly 10-fold increase 
(Foti et al., 2001; Stefan et al., 2011, Figure 3.8B). If Scs2/22 were the only cER-PM tethers, 
cells lacking these proteins should display a dramatic change in PI4P levels, similar to sac1 
mutants. Thus, additional tethering proteins that link the PM and ER likely exist.  
Since Sac1 and Scs2 function at sites where the PM and ER are tightly apposed, we 
hypothesized that additional proteins involved in PM-ER tethering might interact with Sac1 and 
Scs2. We performed stable isotope labeling of amino acids in culture (SILAC) and identified 
Sac1 and Scs2-interacting proteins by quantitative mass spectrometry analysis (Figure 3.1B). We 
identified 26 and 32 high confidence interactions for Sac1 and Scs2 respectively (hits with 
greater then 10 peptides, a false positive rate <1%, and an Xpress Ratio above 20), and 17 
proteins interacted with both Sac1 and Scs2, including each other (Tables 3.1, 3.2). We also  
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Figure 3.1. Identification of candidate PM-ER tethers. 
(A) ER marker Sec61-GFP (green) and PM marker mCherry-2xPHPLCδ (red) expressed in wild 
type cells. Cortical ER and nuclear ER are labeled. Scale bar,  3µm. 
(B) Schematic of Sac1 and Scs2 SILAC experiments followed by quantitative mass 
spectrometery. See Tables 3.1 and 3.2. 
(C) Diagram of candidate tethering proteins. Amino acid length is indicated. MSP, major sperm 
protein domain; TMD, transmembrane domain; PB, poly-basic domain; SMP, synaptotagmin-
like-mitochondrial lipid binding protein. 
(D) GFP-Ist2 and Tcb3-GFP localize to the cER in wild type cells (ER is marked by DsRed-
HDEL). Nuclear ER and cortical ER are indicated. Scale bar, 3 µm.  
(E) Equilibrium density fractionation of cells expressing 3xHA-Ist2, Tcb3-3xHA, and Sac1-
3xFLAG. Fractions were collected and analyzed by immunobotting for Sac1-3xFLAG (ER), 
Dpm1(ER), and Pma1(PM) as organelle markers.  
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Figure 3.2. GFP-Scs2 localizes to the ER, Tcb1-GFP and Tcb2-GFP are enriched in the 
cER. 
(A) GFP-Scs2 localization in wild type cells expressing the ER marked DsRed-HDEL. Scale bar, 
3μm. 
(B) Tcb1-GFP, and Tcb2-GFP localization in wild type cells expressing the ER marked DsRed-
HDEL. Scale bar, 3μm. 
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identified three reported Sac1-interacting proteins, Lcb1, Lcb2, and Dpm1 (Table 3.1; Breslow et 
al., 2010; Faulhammer et al., 2005), and two known Scs2-interacting proteins, Osh1 and Yet1 
(Table 3.2; Loewen et al., 2003; Wilson et al., 2011). Many of the Sac1 and Scs2-interacting 
proteins have known functions in lipid metabolism, protein trafficking, and protein glycosylation, 
while only a small subset had no previously annotated function (Tables 3.1, 3.2). Interestingly 
we identified the reticulons, Rtn1 and 2, and atlastin, Sey1, as Scs2-interacting proteins. These 
proteins have established roles in maintaining the structure of the ER (Hu et al., 2009; Voeltz et 
al., 2006). However loss of these proteins does not disrupt PM-ER contacts (Hu et al., 2009; 
West et al., 2011).  
Among the proteins identified, we considered three as candidate PM-ER tethers: Scs2, 
Ist2, and the yeast tricalbin proteins Tcb1 and Tcb3 (Figure 3.1B). Ist2, Tcb1, and Tcb3, along 
with the other tricalbin Tcb2, were selected because they exhibit exclusively cortical ER 
localization (Toulmay and Prinz, 2012; Fischer et al., 2009; Figures 3.1D and 3.2B) and have no 
annotated functions. Ist2 and the tricalbins also have protein architectures that might be expected 
for an organelle-tethering protein: transmembrane domains and cytoplasmic lipid-binding 
domains. Ist2 is comprised of 8 transmembrane domains and a long cytoplasmic carboxyl-
terminus that binds lipids and localizes to the cell cortex (Fischer et al., 2009; Figure 3.1C). The 
tricalbins contain transmembrane domains in their N-termini and lipid-binding C2 domains in 
their long cytoplasmic carboxyl-termini (Figure 3.1C, Schulz and Creutz, 2004). The tricalbins 
also possess a SMP domain that is found in other proteins localized to ER-organelle contact sites 
and is homologous to a domain found in lipid transfer proteins (Kopec et al., 2010; Toulmay and 
Prinz, 2012).  
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We next confirmed the localization of Ist2 and Tcb3 to the cER. At the midsection of 
yeast cells, GFP-tagged Ist2 and Tcb3 overlapped with the ER marker DsRed-HDEL, 
specifically at the cortical ER (Figure 3.1D). Significant co-localization of both Ist2 and Tcb3 
was observed with the ER marker at the periphery of these cells (Figure 3.1D). Notably, regions 
devoid of ER lacked GFP signal. The other tricalbin family members, Tcb1 and Tcb2, also 
localize to the cER (Figure 3.2B; Toulmay and Prinz, 2012). However, both Ist2 and the 
tricalbins have been suggested to be PM proteins (Creutz et al., 2004; Juschke et al., 2005). To 
resolve these differing results, we performed equilibrium density gradient fractionations that 
efficiently separate ER and PM membranes. Consistent with our microscopy results that 
localized Ist2 and Tcb3 in the cER, both 3xHA-Ist2 and Tcb3-3xHA were present in fractions 
containing the ER markers Sac1-3xFLAG and Dpm1 and absent from the PM marker Pma1 
fraction (Figure 3.1E).  
 
Deletion of tethers results in a loss of cER and accumulation of large cytoplasmic ER 
structures 
To determine if Ist2 and the tricalbin proteins function by tethering the cER to the PM, 
we constructed multiple deletion mutants of each of the tether candidates and scored Sec61-GFP 
localization as an ER marker. In wild type cells, the ER is organized into nuclear ER, a few 
cytoplasmic ER tubes and sheets, and cortical structures juxtaposed to the periphery of the cells 
(Figure 3.3A).  Deletion of all six genes (ist2, scs2/22, tcb1/2/3) resulted in a striking phenotype–
substantial reduction in cER, as large areas of the cell periphery have no associated ER 
(DIC/GFP merge, Figure 3.3A). Occasionally, small regions of the ER closely apposed to the 
cell cortex were observed (Figure 3.3A, arrow). In addition, collapsed ER structures accumulated 
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in the cytoplasm around the nucleus and in the emerging bud of mutant cells (Figure 3.3A). ER 
inheritance appeared to be normal in cells lacking the six genes, as non-nuclear ER was present 
in the bud before nuclear migration (Figure 3.4, asterisk). To verify our results with Sec61-GFP, 
we examined the morphology of the ER using another marker, GFP-HDEL, in multiple sections 
along the Z-axis in cells. In wild type cells, the ER network was clearly visible at the cell cortex 
and remained associated with the periphery through all Z sections observed (Figure 3.3B). 
However, in cells lacking the tether proteins the ER was no longer closely apposed to the PM, as 
GFP-HDEL was not observed at the periphery and mainly localized internally, (Figure 3.3B). 
Based on these results, we termed the strain lacking all six tethering proteins as Δtether cells and 
use this name throughout the study. 
We observed a range of effects upon loss of the VAP proteins, Ist2, or tricalbins either 
alone or in combination. In ist2 single mutant cells and tcb1/2/3 triple mutant cells there was no 
significant loss of cER (marked by yellow arrows, Figure 3.4). Likewise, cER structures were 
readily observed in ist2 tcb1/2/3 quadruple mutant cells, suggesting that the Scs2 and Scs22 VAP 
proteins were sufficient to form cER (Figure 3.4). In scs2 scs22 mutant cells, cER structures 
were reduced compared to wild type cells–but not absent–consistent with roles for Ist2 and the 
tricalbins in cER formation (Figure 3.4). Accordingly, upon loss of Ist2 or the tricalbins in 
scs2/22 cells (ist2 scs2/22 and scs2/scs22 tcb1/2/3 cells, Figure 3.4), we observed a further 
decrease in cER and an increase in enlarged cytoplasmic ER structures (red arrows, Figure 3.4) 
compared to scs2/22 cells. We next confirmed that Ist2 and the tricalbins are sufficient for cER 
formation and localize to the remaining cER in cells expressing only one type of tether. In cells 
lacking all other tethers, both GFP-Ist2 (in tcb1/2/3, scs2/22 cells) and Tcb3-GFP (in ist2, 
scs2/22 cells) localized to the regions of remaining cortical ER, suggesting that the cortical ER  
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Figure 3.3. Scs2/22, Ist2, and the Tricalbins tether the cER to the PM in yeast. 
(A) Localization of the ER marker Sec61-GFP in wild type and Δtether cells (ist2Δ, scs2/22Δ, 
tcb1/2/3Δ). cER is indicated in wild type cells and collapsed ER in Δtether cells. Arrow indicates 
potential remaining cER in Δtether cell. Scale bar, 5 µm.  
(B) Z stacks of wild type and Δtether cells expressing the ER marker GFP-HDEL. Each step is 
0.4µm. Scale bar, 2.5 µm. 
(C) Tcb3-GFP in ist2Δ, scs2/22Δ cells and GFP-Ist2 localization in scs2/22Δ, tcb1/2/3Δ cells 
expressing DsRed-HDEL. Arrow show regions labeled by the ER marker and Ist2 or Tcb3. Scale 
bar, 5 µm.  
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Figure 3.4. Gradual loss of the cER and increase in cytoplasmic ER accumulations in tether 
mutants. 
(A) Fluorescent microscopy of Sec61-GFP in indicated strains. Yellow arrows are highlighting 
cER and red arrows ER accumulations within the cell. * indicates a small budded cell that 
contains ER in a Δtether cell. Scale bar, 5μm. 
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that is still present in an scs2/22 mutant is tethered by Ist2 and the tricalbins (Figure 3.3C). These 
results also demonstrated that Ist2 and the tricalbins do not require the other tethers for their 
localization to PM-ER contacts or tethering function. 
 
Ultrastructural analysis of cER mutants 
Because we observed cytoplasmic ER accumulations in the Δtether mutant cells by 
fluorescence microscopy, we next examined the morphology of these structures at higher 
resolution using electron microscopy. In wild type cells, ER membranes appeared as dark stained 
structures at the periphery of the cell (cER) and as a discontinuous ring within the cell (nuclear 
ER, labeled in blue, Figure 3.5A). The cER (ER adjacent to the PM, labeled in purple) is the 
most abundant non-nuclear ER in wild type cells as very little cytoplasmic ER (green) was 
observed. In striking contrast to the ER morphology in wild type cells, the majority of the ER in 
Δtether mutant is not at the periphery. Instead, retracted masses of ER accumulated within the 
cytoplasm and likely account for the collapsed ER structures observed by fluorescence 
microscopy (Figure 3.5A). In addition to the cytoplasmic network, some Δtether cells also 
contained what appeared to be long ER tubules (Figure 3.6A). However, these structures are 
more likely extended ER sheets, as a tubule would not remain in the same plane of a thin EM 
section (~70nm) for such great distances (up to 5-7µm). Additional examples of Δtether mutant 
cells with collapsed ER structures and long cytoplasmic ER structures are shown in Figure 3.6B. 
Despite the large decrease in ER-PM contacts, mitochondria-ER junctions appear intact (Figure 
3.5A). 
Next, we quantified the loss of cER structures upon sequential deletion of the ER tether 
proteins. We decided to focus on mutants that had obvious cER morphology defects by  
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Figure 3.5. Morphology of Δtether cells and quantification of cER in tether mutants 
(A) Electron microscopy of wild type and Δtether cells. Inset of wild type cell is an enlarged 
region showing PM associated with (open arrow) and without ER (closed arrow). Different ER 
structures are labeled in the right panels: cER in purple, nER in blue, and cytoplasmic ER in 
green. Mitochondria (M), nucleus (N), cell wall (CW) and vacuole (V) are also labeled. A 
mitochondrial-ER contact is shown by an asterisk. Scale bar, 500 nm.  
(B) Quantification of cER expressed as a ratio of the length of cER/length of the PM in wild type 
and mutant cells. Error bars show StdDev (n=30 for each strain); significance was determined by 
one-way ANOVA with post-processing to correct for multple comparions (***P< 0.001; **P< 
0.01; *P< 0.05; ns, not significant P >0.05).  
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Figure 3.6. Additional Δtether electron microscopy 
(A) Electron microscopy showing an extended ER sheet observed in Δtether cells. Scale bar, 
500nm. 
(B) Electron micscopy of a group of Δtether cells. * indicates abnormal ER structures. A region 
of potential cER is indicated. Scale bar, 1μm. 
(C) Electron microscopy of scs2/22Δ, scs2/22Δ tcb1/2/3Δ, and ist2Δ scs2/22Δ cells. cER 
remaining in these mutants is indicated. Scale bar, 500nm. 
Nucleus (N) 
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fluorescent microscopy, and thus we used scs2/22 double mutant cells as a starting point. To 
quantitate the loss of cER in the mutants, we used a ratio of the sum length of cER segments 
(purple) over the circumference of the PM. Consistent with published results (West et al., 2011), 
in wild type cells approximately 40% of the PM was associated with cER structures (0.4 
cER/PM ratio, Figure 3.5B). In scs2/22 mutants the cER/PM ratio was decreased by nearly one-
half (24% of the PM associated with cER; Figures 3.5B, 3.6C), consistent with previously 
published observations (Loewen et al., 2007). Upon further loss of Ist2, the cER/PM ratio 
decreased an additional two-fold (13% of the PM associated with cER structures in ist2, scs2/22 
triple mutant cells; Figures 3.5B, 3.6C). Upon deletion of all six genes (Δtether mutant cells), the 
cER/PM ratio decreased greater than 8-fold as compared to wild type cells (only 4.8% of the PM 
associated with cER, Figure 3.5B). Surprisingly, the cER/PM ratio for tcb1/2/3, scs2/22 mutant 
cells was not significantly different than scs2/22 mutants alone, and loss of the tricalbins only 
exhibited an effect when the other tethers (Scs2/22 and Ist2) were absent (compare ist2 scs2 
scs22 cells to Dtether cells; Figures 3.5B, 3.6C). Our results using both fluorescence and electron 
microscopy suggest a hierarchy amongst the PM-ER tethers where Scs2/22 provide a significant 
contribution, followed by Ist2, and then the tricalbins. It should be noted that in Δtether mutant 
cells, even though there is a large redistribution of cER to the cytoplasm, there appears to be 
small regions of cER present, suggesting the presence of additional unknown tethering proteins 
(Figures 3.5, 3.6B).   
 
PI4P accumulates at the PM in Δtether mutant cells 
The PI phosphatase Sac1 dephosphorylates PI4P on the PM in trans from the ER (Figure 
3.7A; Stefan et al., 2011). In cells where PM-ER connections are disrupted, Sac1 should have 
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less access to its substrate at the PM and PI4P levels should increase. We first confirmed that 
Sac1 was mislocalized to intracellular ER structures in Δtether cells. Similar to other ER markers, 
GFP-Sac1 accumulated in the collapsed ER in Δtether cells (Figure 3.7B). Sac1 expression levels 
were not significantly different in whole cell lysates from wild type and Δtether mutant cells 
(Figure 3.8A). To monitor Sac1 function, we performed 3H-inositol labeling experiments and 
HPLC analysis to measure cellular PI levels in wild type and the tether mutant strains (Table 3.3). 
Consistent with a requirement for ER-localized Sac1 to be in close proximity to the PM, mutants 
with reduced cER displayed increased PI4P levels (Figure 3.7C). Increases in PI4P correlated 
with decreases in cER, as scs2/22 and scs2/22, tcb1/2/3 mutant cells had a modest increase in 
PI4P (greater than 2-fold), while ist2, scs2/22 mutants with significantly reduced cER, 
accumulated higher PI4P levels (4-fold). In cells lacking only Ist2 (ist2 mutant cells) or the 
tricalbins (tcb1/2/3 cells), PI4P levels were similar to wild type (Table 3.3). In Δtether cells, in 
which the cER/PM ratio is reduced more than 8-fold (only 5% of the PM is associated with cER), 
PI4P levels increased greater than 7-fold (Figure 3.7C).   
 In addition to PI4P at the PM, the Sac1 PI phosphatase regulates pools of PI4P at the 
Golgi and ER (Faulhammer et al., 2005). We then addressed whether the ER tether proteins 
specifically regulate PI4P levels at the PM. For this, we visualized PI4P in wild type and Δtether 
cells using a fluorescent reporter that binds to PI4P (GFP-2xPHOsh2; Roy and Levine, 2004). In 
wild type cells, the PI4P sensor was present at both Golgi compartments and the PM, with 
enriched PM localization in the bud (Figure 3.7D). However, similar to sac1 mutant cells, the 
PI4P reporter was shifted to the PM in Δtether cells, with an even distribution in both mother and 
daughter cells (Figure 3.7D).  
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Figure 3.7. Loss of ER-PM contacts results in misregulation of PI4P at the PM. 
(A) Schematic for Sac1 phosphatase function. Sac1 is an integral ER membrane protein that 
dephosphorylates the lipid PI4P at the PM. 
(B) Localization of GFP-Sac1 in wild type and Δtether cells. Scale bar, 5 µm.  
C) Cellular PI4P levels in wild type and ER tether mutant cells, as measured by 3H-inositol 
labeling and HPLC analysis. Error bars show StdDev (n=3). See also Table 3.3. 
(D) Localization of the PI4P reporter GFP-2xPHOsh2 in wild type, Δtether, and sac1Δ cells. PM 
and Golgi pools of PI4P are indicated. Mother cells are labeled (m). Scale bar, 5 µm. 
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Figure 3.8. GFP-Sac1 levels do not change in Δtether strain and genetic test of tether/sac1 
double mutant.  
(A) Whole cell lysates of GFP-Sac1 expressed in wild type and Δtether cells. G6PDH is a 
loading control.  
(B) Quantification of PI4P by 3H-inositol labeling and HPLC of wildtype, ist2Δ scs2/22Δ, sac1ts, 
and ist2Δ scs2/22Δ sac1ts cells labeled at 38°C. Error bars are the StdDev (n=3). Significance 
determined by one-way ANOVA with post-processing to correct for multple comparions. 
(*P= .01-0.05; ns, not significant P >0.05). 
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If the ER tether proteins regulate PI4P metabolism through the Sac1 phosphatase, then 
loss of ER tether proteins should not result in a significant increase in PI4P in cells lacking Sac1 
function. We measured PI4P levels in an ist2, scs2/22, sac1ts temperature conditional strain (ist2, 
scs2/22, sac1 quadruple null mutants were inviable, our unpublished data) and sac1ts single 
mutant cells at the non-permissive temperature. PI4P levels in ist2, scs2/22, sac1ts quadruple 
mutant cells were not significantly increased as compared to PI4P in sac1ts single mutant cells 
(13.4% ±1 and 11.6% ±2.5 respectively; Figure 3.8B). Similar to our previous results, PI4P 
levels were increased (>3-fold) in ist2, scs2/22 triple mutant cells as compared to wild type cells 
(Figure 3.8B). Taken together, our results indicate that the ER tether proteins facilitate Sac1 
interactions with the PM to regulate PI4P. 
 
Identification of regions in Scs2, Ist2, and Tcb3 involved in ER-PM tethering and 
localization 
To better understand the mechanisms of ER-PM tethering, we identified domains in the 
ER tether proteins necessary for their function. We focused on Scs2 and Ist2, since our results 
implicated these proteins as key ER-PM tethers. Ist2 consists of eight transmembrane domains 
comprising a putative ion channel followed by a long cytoplasmic C-terminus containing a 
polybasic region rich in lysine and histidine residues necessary for cortical localization of Ist2 
(Juschke et al., 2005). The Ist2 polybasic region also binds to PI(4,5)P2-containing liposomes in 
vitro (Fischer et al., 2009). Similar to our previous results, expression of full-length Ist2 in 
Δtether cells was sufficient to restore some cER (Figures 3.3C, 3.9A, 3.10D). Interestingly the 
last two transmembrane domains and the extended C-terminus (GFP-Ist2490-946) were sufficient 
to form cER when expressed in Δtether cells (Figures 3.9A, 3.10D). The C-terminal polybasic 
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domain was required for cER tethering, as the C-terminal truncated protein (GFP-Ist21-928) did 
not restore cER and instead localized to cytoplasmic ER structures in Δtether cells (Figures 3.9A, 
3.10D). As an independent test for tethering function, we measured PI4P levels in Δtether mutant 
cells expressing the Ist2 constructs. Consistent with the ability to form cER, wild type GFP-Ist2 
and the mutant protein consisting of the last two transmembrane domains and the C-terminus 
(GFP-Ist2490-946) were able to reduce PI4P levels, but Ist2 lacking the polybasic domain (GFP-
Ist21-928) was not (Figure 3.9B). Thus, the C-terminus was necessary for Ist2 tethering and the 
proposed ion channel of Ist2 was dispensable for ER-PM tethering. 
Since the C-terminal polybasic domain was necessary for Ist2 to tether the ER and PM, 
we tested whether the polybasic domain was sufficient for PM targeting when expressed on its 
own. A previous study suggested it has weak, if any, affinity for the PM (Juschke et al., 2005). 
To increase the binding affinity for its target at the PM, we generated a tandem polybasic domain 
GFP construct (GFP-2xIst2928-946). Strikingly, the tandem Ist2 polybasic domain (GFP-2xIst2928-
946) tightly associated with the PM (Figure 3.10A) compared to a single polybasic domain 
(Figure 3.10B), and still localized to the PM in Δtether cells (Figure 3.10C). 
 The VAP protein Scs2 contains a single transmembrane domain (TMD) and a 
cytoplasmic MSP domain (Figures 3.1C and 3.9C). As expected, expression of full-length Scs2 
in Δtether cells was sufficient to restore cER (Figures 3.9C, 3.10E) and lower cellular PI4P 
levels (Figure 3.9D). A truncated form of Scs2 lacking the TMD (GFP-Scs21-225) did not localize 
to the ER and instead was in the nucleus, and weakly at the PM at sites of polarized growth 
(Figures 3.9C, 3.10E; Loewen et al., 2007). The mutant Scs2 protein lacking its TMD failed to 
reduce PI4P levels in the Δtether mutant cells (Figure 3.9D), suggesting Scs2 must be anchored 
in the ER to function as a tether. A mutant form of Scs2 (Kx6) bearing substitutions in basic  
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Figure 3.9. Ist2 C-terminus is required for tethering and association with the PM. 
(A) Localization and models of GFP-Ist2, GFP-Ist2490-946, and GFP-Ist21-928 constructs expressed 
in Δtether cell. Scale bar, 3 µm.  
(B) PI4P levels in Δtether cells expressing GFP-Ist2, GFP-Ist2490-946, or GFP-Ist21-928. Error bars 
show StdDev (n=2).  See Table 3.3. 
(C) Localization of GFP-Scs2, GFP-Scs2Kx6, and GFP-Scs21-225 in Δtether cells.  Scale bar, 3 µm. 
See also Table 3.4. 
(D) PI4P measurements in Δtether cells carrying empty vector or expressing SCS2, scs2Kx6, or 
scs21-225. Error bars show StdDev (n=2). See also Table 3.3. 
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Figure 3.10. The C-terminus of Ist2 is sufficient to target to the PM and additional images 
of tether constructs. 
(A) Localization of the tandem Ist2 polybasic domain (GFP-2xIst2928-946) expressed in wild type 
cells. Scale bar, 5µm. 
(B) Localization of GFP-1xIst2928-946 in wild type cells. Scale bar, 5µm. 
(C) Localization of mCherry-2xIst2928-946 in Δtether cells expressing the ER marker GFP-HDEL 
Scale bar, 3µm. 
(D) ER-PM contact site rescue and localization of GFP-Ist2, GFP-Ist2490-946, and GFP-Ist21-928 in 
Δtether cells expressing the ER marker DsRED-HDEL. Scale bar, 3µm. 
(E) ER-PM contact site rescue and localization of GFP-Scs2, GFP-Scs2Kx6, and GFP-Scs21-225 in 
Δtether cells expressing the ER marker DsRED-HDEL. Scale bar, 3µm. 
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Figure 3.11. The MSP domain is sufficient for ER-PM tethering. 
(A) Localization and models of GFP-Sac1 and GFP-MSP-Sac1 (GFP-Scs21-129-Sac1) expressed 
in Δtether cells. Scale bar, 3µm. 
(B) Localization of Tcb3-GFP and Tcb31-491-GFP (Lacking C2 domains) in tcb3Δ cells, nER is 
indicated. Scale bar, 5µm. 
  
	   148 
lysine residues within the MSP domain involved in binding to FFAT peptides and potentially to 
PI lipids (Kagiwada and Hashimoto, 2007) failed to restore cER (Figures 3.9C, 3.10E) or lower 
PI4P levels in Δtether mutant cells (Figure 3.9D). In addition to the Kx6 mutant, we also tested 
several other substitutions within the MSP domain of Scs2 (Table 3.4). The Scs2 mutant proteins 
showed a wide range of activity, including full wild type function (e.g. L86A), partial activity 
(e.g. K84A, L86A), and complete loss of function (e.g. the T41A, T42A and P44S, P51S mutant 
proteins; Table 3.4). We also tested whether the MSP domain was sufficient for ER-PM tethering 
when fused to another ER membrane protein. Expression of a GFP-MSP-Sac1 fusion protein in 
Δtether cells was sufficient to restore cER (Figure 3.11A). Taken together, these results implicate 
the MSP domain in Scs2 tethering function, consistent with previous findings (Loewen et al., 
2007).   
Our results showed that the tricalbins are sufficient for cER formation and that Tcb3-GFP 
remained localized to ER-PM contacts in cells lacking Ist2 and Scs2/22 (Figure 3.3C). The 
tricalbins contain multiple lipid-binding C2 domains (Figure 3.1C) that could be involved in ER-
PM targeting. Interestingly, a mutant form of Tcb3 lacking the C2 domains (Tcb31-419-GFP) was 
observed in both nuclear and cortical ER structures, in contrast to full-length Tcb3-GFP that 
localized exclusively to the peripheral ER (Figure 3.11B). Thus, the C2 domains may serve in 
stabilizing the tricalbin proteins at ER-PM junctions, consistent with previous findings (Toulmay 
and Prinz, 2012). 
 
Cells lacking PM-ER contacts require the UPR for survival 
Due to the dramatic changes in ER morphology, we reasoned that ER functions might be 
affected in the Δtether cells. We first examined if there was a defect in protein trafficking from 
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the ER. However, glycosylation and delivery of the cargo protein carboxypeptidase Y (CPY) to 
the vacuole appeared normal, implying that ER export is unaffected by the change in ER 
morphology in Δtether cells (Figure 3.13A). We then tested whether the Δtether cells were 
sensitive to ER stress induced by tunicamycin. Tunicamycin blocks N-linked protein 
glycosylation in the ER leading to misfolding of both luminal and integral membrane proteins. 
Interestingly, the Δtether strain was hypersensitive to tunicamycin-induced ER stress as 
compared to wild type cells and sac1 mutant cells (Figure 3.12A). Thus, the growth defect of 
Δtether cells under ER stress conditions was not simply due to loss of Sac1 function.  
The sensitivity of Δtether cells to an ER stress suggested a potential impairment of the 
unfolded protein response (UPR).  The UPR detects misfolded proteins in the ER and relays this 
signal to the nucleus, resulting in increased expression of ER chaperones, lipid synthesis 
enzymes, ER-associated degradation machinery (ERAD), and membrane trafficking protein 
(Travers et al., 2000). To determine if ER-PM contacts are required for the UPR, we measured 
induction of an UPRE-LacZ reporter in wild type and Δtether cells (Cox and Walter, 1996). 
Untreated wild type cells displayed low levels of UPRE-LacZ activity under basal conditions, 
but UPRE-LacZ activity was increased approximately 10-fold when wild type cells were 
exposed to an ER stress, the reducing agent DTT (Figure 3.12B). Unexpectedly, Δtether cells 
displayed constitutive UPR signaling, as there was a surprisingly high level of UPRE-LacZ 
activity (comparable to DTT-induced levels in wild type cells) even without the addition of DTT. 
The UPRE-LacZ activity further increased when Δtether cells were treated with DTT (Figure 
3.12B). To determine if the constitutive induction of the UPR correlated with defects in cER 
formation, we measured basal UPR activity in each of the tether mutants. Interestingly, only 
mutants with cER defects constitutively induced the UPR and basal activity increased with 
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decreased cER formation (Figure 3.13B). The Δtether cells displayed significantly higher basal 
UPR signaling than sac1 mutants (Figure 3.13B), implying ER stress in the Δtether cells was not 
entirely due to loss of Sac1 function. As an independent test, basal expression of Kar2 (yeast BIP, 
a protein induced during UPR) were moderately elevated in Δtether cells as compared to wild 
type cells in the absence of ER stress (Figure 3.13C). Both wild type and Δtether cells increased 
Kar2 expression in response to tunicamycin, indicating that Δtether cells possess an intact UPR 
signaling pathway (Figure 3.13C).  
The Δtether cells undergo continuous UPR signaling even in the absence of exogenous 
ER stress-inducing agents (e.g. tunicamycin or DTT), implying that the loss of PM-ER contacts 
disrupts one or more processes in the ER. While Δtether cells grew normally under non-stress 
conditions, Δtether cells were hypersensitive to tunicamycin, as if they cannot overcome 
additional ER stress. These results suggested that the change in ER morphology and increased 
ER stress experienced by Δtether cells is compensated by the UPR (Figure 3.12C). We then 
predicted that loss of UPR signaling would compromise the viability of Δtether cells. To test if 
the UPR was critical, we deleted the IRE1 gene that encodes kinase and RNAse activities 
required for UPR signaling. Compared to wild type, Δtether, and ire1 cells, the growth of ire1 
Δtether mutant cells was severely impaired in both serial dilution plating assays and liquid 
cultures (Figures 3.12D, 3.12E). Loss of Hac1, a transcription factor downstream of Ire1 (Cox 
and Walter, 1996), also resulted in a severe synthetic growth defect in Δtether mutant cells 
(Figure 3.13D). The synthetic relationship between loss of PM-ER contacts and the UPR was not 
due to impaired protein trafficking out of the ER, as CPY was efficiently sorted in the ire1 
Δtether mutant (Figure 3.13E). Thus, the Δtether cells are defective for critical ER functions that 
are compensated by up-regulation of the UPR. 
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Figure 3.12. The UPR is critical for the growth of cells lacking PM-ER contacts 
(A) Serial dilutions of wild type, Δtether, and sac1Δ cells grown for indicated times at 26°C on 
YNB or YNB + 0.8mg/ml tunicamycin. 
(B) UPR assay using UPRE-LacZ reporter. Induction of the UPR was measured by b-
galactosidase activity in indicated strains treated with or without 8mM DTT for 1 hour. Error 
bars show StdDev (n=3 assays performed in duplicate). 
(C) Diagram of the UPR pathway and a potential link to disruption of PM-ER contacts. Loss of 
PM-ER contacts results in ER dysfunction that is sensed by Ire1, which induces the UPR. 
(D) Serial dilutions of wild type, Δtether, ire1Δ, and Δtether /ire1Δ mutant cells grown on YPD 
plates at 26°C. 
(E) Liquid growth assays of wild type, Δtether, ire1Δ, and Δtether/ire1Δ mutant cells. Cells were 
grown in YPD at 26°C and OD600 measurements were taken at indicated time points. 
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Figure 3.13. The UPR is critical for growth of cells lacking cER, but trafficking out of the 
ER is normal. 
(A) CPY processing in wild type and Δtether mutant cells. Cells were pulsed with 35S methionine 
and cysteine for 10 min and chased for 0 and 30min. p2 (Golgi) and m (mature) forms are 
indicated. 	  
(B) UPR reporter assay using UPRE-LacZ (pJC104). Induction of the UPR was measured by β-
galactosidase activity from indicated strains with no treatment. Error bars are StdDev (n=3). 
(C) Whole cell lysates of wild type and Δtether cells treated with or with out (UT) 1ug/ml 
tunicmycin for 90 minutes. Samples were probed for Kar2, a protein whose levels increase upon 
ER stress, and G6PDH as a loading control. Normalized intensity of Kar2 (normalized to 
G6PDH) ratio to untreated wild type is indicated. 
(D) Serial dilutions of the following strains harboring a CEN URA HAC1 plasmid were plated on 
5FOA plates to select for loss of the HAC1 plasmid: Δtether, hac1Δ and three independent 
isolates Δtether/hac1Δ double mutants. 
(E) CPY processing in wild type, Δtether, ire1Δ, and Δtether/ire1Δ double mutants. . Cells were 
pulsed with 35S methionine and cysteine for 10 min and chased for 0 and 30min. p2 (Golgi) and 
m (mature) forms are indicated.  
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Discussion 
Multiple conserved tethering proteins form ER-PM junctions  
PM-ER membrane contact sites are major sites for calcium and lipid signaling in 
eukaryotic cells. Yet, relatively little is known about the structural components of membrane 
junctions between these organelles. We have identified Ist2 (related to the mammalian TMEM16 
family of ion channels) and the tricalbins (C2 domain-containing proteins similar to the extended 
synaptotagmin-like proteins E-Syt1/2/3) as ER tether proteins that function with the VAP 
orthologs Scs2 and Scs22 to establish junctions between the ER and PM. Upon loss of all six ER 
tether proteins, the morphology of the cortical ER was drastically altered from a network of 
sheets and tubes attached to the PM in wild type cells, to a near total loss of PM-ER contacts and 
accumulations of ER in the cytoplasm. Importantly, our results suggest critical roles for PM-ER 
contacts in regulating phosphoinositide signaling at the PM and ER morphology and homeostasis 
(Figure 3.14).  
Of the PM-ER tethering proteins analyzed in our study, Scs2 appeared to be the most 
important. Loss of Scs2 alone resulted in a clear reduction in cER compartments (Loewen et al., 
2007; Figure 3.4A). Though Scs2 has a critical role in PM-ER tethering, Scs2 and other VAP 
family members may function as general tethers for several ER-organelle connections. VAP 
proteins have been implicated in ER-Golgi and ER-endosome contacts in mammalian cells 
(Peretti et al., 2008; Rocha et al., 2009). Scs2 is not enriched at specific ER-organelle contact 
sites and instead localizes throughout the ER (Figure 3.2A). These results suggest that the VAP 
proteins may cycle between at least two states: an active tethering state at organelle junctions and 
an inactive state diffuse throughout the ER network. This idea is consistent with VAP 
localization and may allow the VAP proteins to make contacts with several organelles as needed 
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through regulated interactions with additional tethering factors. How the VAP protein Scs2 is 
regulated and the mechanisms by which Scs2 facilitates ER tethering are unclear. One possibility 
is that Scs2 binds to specific FFAT-containing ORP (oxysterol-binding protein related proteins) 
family members at membrane contact sites. Several ORP family members have been observed at 
ER-organelle contact sites (Peretti et al., 2008; Rocha et al., 2009; Schulz et al., 2009; Stefan et 
al., 2011). However ORPs (e.g. the Osh proteins in yeast) do not appear to be required for PM-
ER tethering in vivo (Loewen et al., 2007; Schulz et al., 2009; Stefan et al., 2011). The Scs2 
MSP domain has been suggested to bind negatively charged lipids such as PI4P (Kagiwada and 
Hashimoto, 2007). However, PI4P is not sufficient for Scs2 localization, as the MSP domain 
targets to sites of polarized growth and it was not observed at Golgi compartments that are 
enriched in PI4P (Loewen et al., 2007; Figure 3.9). Thus, Scs2 may interact with as yet 
unidentified proteins or lipids on target organelles to facilitate tethering.  
 Unlike the VAP orthologs Scs2/22, Ist2 and the tricalbins exclusively localized to the 
cortical ER where they likely function as specific tethers between the cER and PM (Figure 3.1D; 
Fischer et al., 2009; Toulmay and Prinz, 2012). Their restricted localization to the cER implies 
that both Ist2 and the tricalbins make extensive contacts with the PM. The tricalbins may bind 
directly to PM lipids as each contains lipid-binding C2 and SMP domains (Schulz and Creutz, 
2004; Toulmay and Prinz, 2012). The C-terminus of Ist2 bound to PI(4,5)P2 containing 
liposomes in vitro and was both necessary and sufficient for PM interaction (Figure 3.9; Fischer 
et al., 2009). Interestingly, a recent study found that Ist2 regulates the close association of cER 
with the PM (within 30 nm; Wolf et al., 2012), consistent with the idea that Ist2 directly contacts 
the PM.  
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Figure 3.14. Model for PM-ER tethering in yeast 
Three families of integral ER proteins tether the cortical ER to the PM: the VAP proteins 
Scs2/22, Ist2, and the tricalbins. Loss of ER-PM tethers results in dramatic changes in ER 
morphology, elevated PI4P levels at the PM, and activation of the unfolded protein response 
(UPR). 
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Similar to Scs2, Ist2 and the tricalbins are conserved in higher eukaryotes, including 
mammals. Ist2 is related to the TMEM16/anoctamin proteins, some of which are calcium-
activated chloride channels (Caputo et al., 2008; Yang et al., 2008). Interestingly TMEM16a 
contains a cytoplasmic region that binds PI(4,5)P2 in vitro and targets to cER-PM junctions in 
yeast cells (Fischer et al., 2009). The tricalbins are related to the mammalian extended 
synaptogamin proteins (E-Syt1/2/3), which share a similar architecture of N-terminal membrane-
anchoring domains followed by cytoplasmic SMP and C2 domains. Although some PM-ER 
tethers in higher eukaryotes are known (e.g. STIM proteins and junctophilin), we propose Ist2 
and the tricalbin orthologs have conserved roles as ER-organelle tethers in other eukaryotes. 
 
ER inheritance and establishment of the cortical ER in daughter cells 
It is worth noting that Ist2, Tcb2, and Tcb3, each of which are exclusively localized to the 
cER, are encoded by mRNAs that are transported into the growing bud by the myosin motor 
protein Myo4, the mRNA-binding protein She2, and the Myo4 adaptor protein She3 (Shepard et 
al., 2003). Myo4 and She3 are also required for the efficient inheritance of cER, which is derived 
from nuclear ER and is carried by Myo4 into the bud along actin cables (Estrada et al., 2003). 
Thus Myo4 transports ER into the bud and delivers mRNAs that encode ER-PM tethering 
proteins for cortical ER formation. This system likely evolved because pre-existing cER 
membrane proteins in the mother cell, such as Ist2 and the tricalbins that localize exclusively to 
the cER, are unable to enter the bud due to the proposed diffusion barrier created by the septin 
ring at the mother-bud neck. In contrast, Scs2 localizes to nuclear and cytoplasmic ER structures, 
in addition to the cER, and thus pre-existing Scs2 protein can be inherited from the mother cell. 
Cells lacking Scs2 have cER defects that are more pronounced in the bud (Loewen et al., 2007). 
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Thus Scs2 may initially establish the cER in the newly forming bud. Subsequently, Ist2 and the 
tricalbins further stabilize cER-PM contacts following their translation and insertion into the 
newly formed cER.  
 
Roles for PM-ER junctions 
The identification of proteins that function in the establishment of PM-ER junctions 
provides a foundation for future investigations into the roles for ER-PM contacts. We found that 
loss of PM-ER connections resulted in the dramatic accumulation of PI4P at the PM, consistent 
with previous work indicating that Sac1 functions at PM-ER junctions (Stefan et al., 2011).  PI 
4-kinase activity has been implicated in several important cellular processes at the PM, including 
signaling responses to numerous stimuli in both yeast and metazoan cells (Audhya and Emr, 
2002; Balla et al., 2008; Jesch et al., 2010; Hammond et al., 2012; Yavari et al., 2010). ER-PM 
contacts serve as important sites for the modulation of PI4P levels and may contribute to the 
regulation of cell signaling pathways controlled by PI4P. It will also be interesting to determine 
whether processes regulated by PM-ER junctions in metazoan cells (e.g. lipid and Ca2+ transport) 
are affected in Δtether yeast cells. 
Unexpectedly, cells lacking cER exhibited continuous UPR signaling and required the 
UPR for viability, suggesting one or more critical processes in the ER require PM-ER contacts 
for full function. In the absence of PM-ER connections these processes are perturbed–resulting in 
imbalances in the ER and induction of the UPR. Thus, constitutive UPR signaling may be 
necessary as a protective mechanism to compensate for the disruption of ER homeostasis upon 
loss of PM-ER tethers. The compromised ER function in the Δtether cells and synthetic growth 
defect of Δtether cells lacking IRE1 was not due to impaired protein trafficking out of the ER, as 
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biosynthetic sorting and processing of the cargo protein CPY were normal. In addition, even with 
strong constitutive UPR signaling in Δtether cells, expression levels of the UPRE-LacZ reporter 
and the ER chaperone Kar2 (BIP) were further induced when Δtether cells were treated with a 
protein folding stress. These results suggest that the constitutive UPR signaling in Δtether cells is 
not the accumulation of unfolded proteins, but mis-regulation of additional processes in the ER. 
Consistent with this, cells impaired in several ER processes (e.g. protein glycosylation and 
folding; the ERAD pathway, ion transport, and lipid metabolism) exhibit elevated UPR signaling 
(Jonikas et al., 2009), as well as synthetic growth defects upon inactivation of the UPR (Thibault 
et al., 2011).    
 Altogether, our study has (1) revealed a complex system composed of multiple tethering 
factors involved in the formation of PM-ER membrane junctions,  (2) provided a more detailed 
understanding of phosphoinositide signaling at the PM, and (3) uncovered an unexpected role for 
ER-PM contacts in ER organization and function. In addition, the ER tether proteins possess 
lipid-binding domains and may serve as sensors of membrane composition to transmit signals 
between the ER and PM. Upon loss of PM-ER signaling, cells may become dependent on other 
cell signaling and stress response systems, such as the UPR, to maintain organelle homeostasis 
and integrity. 
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Tables 
Table	  3.1.	  Sac1	  SILAC	  
ORF Total peptides(H/L) Xpress Process 
Sac1* 179(177/2) 123.01 Bait 
MNN11 10(10/0) 31.89 Protein glycosylation 
(Golgi) MNN5 10(10/0) 23.47 
ALG2 11(11/0) 38.51  
 
 
Protein glycosylation 
(ER) 
DPM1* 25(24/1) 25.06 
OST1* 11(11/0) 22.36 
OST3 10(10/0) 61.1 
PMT1* 18(18/0) 68.2 
PMT2* 12(12/0 24.59 
WBP1* 17(17/0) 24.3 
CHO2 16(16/0) 21.39  
 
 
Lipid metabolism 
ERG2* 10(10/0) 23.1 
ERG9* 14(14/0) 26.19 
LCB1 25(25/0) 137.91 
LCB2 32(32/0) 93.11 
OLE1* 10(10/0) 25.33 
SCS2* 18(17/1) 39.26 
SLC1 10(9/1) 37.56 
ERV25* 10(10/0) 50.53 Protein trafficking and 
modification GSF2* 12(12/0 90.56 
SEC63* 27(27/0) 27.66 
RTN1* 25(25/0) 30.54 ER Shape 
IST2* 16(16/0) 79.17  
 
Other/Unknown 
MSC7 15(15/0) 22.47 
SPF1* 42(40/2) 45.92 
TCB3* 14(14/0) 24.2 
TYW1 12(12/0) 63.26 *denotes	  overlapping	  protein	  in	  Sac1	  and	  Scs2	  interactomes	  Proteins	  highlighted	  in	  red	  are	  candidate	  tethers.	  	  	  
Table	  3.2.	  Scs2	  SILAC	  
ORF Total peptides(H/L) Xpress Process 
SCS2* 86(83/3) 163.4 Bait 
DPM1* 33(33/0) 83.33  
 
 
Protein glycosylation 
PMT2* 14(14/1) 56.59 
PMT1* 27(27/0) 49.48 
OST1* 12(11/1) 45.72 
STT3 12(11/1) 82.3 
WBP1* 13(13.0) 40.32 
ERG2* 15(15/0) 43.25  
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ERG9* 12(12/0) 29.34  
 
Lipid metabolism 
ERG11 13(13/0) 40.73 
OLE1* 21(21/0) 101.41 
OSH1 14(14/0) 32.94 
SAC1* 34(31/3) 25.06 
YET1 11(11/0) 37.51 
EMC1 10(10/0) 33.49  
 
 
Protein trafficking and 
modification 
EMP24 14(14/0) 68.17 
ERP1 16(14/2) 32.67 
ERV25* 16(16/0) 99.3 
GPI17 10(10/0) 34.09 
GSF2* 22(22/0) 48.8 
PGA3 10(10/0) 48.19 
SEC63* 19(19/0) 30.4 
STE24 11(11/0) 81.04 
RTN1* 33(30/3) 80.84  
ER shape RTN2 10(10/0) 71.12 
SEY1 43(43/0) 63.49 
IST2* 24(23/1) 70.23  
 
 
Other/Unknown 
PEP4 36(31/5) 50.25 
PEX30 20(20/0) 83.69 
PHO88 14(14/0) 108.11 
SPF1* 41(40/1/) 43.63 
TCB1 24(23/1) 30.54 
TCB3* 30(30/0) 52 *denotes	  overlapping	  protein	  in	  Sac1	  and	  Scs2	  interactomes	  Proteins	  highlighted	  in	  red	  are	  candidate	  tethers.	  	  	  
Table 3.3. Phosphoinositide levels in all strains examined. 
 
Strain 
PI levels (% of the total 3H-labeled PtdIns + PIPs) 
PI3P PI4P PI(3,5)P2 PI(4,5)P2 
Wild type 1.16±0.26 1.39±0.41 0.11±0.04 0.87±0.17 
ist2Δ 1.46±0.36 2.44±0.51 0.11±0.07 0.92±0.50 
tcb1Δ tcb2Δ tcb3Δ 1.66±0.40 1.82±0.70 0.14±0.07 1.00±0.34 
ist2Δ tcb1Δ tcb2Δ tcb3Δ 1.28±0.26 2.60±0.63 0.19±0.16 1.56±1.16 
scs2Δ scs22Δ 1.42±0.22 3.23±1.03 0.27±0.18 1.86±0.66 
scs2Δ scs22Δ tcb1Δ tcb2Δ tcb3Δ 1.48±0.47 3.39±1.04 0.16±0.08 1.48±0.70 
ist2Δ scs2Δ scs22Δ 1.09±0.15 5.79±0.51 0.24±0.07 1.70±0.65 
Δtether: ist2Δ scs2Δ scs22Δ tcb1Δ tcb2Δ tcb3Δ 1.23±0.18 10.1±0.68 0.12±0.03 0.61±0.03 
N=3     
     
Δtether: ist2Δ scs2Δ scs22Δ tcb1Δ tcb2Δ tcb3Δ     
+ [CEN GFP-IST2] 1.82±0.65 4.52±2.11 0.22±0.11 1.46±0.69 
+ [CEN GFP-ist2490-946] 2.08±0.20 5.84±0.13 0.31±0.13 1.70±0.64 
+ [CEN GFP-ist21-928] 2.16±0.63 13.1±2.21 0.14±0.03 0.63±0.18 
+ [CEN SCS2] 2.00±0.04 3.57±0.13 0.16±0.04 1.22±0.50 
+ [CEN scs2 K80A, K84A, K119A, K120A, K122A, K124A] 2.00±0.72 11.3±2.41 0.21±0.02 0.91±0.10 
+ [CEN scs1-225] 1.69±0.45 11.4±2.54 0.11±0.02 0.57±0.28 
+ [empty vector] 2.14±0.10 10.2±0.25 0.14±0.01 0.65±0.01 
N=2     
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All 38°C     
wild type 1.75±0.38 1.58±0.22 0.22±0.02 2.02±0.77 
ist2Δ scs2Δ scs22Δ 1.68±0.41 6.47±1.60 0.21±0.04 0.94±0.13 
sac1Δ [CEN sac1ts] 1.80±0.05 11.6±2.53 0.20±0.04 0.92±0.26 
ist2Δ scs2Δ scs22Δ sac1Δ[CEN sac1ts] 1.52±0.17 13.5±1.01 0.12±0.02 0.39±0.08 
N=3     
 
Yeast strains incubated at the indicated temperatures were labeled and processed as described in 
our Extended Experimental Procedures. The mean peak area (cpm) of each PI species is reported 
as a percentage of the total 3H-labeled lipids. The values reported are the mean (± standard 
deviation) of at least two independent experiments. 
 
 
Table 3.4.  Tethering function of variant Scs2 proteins. 
Scs2  
Substitution  
Cortical ER 
Formationa 
Growth on 
Tunicamycinb 
Growth on  
(–)inositolc  
Scs2 (wild type) ++ ++ ++ 
M226Stop (∆TMD) - - - 
P44S, P51S - - - 
T41A, T42A  - - - 
K80A, K84A, K119A, K120A, K122A, K124A - - - 
K119A, K120A, K122A, K124A -/+ -/+ + 
K80A, K84A ++ ND ND 
L86A ++ ++ ++ 
K84A, L86A + + + 
K84D, L86D -/+ - - 
P44S ++ ND ND 
P51S + -/+ + 
 
aMutant Scs2 proteins bearing the indicated substitutions were expressed in Δtether cells co-
expressing Sec61-GFP, and cortical ER formation was assessed as none/weak/partial/strong (-, 
-/+, +, ++).  
b,cAlso shown are the growth phenotypes on media containing 0.8 µg/ml tunicamycin and 
media lacking inositol (scored as -, -/+, +, ++). No growth (-) indicates the loss of Scs2 
function. ND, not determined. 
bGrowth on tunicamycin correlates with cortical ER formation; see Figures 3.12 and 3.13. 
cGrowth on media lacking inositol monitors interaction with FFAT motifs (see Kaiser et al., 
2005; Loewen and Levine, 2005; Loewen et al., 2007; Kagiwada and Hashimoto, 2007; 
Nakamichi et al., 2011).   
 
 
Table 3.4. Strains used in this study 
Strain Genotype Referenc
e 
SEY621
0 
MATα leu2‐3,112 ura3‐52 his3‐Δ 200 trp1‐Δ901 lys2‐801 suc2‐Δ9 Robinson 
et al., 1988 
SEY621 MATa leu2‐3,112 ura3‐52 his3‐Δ 200 trp1‐Δ901 lys2‐801 suc2‐Δ9 Robinson 
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0.1 et al., 1988 
MFY62 SEY6210.1 sac1∆::TRP1 Foti et al., 
2001 
DBY35
4 
SEY6210.1 scs2∆::TRP1  This study 
DBY35
6 
SEY6210.1 scs2∆::TRP1 scs22∆:: HISMX6 Stefan et 
al., 2011 
JMY55
6 
SEY6210 arg4∆::KANMX6 Macgurn 
et al., 2011 
ANDY1
49 
SEY6210 SAC1-6xHIS-TEV-3xFLAG::TRP1 arg4∆::KANMX6 This Study 
ANDY2
50 
SEY6210.1 scs2∆::TRP1 arg4∆::KANMX6 This Study 
ANDY1
21 
SEY6210 tcb3∆::HISMX6 This Study 
ANDY1
13 
SEY6210.1 ist2∆::HISMX6 This Study 
ANDY1
29 
SEY6210.1 ist2∆::HISMX6 scs2∆::TRP1 scs22∆:: HISMX6 This Study 
ANDY1
51 
SEY6210 SAC1-6xHIS-TEV-3xFLAG::TRP1 ist2∆::HISMX6  This Study 
ANDY1
53 
SEY6210.1 SEC61-GFP::TRP1 ist2∆::HISMX6 scs2∆::TRP1 scs22∆::HISMX6  This Study 
ANDY1
57 
SEY6210.1 SEC61-GFP::KANMX6 This Study 
ANDY1
61 
SEY6210.1 SEC61-GFP::KANMX6 ist2∆::HISMX6 This Study 
ANDY1
63 
SEY6210.1 ist2∆::HISMX6 scs2∆::TRP1 scs22∆::HISMX6 sac1∆::TRP1 and 
harboring pRS416sac1ts-23 
This Study 
ANDY1
73 
SEY6210.1 SEC61-GFP::TRP1 ist2∆::HISMX6 tcb1∆::KANMX6 tcb2∆::KANMX6 
tcb3∆::HISMX6 
This Study 
ANDY1
76 
SEY6210.1 ist2∆::HISMX6 tcb1∆::KANMX6 tcb2∆::KANMX6 tcb3∆::HISMX6 This Study 
ANDY1
85 
SEY6210 SEC61-GFP::KANMX6 tcb1∆::KANMX6 tcb2∆::KANMX6 
tcb3∆::HISMX6 
This Study 
ANDY1
88 
SEY6210.1 SEC61-GFP::KANMX6 scs2∆::TRP1 scs22∆::HISMX6 This Study 
ANDY1
96 
SEY6210.1 scs2∆::TRP1 scs22∆::HISMX6 tcb1∆::KANMX6 tcb2∆::KANMX6 
tcb3∆::HISMX6 
This Study 
ANDY1
98 
SEY6210.1 ist2∆::HISMX6 scs2∆::TRP1 scs22∆::HISMX6 tcb1∆::KANMX6 
tcb2∆::KANMX6 tcb3∆::HISMX6 
This Study 
ANDY2
00 
SEY6210.1 SEC61-GFP::TRP1 scs2∆::TRP1 scs22∆::HISMX6 tcb1∆::KANMX6 
tcb2∆::KANMX6 tcb3∆::HISMX6 
This Study 
ANDY2
01 
SEY6210.1 SEC61-GFP::TRP1 ist2∆::HISMX6 scs2∆::TRP1 scs22∆::HISMX6 
tcb1∆::KANMX6 tcb2∆::KANMX6 tcb3∆::HISMX6 
This Study 
ANDY2
14 
SEY6210.1 tcb1∆::KANMX6 tcb2∆::KANMX6 tcb3∆::HISMX6 This Study 
ANDY2
15 
SEY6210.1 TCB1-GFP::TRP1 This Study 
ANDY2
17 
SEY6210.1 TCB2-GFP::TRP1 This Study 
ANDY2
19 
SEY6210.1 TCB3-GFP::TRP1 This Study 
ANDY2
22 
SEY6210.1 TCB3-GFP::KANMX6 ist2∆::HISMX6 scs2∆::TRP1 scs22∆::HISMX6 This Study 
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ANDY2
33 
SEY6210.1 ist2∆::HISMX6 scs2∆::TRP1 scs22∆::HISMX6 tcb1∆::KANMX6 
tcb2∆::KANMX6 tcb3∆::HISMX6 ire1∆::NATMX and harboring pRS416IRE1 
This Study 
ANDY2
36 
SEY6210.1 ist2∆::HISMX6 scs2∆::TRP1 scs22∆::HISMX6 tcb1∆::KANMX6 
tcb2∆::KANMX6 tcb3∆::HISMX6 ire1∆::NATMX 
This Study 
ANDY2
42 
SEY6210.1 ist2∆::HISMX6 scs2∆::TRP1 scs22∆::HISMX6 tcb1∆::KANMX6 
tcb2∆::KANMX6 tcb3∆::HISMX6 hac1∆::NATMX and harboring pRS416HAC1 
This Study 
 
Table 3.5. Plasmids used in this study 
Plasmid Description Source 
pAM20 pRS416-PIST2-3xHA-IST2 This study 
pAM21 pRS415-PIST2-GFP-IST2 This study 
pAM22 pRS416-PIST2-GFP-IST2 This study 
pAM23 pRS416-PIST2-GFP-ist21-928 This study 
pAM24 pRS416-PIST2-GFP-ist2490-946 This study 
pAM25 pRS416-PIST2-GFP-ist2928-946 This study 
pAM26 pRS416-PIST2-GFP-2xist2928-946 This study 
pAM27 pRS415-PGPD-mCherry-2xist2928-946 This study 
pAM28 pRS416-PSCS2-3xFLAG-SCS2 This study 
pAM29 pRS415-PSCS2-GFP-SCS2 This study 
pAM30 pRS416-PSCS2-GFP-SCS2 This study 
pAM31 pRS416-PSCS2-GFP-scs2 K80A, K84A, K119A, K120A, K122A, K124A This study 
pAM32 pRS416-PSCS2-GFP-scs21-225 This study 
pHY5 pRS416-SCS2 This study 
pHY6 pRS416-scs2 K80A, K84A, K119A, K120A, K122A, K124A This study 
pHY7 pRS416-scs21-225 This study 
pHY8 pRS416-scs2P44S, P51S	   This study 
pHY9 pRS416-scs2T41A, T42A 	   This study 
pHY10 pRS416-scs2K119A, K120A, K122A, K124A This study 
pHY11 pRS416-scs2K80A, K84A This study 
pHY12 pRS416-scs2L86A This study 
pHY13 pRS416-scs2K84A, L86A This study 
pHY14 pRS416-scs2K84D, L86D This study 
pHY15 pRS416-scs2P44S This study 
pHY16 pRS416-scs2P51S This study 
pAM36 pRS416-IRE1 This study 
pAM37 pRS415-PADH1-GFP-SAC1 This study 
pAM38 pRS415-PADH1-GFP-SCS21-129(MSP)-SAC1 This study 
pAM39 pRS416-HAC1 This study 
pYL95 pRS415- PGPD-mCherry-2xPHPlcδ This study 
pAM40 pRS306-DsRED-HDEL This study 
pAM41 pRS305-DsRED-HDEL This study 
pAM42 pRS306-GFP-HDEL This study 
 pRS416-DsRED-HDEL (Audhya and Emr, 2003) 
pCS276 pRS426-PCPY-GFP-2xPHOsh2 (Stefan et al., 2011) 
MFB65 pRS416-sac1ts-23 (Foti et al., 2001) 
pJC104 4xUPRE-PCYC1-lacZ (Cox et al., 1996) 
pAM43 pRS415-TCB3-GFP This study 
pAM44 pRS415-TCB31-491-GFP (This study 
 
 
 
 
	   166 
References  
 
Audhya, A., and Emr, S.D. (2002). Stt4 PI 4-kinase localizes to the plasma membrane and 
functions in the Pkc1-mediated MAP kinase cascade. Dev Cell 2, 593-605. 
 
Audhya, A., and Emr, S.D. (2003). Regulation of PI4,5P2 synthesis by nuclear-cytoplasmic 
shuttling of the Mss4 lipid kinase. EMBO J 22, 4223-4236. 
 
Balla, A., Kim, Y.J., Varnai, P., Szentpetery, Z., Knight, Z., Shokat, K.M., and Balla, T. (2008). 
Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires 
phosphatidylinositol 4-kinase IIIalpha. Mol Biol Cell 19, 711-721. 
 
Breslow, D.K., Collins, S.R., Bodenmiller, B., Aebersold, R., Simons, K., Shevchenko, A., 
Ejsing, C.S., and Weissman, J.S. (2010) Orm family proteins mediate sphingolipid homeostasis. 
Nature 463, 1048-1053. 
 
Caputo, A., Caci, E., Ferrera, L., Pedemonte, N., Barsanti, C., Sondo, E., Pfeffer, U., Ravazzolo, 
R., Zegarra-Moran, O., and Galietta, L.J. (2008). TMEM16A, a membrane protein associated 
with calcium-dependent chloride channel activity. Science 322, 590-594. 
 
Carrasco, S., and Meyer, T. (2011). STIM proteins and the endoplasmic reticulum-plasma 
membrane junctions. Annu Rev Biochem 80, 973-1000. 
 
Cox, J.S., and Walter, P. (1996). A novel mechanism for regulating activity of a transcription 
factor that controls the unfolded protein response. Cell 87, 391-404. 
 
Creutz, C.E., Snyder, S.L., and Schulz, T.A. (2004). Characterization of the yeast tricalbins: 
membrane-bound multi-C2-domain proteins that form complexes involved in membrane 
trafficking. Cell Mol Life Sci 61, 1208-1220. 
 
Estrada, P., Kim, J., Coleman, J., Walker, L., Dunn, B., Takizawa, P., Novick, P., and Ferro-
Novick, S. (2003). Myo4p and She3p are required for cortical ER inheritance in Saccharomyces 
cerevisiae. J Cell Biol 163, 1255-1266. 
 
Faulhammer, F., Konrad, G., Brankatschk, B., Tahirovic, S., Knodler, A., and Mayinger, P. 
(2005). Cell growth-dependent coordination of lipid signaling and glycosylation is mediated by 
interactions between Sac1p and Dpm1p. J Cell Biol 168, 185-191. 
 
Fischer, M.A., Temmerman, K., Ercan, E., Nickel, W., and Seedorf, M. (2009). Binding of 
plasma membrane lipids recruits the yeast integral membrane protein Ist2 to the cortical ER. 
Traffic 10, 1084-1097. 
 
Foti, M., Audhya, A., and Emr, S.D. (2001). Sac1 lipid phosphatase and Stt4 
phosphatidylinositol 4-kinase regulate a pool of phosphatidylinositol 4-phosphate that functions 
in the control of the actin cytoskeleton and vacuole morphology. Mol Biol Cell 12, 2396-2411. 
	   167 
Hammond, G.R., Fischer, M.J., Anderson, K.E., Holdich, J., Koteci, A., Balla, T., and Irvine, 
R.F. (2012). PI4P and PI(4,5)P2 are essential but independent lipid determinants of membrane 
identity. Science 337, 727-730. 
 
Hayashi, M., Raimondi, A., O'Toole, E., Paradise, S., Collesi, C., Cremona, O., Ferguson, S.M., 
and De Camilli, P. (2008). Cell- and stimulus-dependent heterogeneity of synaptic vesicle 
endocytic recycling mechanisms revealed by studies of dynamin 1-null neurons. Proc Natl Acad 
Sci USA 105, 2175-2180. 
 
Hepler, P.K., Palevitz, B.A., Lancelle, S.A., Mccauley, M.M., and Lichtscheidl, I. (1990). 
Cortical Endoplasmic-Reticulum in Plants. Journal of Cell Science 96, 355-373. 
 
Hu, J., Shibata, Y., Zhu, P.P., Voss, C., Rismanchi, N., Prinz, W.A., Rapoport, T.A., and 
Blackstone, C. (2009). A class of dynamin-like GTPases involved in the generation of the 
tubular ER network. Cell 138, 549-561. 
 
Jesch, S.A., Gaspar, M.L., Stefan, C.J., Aregullin, M.A., and Henry, S.A. (2010) Interruption of 
inositol sphingolipid synthesis triggers Stt4p-dependent protein kinase C signaling. J Biol Chem 
285, 41947-41960. 
 
Jonikas, M.C., Collins, S.R., Denic, V., Oh, E., Quan, E.M., Schmid, V., Weibezahn, J., 
Schwappach, B., Walter, P., Weissman, J.S. (2009). Comprehensive characterization of genes 
required for protein folding in the endoplasmic reticulum. Science 323, 1693-1697. 
 
Juschke, C., Wachter, A., Schwappach, B., and Seedorf, M. (2005). SEC18/NSF-independent, 
protein-sorting pathway from the yeast cortical ER to the plasma membrane. J Cell Biol 169, 
613-622. 
 
Kagiwada, S., and Hashimoto, M. (2007). The yeast VAP homolog Scs2p has a 
phosphoinositide-binding ability that is correlated with its activity. Biochem Biophys Res 
Commun 364, 870-876. 
 
Kaiser, S.E., Brickner, J.H., Reilein, A.R., Fenn, T.D., Walter, P., and Brunger, A.T. (2005). 
Structural basis of FFAT motif-mediated ER targeting. Structure 13, 1035-1045. 
 
Kopec, K.O., Alva, V., and Lupas, A.N. (2010) Homology of SMP domains to the TULIP 
superfamily of lipid-binding proteins provides a structural basis for lipid exchange between ER 
and mitochondria. Bioinformatics 26, 1927-1931. 
 
Liou, J., Kim, M.L., Heo, W.D., Jones, J.T., Myers, J.W., Ferrell, J.E., Jr., and Meyer, T. (2005). 
STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol 15, 
1235-1241. 
 
Loewen, C.J., Roy, A., and Levine, T.P. (2003). A conserved ER targeting motif in three families 
of lipid binding proteins and in Opi1p binds VAP. EMBO J 22, 2025-2035. 
 
	   168 
Loewen, C.J., and Levine, T.P. (2005). A highly conserved binding site in vesicle-associated 
membrane protein-associated protein (VAP) for the FFAT motif of lipid-binding proteins. J Biol 
Chem 280, 14097-14104. 
 
Loewen, C.J., Young, B.P., Tavassoli, S., and Levine, T.P. (2007). Inheritance of cortical ER in 
yeast is required for normal septin organization. J Cell Biol 179, 467-483. 
 
Longtine, M.S., McKenzie, A., 3rd, Demarini, D.J., Shah, N.G., Wach, A., Brachat, A., 
Philippsen, P., and Pringle, J.R. (1998). Additional modules for versatile and economical PCR-
based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14, 953-961. 
 
MacGurn, J.A., Hsu, P.C., Smolka, M.B., and Emr, S.D. (2011) TORC1 regulates endocytosis 
via Npr1-mediated Phosphoinhibition of a ubiquitin ligase adaptor. Cell 147, 1104-1117. 
 
Nakamichi, S., Yamanaka, K., Suzuki, M., Watanabe, T., and Kagiwada, S. (2011) Human 
VAPA and the yeast VAP Scs2p with an altered proline distribution can phenocopy amyotrophic 
lateral sclerosis-associated VAPB(P56S). Biochem Biophys Res Commun 404, 605-609. 
 
Park, C.Y., Hoover, P.J., Mullins, F.M., Bachhawat, P., Covington, E.D., Raunser, S., Walz, T., 
Garcia, K.C., Dolmetsch, R.E., and Lewis, R.S. (2009). STIM1 clusters and activates CRAC 
channels via direct binding of a cytosolic domain to Orai1. Cell 136, 876-890. 
 
Peretti, D., Dahan, N., Shimoni, E., Hirschberg, K., and Lev, S. (2008). Coordinated lipid 
transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins 
and is essential for Golgi-mediated transport. Mol Biol Cell 19, 3871-3884. 
 
Pichler, H., Gaigg, B., Hrastnik, C., Achleitner, G., Kohlwein, S.D., Zellnig, G., Perktold, A., 
and Daum, G. (2001). A subfraction of the yeast endoplasmic reticulum associates with the 
plasma membrane and has a high capacity to synthesize lipids. Eur J Biochem 268, 2351-2361. 
 
Porter, K.R., and Palade, G.E. (1957). Studies on the endoplasmic reticulum. III. Its form and 
distribution in striated muscle cells. J Biophys Biochem Cytol 3, 269-300. 
 
Robinson, J.S., Klionsky, D.J., Banta, L.M., and Emr, S.D. (1988). Protein sorting in 
Saccharomyces cerevisiae: isolation of mutants defective in the delivery and processing of 
multiple vacuolar hydrolases. Mol Cell Biol 8, 4936-4948. 
 
Rocha, N., Kuijl, C., van der Kant, R., Janssen, L., Houben, D., Janssen, H., Zwart, W., and 
Neefjes, J. (2009). Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-
RILP-p150 Glued and late endosome positioning. J Cell Biol 185, 1209-1225. 
 
Roy, A., and Levine, T.P. (2004). Multiple pools of phosphatidylinositol 4-phosphate detected 
using the pleckstrin homology domain of Osh2p. J Biol Chem 279, 44683-44689. 
 
	   169 
Schulz, T.A., Choi, M.G., Raychaudhuri, S., Mears, J.A., Ghirlando, R., Hinshaw, J.E., and Prinz, 
W.A. (2009). Lipid-regulated sterol transfer between closely apposed membranes by oxysterol-
binding protein homologues. J Cell Biol 187, 889-903. 
 
Schulz, T.A., and Creutz, C.E. (2004). The tricalbin C2 domains: lipid-binding properties of a 
novel, synaptotagmin-like yeast protein family. Biochemistry 43, 3987-3995. 
 
Shepard, K.A., Gerber, A.P., Jambhekar, A., Takizawa, P.A., Brown, P.O., Herschlag, D., 
DeRisi, J.L., and Vale, R.D. (2003). Widespread cytoplasmic mRNA transport in yeast: 
identification of 22 bud-localized transcripts using DNA microarray analysis. Proc Natl Acad Sci 
USA 100, 11429-11434. 
 
Shibata, Y., Voeltz, G.K., and Rapoport, T.A. (2006). Rough sheets and smooth tubules. Cell 
126, 435-439. 
 
Stefan, C.J., Manford, A.G., Baird, D., Yamada-Hanff, J., Mao, Y., and Emr, S.D. (2011). Osh 
proteins regulate phosphoinositide metabolism at ER-plasma membrane contact sites. Cell 144, 
389-401. 
 
Suzuki, E., and Hirosawa, K. (1994). Immunolocalization of a Drosophila phosphatidylinositol 
transfer protein (rdgB) in normal and rdgA mutant photoreceptor cells with special reference to 
the subrhabdomeric cisternae. J Electron Microsc 43, 183-189. 
 
Thibault, G., Ismail, N., and Ng, D.T. (2011) The unfolded protein response supports cellular 
robustness as a broad-spectrum compensatory pathway. Proc Natl Acad Sci USA 108, 20597-
20602. 
 
Toulmay, A., and Prinz, W.A. (2011). Lipid transfer and signaling at organelle contact sites: the 
tip of the iceberg. Curr Opin Cell Biol 23, 458-463. 
 
Toulmay, A., and Prinz, W.A. (2012). A conserved membrane-binding domain targets proteins 
to organelle contact sites. J Cell Sci 125, 49-58. 
 
Travers, K.J., Patil, C.K., Wodicka, L., Lockhart, D.J., Weissman, J.S., and Walter, P. (2000). 
Functional and genomic analyses reveal an essential coordination between the unfolded protein 
response and ER-associated degradation. Cell 101, 249-258. 
 
Voeltz, G.K., Prinz, W.A., Shibata, Y., Rist, J.M., and Rapoport, T.A. (2006). A class of 
membrane proteins shaping the tubular endoplasmic reticulum. Cell 124, 573-586. 
 
West, M., Zurek, N., Hoenger, A., and Voeltz, G.K. (2011). A 3D analysis of yeast ER structure 
reveals how ER domains are organized by membrane curvature. J Cell Biol 193, 333-346. 
 
Wilson, J.D., Thompson, S.L., and Barlowe, C. (2011).Yet1p-Yet3p interacts with Scs2p-Opi1p 
to regulate ER localization of the Opi1p repressor. Mol Biol Cell 22, 1430-1439. 
 
	   170 
Wolf, W., Kilic, A., Schrul, B., Lorenz, H., Schwappach, B., and Seedorf, M. (2012) Yeast Ist2 
recruits the endoplasmic reticulum to the plasma membrane and creates a ribosome-free 
membrane microcompartment. PLoS One 7, e39703. 
 
Yang, Y.D., Cho, H., Koo, J.Y., Tak, M.H., Cho, Y., Shim, W.S., Park, S.P., Lee, J., Lee, B., 
Kim, B.M., et al. (2008). TMEM16A confers receptor-activated calcium-dependent chloride 
conductance. Nature 455, 1210-1215. 
 
Yavari, A., Nagaraj, R., Owusu-Ansah, E., Folick, A., Ngo, K., Hillman, T., Call, G., Rohatgi, R., 
Scott, M.P., and Banerjee, U. (2010) Role of lipid metabolism in smoothened derepression in 
hedgehog signaling. Dev Cell 19, 54-65. 
 
  
 
	   171 
Chapter V 
Conclusions and future directions 
  
ER-PM contacts are important platforms for direct intracellular communication between 
the ER and PM. However, despite being first described in the 1950s, the research on these 
conserved structures in many systems had remained mostly limited to Ca2+ signaling in muscle 
cells. In the last decade, research on the functions of ER-PM contact sites has expanded, yet how 
these junctions are formed in many systems is not known. Through the work presented in my 
thesis focusing on understanding the paradox of how ER localized Sac1 regulates PI4P on the 
PM, we have uncovered both the mechanism of Sac1 function and ER-PM contact site formation 
in yeast. Our work has identified conserved families of ER-PM tethering proteins in yeast that 
mediate ER-PM junction formation and are required for Sac1 regulation of PM PI4P. Notably we 
uncovered a novel function for ER-PM contacts in maintaining ER homeostasis and function. In 
addition we discovered an important new and shared role for the yeast oxysterol binding proteins 
in regulating Sac1 and PI4P metabolism at ER-PM contact sites. Hopefully our studies will serve 
as a foundation for future work on ER-PM contacts in other systems.  
Since we started the initial investigations on PI4P regulation at ER-PM contacts, the field 
of ER-PM and ER-organelle contacts has expanded, with a large amount of exciting research 
being published. These new studies, together with our work, have increased the understanding of 
ER-PM contact site formation and function. However, new questions and puzzles have arisen 
that will drive future research in this area. In the following section the culmination of this 
exciting recent work on ER-PM contacts will be highlighted and the important next questions 
will be discussed. 
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ER-PM tethering proteins 
 In chapter four, we elucidated the mechanism for ER-PM tethering in yeast. Out of the 
six proteins identified, the VAP protein Scs2 was the most critical component of ER-PM 
tethering. Scs2 was first implicated in ER-PM contacts by the Levine group and our subsequent 
work found that deletion of Scs2 was required to reveal the additive phenotypes of deletion 
mutants of the other tethering genes (Loewen et al., 2007; Manford et al., 2012). However, 
unlike Ist2 and the tricalbins, the mechanism of how VAP proteins tether organelles is still an 
outstanding question. Scs2 is critical for ER-PM tethering in yeast and is sufficient to rescue 
many of the ER-PM defects in the Δtether cells (Manford et al., 2012). In addition, in another 
critical difference from the other tethers identified, Scs2/VAP localize to all of the ER in yeast 
and mammalian cells (Alpy et al., 2013; Loewen et al., 2003). This suggests a regulated 
mechanism for the VAP tethering function, where it’s tethering is activated at ER-organelle 
junctions. One simple mechanism for this localized tethering activation is through specific 
interactions with FFAT containing proteins. In yeast and mammalian cells the VAP proteins 
have been shown to bind lipid transfer proteins that contain the VAP binding FFAT motif, but 
also PH domains that would bind phosphoinositides on another organelle (Kawano, 2006; Lehto 
et al., 2005; Loewen et al., 2003; Mesmin et al., 2013; Peretti et al., 2008; Rocha et al., 2009). In 
addition, recent work in mammalian cells has identified transmembrane proteins on endosomes 
that contain FFAT motifs that interact with the VAP proteins (Alpy et al., 2013). However, in 
many of these mammalian experiments both a VAP protein and an FFAT containing proteins are 
over expressed, resulting in large induced ER-Golgi or ER-Endosome contacts. Determining 
whether these proteins mediate these contacts at endogenous expression levels is difficult, but is 
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needed to address whether these are important for tethering complexes or simply recruiting 
proteins to these junctions. In support of this, at least for ER-PM tethering in yeast, no FFAT 
containing proteins can recapitulate the scs2 ER-PM tethering mutant phenotype (Loewen et al., 
2007). Thus, it is still an open question for how the VAP proteins mediated tethering in yeast and 
in other systems. Whether there are unidentified PM localized FFAT containing proteins that 
mediate the Scs2 tethering function or a completely FFAT independent mechanism are questions 
that remain to be addressed. In addition, if FFAT interactions are independent of VAP tethering 
function, elucidating how lipid transfer protein recruitment and ER-organelle tethering are 
integrated together is an important question. Taking advantage of Scs2 phenotypes that are 
dependent on FFAT binding (inositol auxotrophy) and tethering (sensitivity to tunicamycin) 
could be used to screen for separation of function alleles of SCS2. In addition, identifying 
potential PM binding partners of Scs2 could provide a mechanism for ER-PM tethering. As we 
have generated an Scs2 interactome, candidate tests for ER-tethering defects could be done for 
all PM proteins identified by our Scs2 mass spec analysis.  
In addition to the yeast VAP proteins, two other families of tethering proteins mediate 
ER-PM contacts in yeast (Manford et al., 2012; Toulmay and Prinz, 2012; Wolf et al., 2012). 
These proteins are conserved in mammalian cells and likely facilitate ER-organelle tethering 
other systems. While the VAP proteins discussed above have known roles in tethering in higher 
eukaryotes, it was not known if relatives of Ist2 or tricalbins (mammalian extended 
synaptotagmin (E-Syt)) function as tethers. In fact the E-Syts had been shown to be PM proteins 
(Min et al., 2007). A recent paper reexamined the localization of these proteins, in part due to the 
recent observations in yeast. Consistent with the yeast work, E-Syt2 and E-Syt3 localized to the 
cortex of cells, but also colocalized with ER markers (Giordano et al., 2013). This indicates that 
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although E-Syt2 and E-Syt3 appear to be a PM proteins, overexpression actually induces massive 
cER formation. Interestingly expression of E-Syt1 did not induce cER and it localized 
throughout the ER network, but upon increased cytoplasmic Ca2+ E-Syt1 dramatically induced 
ER-PM contacts. Importantly, knock down of all three E-Syts was shown to significantly 
reduced the levels of ER-PM contact, confirming that the E-Syts at endogenous expression levels 
is required for a portion of the ER-PM contacts in the cell (Giordano et al., 2013). Surprisingly, 
the triple knock down cells still could induce a STIM1 translocation and store operated calcium 
entry (SOCE see below), indicating that though reduced, ER-PM contacts were still present.  
 Another recent study uncovered a role for E-Syt1 induced ER-PM contacts in linking two 
established ER-PM contact site functions, lipid transfer and SOCE Ca2+ signaling. As reviewed 
in the introduction chapter, upon activation PLC, large amounts of PIP2 is hydrolyzed on the PM 
releasing IP3. IP3 binds to the IP3 receptor, triggering the release of the Ca2+ stores in the ER. 
This drop in ER Ca2+ stores induces STIM oligomerization and translocation to ER-PM contacts, 
where the STIM proteins subsequently activate the PM Ca2+ channel ORAI (reviewed in 
Carrasco and Meyer, 2011). Using a genetically encoded fluorescent ER-PM reporter and TIRF 
microscopy, this new study found that upon the increase cytoplasmic pool of Ca2+ from SOCE, 
there was an increase in the number ER-PM junctions and the distance of the ER to the PM 
became smaller (Chang et al., 2013). Consistent with the findings of the study described in the 
previous paragraph, the increase in number and tightening of ER-PM contacts was mediated by 
the calcium regulated extended synaptotagmin, E-Syt1. The authors reasoned that a likely 
function for increasing the number and shortening the distance of ER-PM contacts was for lipid 
transfer of phosphatidylinositol for the regeneration of PI(4,5)P2. This is a similar to function 
rdgB PI transfer protein and the specialized ER-PM contacts in the fly eye. Consistent with this 
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hypothesis, the mammalian homolog of rdgB, Nir2, was recruited to ER-PM junctions after Ca2+ 
elevation in an E-Syt1 dependent manner. Nir2 also contains a FFAT motif and its localization to 
the ER-PM junction requires interaction with VAPA, which was also recruited to these sites after 
Ca2+ elevation. Notably, PI(4,5)P2 regeneration for subsequent rounds of signaling was impaired 
in cells treated with siRNAs to Nir2 or E-Syt1 (Chang et al., 2013).. Taken together both of 
theses recent studies identify a conserved role for the tricalbin/E-Syts in ER-PM tethering in 
mammalian cells and integrate them into two important functions for ER-PM contacts. In 
addition the SOCE signaling pathway now possess a phosphoinositide cycle, with PI(4,5)P2 
hydrolysis at the beginning of the cycle and PI(4,5)P2 generation at the end.  
As indicated in both of these studies, the E-Syts are not the only ER-PM tethers in 
mammalian cells. It is still unknown what additional proteins facilitate the stable ER-PM 
contacts in mammalian cells and identifying these factors is an important next step for future 
work. Intriguingly, the other tethering protein identified in yeast, Ist2, has at least 10 family 
members of the TMEM16/anoctamin family of proteins in mammalian cells and it is unknown if 
whether any of these function as tethers (Duran et al., 2012). As highlighted in yeast, redundancy 
may play a major role in ER-PM tethering in higher eukaryotes. Thus siRNA screens that have 
identified components of SOCE, may have missed the ER-PM tethering proteins. Similar 
proteomic approaches to the ones described in chapter 4, using proteins that function at these 
sites as baits, could be helpful to identify additional mammalian tethering proteins.  
 
The mechanism of ORP PI4P regulation 
 In chapter three we uncovered a role for the yeast oxysterol-binding homology 
(OSH) family of lipid transfer proteins as key regulators of PI4P metabolism. OSH mutants, 
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where all seven family members are deleted, exhibit a massive accumulation of PI4P in cells, 
which can be mitigated by expression of any one of the Osh proteins. This indicates that a shared 
and likely essential function of all of the Osh proteins is in PI4P regulation. The accumulation of 
PI4P in osh mutants was through regulation of Sac1 PI4P phosphatase function, as osh/sac1 
double mutants do not have a further increase in PI4P levels beyond that of Osh alone. 
Consistent with this the conserved ORD domain of the Osh proteins can stimulate Sac1 
phosphatase activity in vitro. However the details of the Osh-Sac1 regulation mechanism is 
unclear. We proposed that the Osh proteins could bind and present PI4P substrate to Sac1 that 
was acting in trans from the ER to the PI4P on the PM. The presentation model for a lipid-
modifying enzyme has been suggested for Sec14 PI transfer proteins that bind PI and stimulate 
PI4-kinase activity (Schaaf et al., 2008). Interestingly, recent studies have provided new 
structural details into the Osh-PI4P interaction. Although all of the Osh proteins were assumed to 
bind sterols in their conserved oxysterol binding protein related domain (ORD), complexes of 
ORD domains of Osh3 and Osh4 bound to PI4P have been recently solved (de Saint-Jean et al., 
2011; Tong et al., 2013). These structures revealed that Osh4 binds PI4P and sterol in the same 
conserved pocket, while Osh3’s ORD cannot bind sterol at all, consistent with the low sterol 
transfer activity of Osh3. Intriguingly, the structure of the ORD domain of Osh3 bound to PI4P 
demonstrate that the residues which facilitate PI4P binding are conserved amongst ORD domains 
and those specifically involved in sterol binding in Osh4 are not. This is consistent with PI4P 
metabolism being a shared function of the Osh proteins.  
These structures raise new questions on how PI4P binding by the Osh protein integrates 
into Sac1 PI4P turnover. It has been proposed for the mammalian oxysterol binding protein 
(OSBP) and Osh4 that sterol and PI4P transfer is coupled, where sterol delivery to the Golgi 
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would result in PI4P transfer back to the ER for Sac1 turnover in cis (de Saint-Jean et al., 2011; 
Mesmin et al., 2013). A reconstitution of this process was recently published and the ORD 
domains of Osh4 and OSBP can transfer PI4P in vitro (Mesmin et al., 2013). However, as 
highlighted in the introduction, the evidence of PI4P transfer specifically in vivo is lacking. 
Whether this is the primary mechanism for Sac1 PI4P regulation in vivo, especially at the PM, 
remains to be addressed. To complicate the Osh family even further, Osh6 and Osh7 have 
recently been shown to primarily bind phosphatidylserine (PS) in vivo and mediate transfer of PS 
from the ER to the PM (Maeda et al., 2013). In the most convincing demonstration of an in vivo 
transfer activity by an Osh protein, retargeting Osh6 to the ER-vacuole contacts result in the 
detection of PS on the vacuole membrane. This mix of various lipid transfer substrates of the 
Osh family, but a shared function in PI4P regulation provides ample opportunity for future 
investigation. In the short term, direct in vivo tests for trans and cis activities of Sac1 would shed 
light on the primary mechanism of Sac1 PI4P regulation. We have generated Sac1 mutants that 
may function only in cis which could be used to address this question. 
 
Identifying new functions for ER-PM contacts  
An important and novel phenotype of yeast cells lacking ER-PM contacts is the induction 
of the unfolded protein response (UPR). In chapter four we reasoned that this constitutive UPR 
signaling and the requirement for this signaling to maintain viability of Δtether cells, indicated 
that the UPR was compensating the disruption to pathways or process in the ER that require 
these contacts for function. However, we were unable to determine the pathways or processes 
that were affected in this mutant, and therefore could not identify potential new functions for ER-
PM contacts. Although we have tested specific pathways directly in chapter 4, more global 
	   178 
approaches, such as expression profiling, would be more comprehensive in identifying all the 
perturbation in Δtether cells. This approach has been a successful in identifying specific subsets 
of UPR regulated genes that are induced in mutants that rely on UPR signaling for viability 
(Thibault et al., 2011; 2012). This analysis helped determine which pathways are upregulated by 
the UPR to compensate for the ER dysfunction in these mutants. In addition, as the UPR 
counteracts defects Δtether cells, assaying Δtether cells with a crippled or conditional UPR 
system would reveal more potent phenotypes. Alternatively, isolating suppressors of 
Δtether/UPR double mutants could identify pathways linked to ER-PM contact phenotypes. In 
addition to identifying more functions in yeast, as more is understood about the proteins that 
tether ER and PM in other systems, additional phenotypes will likely be discovered in higher 
eukaryotes. Furthermore, testing if the functions identified in yeast are conserved or whether ER-
PM contacts have a role in development are exciting questions to be addressed.  
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Abstract 
Sac family phosphoinositide phosphatases are an essential family of CX5R(T/S) based 
enzymes, involved in numerous aspects of cellular function such as  phosphoinositide 
homeostasis, cellular signaling, and membrane trafficking. Genetic deletions of several Sac 
family members result in lethality in animal models and mutations of the Sac3 gene have been 
found in human hereditary diseases.  Here we report the crystal structure of a founding member 
of this family, the Sac phosphatase domain of yeast Sac1. The 2.0 Å resolution structure reveals 
that the Sac domain is comprised of two closely packed sub-domains, a novel N-terminal sub-
domain and the phosphoinositide phosphatase catalytic sub-domain. The structure further reveals 
a striking conformation of the catalytic P-loop and a large positively charged groove at the 
catalytic site. These findings suggest an unusual mechanism for its dephosphorylation function. 
Homology structural model of human Fig4/Sac3 allows the mapping of several disease related 
mutations and provides a framework for the understanding of the molecular mechanisms of 
human diseases.  
 
 
 
 
 
 
 
 
 
 183 
Introduction 
Phosphoinositides (PIs) control numerous cellular processes such as cell signaling, 
proliferation, cytoskeleton organization, membrane trafficking, ion channel activity, transcription 
and mRNA trafficking (De Matteis and Godi, 2004; Di Paolo and De Camilli, 2006; Odorizzi et 
al., 2000). PIs localize at membrane-cytoplasmic interfaces and achieve their functions through 
the binding of proteins to their cytoplasmic-exposed phosphorylated inositol head groups, which 
can be reversibly phosphorylated at the 3’, 4’, and 5’ positions to generate an ensemble of seven 
biological active derivatives. Each PI isoform has a specific intracellular distribution, which 
provides spatial and temporal cues within the cell for PI-binding proteins. The recruitment of 
specific PI-binding proteins promotes the assembly of macromolecular complexes to initiate a 
series of physiological events including membrane trafficking and cytoskeletal dynamics. 
Moreover, in response to extracellular stimuli, PIs also serve as precursors for second messagers 
to initiate downstream intracellular signaling pathways. To maintain the selective concentration 
of specific PI species, as well as to generate the dynamic PI composition changes in response to 
acute signaling inputs, eukaryotic cells encode a large number of PI metabolizing enzymes: 
including PI kinases and PI phosphatases. Despite their physiological importance, the properties 
of many of these enzymes remain poorly characterized.  
One class of these enzymes contains a conserved PI phosphatase module termed the Sac 
domain. The Sac phosphatase domain comprises approximately 500 amino acids and contains 
seven highly conserved motifs including the conserved catalytic CX5R(T/S) motif, which is 
essential for catalytic activity (Hughes et al., 2000a). There are five Sac phosphatase domain-
containing proteins in human, which appear to fall into two subfamilies. Members of the first 
subfamily, including the transmembrane protein Sac1, cytosolic proteins Sac2/INPP5f, and 
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Sac3/Fig4, have an N-terminal Sac phosphatase and no other recognizable structural domains. 
The second subfamily comprises two synaptojanin homologues, which have a PI 5-phosphatase 
domain immediately after the N-terminal Sac phosphatase module (Figure A1.1). In yeast, there 
are also five Sac domain-containing enzymes including Sac1, Fig4 and three synaptojanin like 
proteins (Sjl1,2,3)  
Sac1 is a 67kD type II membrane protein that localizes to the endoplasmic reticulum (ER) 
and Golgi apparatus (Nemoto et al., 2000; Whitters et al., 1993). It was originally identified by 
two independent genetic screens searching for modifiers of actin cytoskeleton defects and of 
trans-Golgi network exocytic failure caused by inactivation of Sec14p, the major yeast 
phosphatidylinositol/phosphatidylcholine transfer protein (Bankaitis et al., 1990; Cleves et al., 
1989; Novick et al., 1989). In yeast, loss of Sac1 function has been implicated in a broad range 
of cellular defects (Strahl and Thorner, 2007), such as disorganization of the actin cytoskeleton 
(Novick et al., 1989), inositol auxotrophy (Whitters et al., 1993), cold sensitivity for growth 
(Novick et al., 1989), multiple drug sensitivities (Hughes et al., 1999), abnormal vacuolar 
morphology (Foti et al., 2001; Tahirovic et al., 2005), cell wall defects (Schorr et al., 2001), and 
unbalanced sphingolipid synthesis (Brice et al., 2009). Sac1 mutants in Drosophila die as 
embryos with defects in dorsal closure (Wei et al., 2003). Mouse strains deficient in Sac1 are 
embryonic lethal (Liu et al., 2009; Liu et al., 2008). Knock-down of Sac1 expression in 
mammalian cell lines results in disorganization of Golgi membranes and mitotic spindles (Liu et 
al., 2009; Liu et al., 2008). These findings suggest essential roles for Sac1 mediated PI 
metabolism in multicellular organisms.  
In vitro studies have demonstrated that Sac1 dephosphorylates a number of PIs, including 
PI(3)P, PI(4)P, and PI(3,5)P2 (Guo et al., 1999). In vivo, genetic ablation of Sac1 activity in yeast 
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results in a 10-fold increase in the steady state levels of PI(4)P with little effect on PI(4,5)P2 and 
modest increases in the levels of the 3-OH PIP species (Guo et al., 1999; Nemoto et al., 2000; 
Rivas et al., 1999), suggesting that yeast Sac1 is a major pathway for PI(4)P dephosphorylation 
in vivo.  
While Sac1 primarily dephosphorylates PI(4)P, other Sac phosphatase members have 
been shown to regulate other PI isoforms in vivo. Fig4 (Sac3 in mammal) was originally 
identified in a screen for genes induced by mating pheromone in S. cerevisiae (Erdman et al., 
1998). Sac3 is a phosphoinositide 5-phosphatase that specifically hydrolyzes PI(3,5)P2 to 
generate PI(3)P both in vitro and in vivo (Duex et al., 2006a; Duex et al., 2006b; Rudge et al., 
2004). Interestingly, Sac3/Fig4p forms a complex with a PI(3)P-5-kinase Fab1p and a scaffold 
protein Vac14p. This complex is also conserved in mammals and is responsible for the acute 
regulation of subcellular levels of PI(3,5)P2 (Botelho et al., 2008; Jin et al., 2008; Sbrissa et al., 
2008). Genetic mutations affecting the function of Sac3/Fig4 lead to neurological diseases, 
including Charcot-Marie-Tooth (CMT) disease Type 4J, a subset of Amyotrophic Lateral 
Sclerosis (ALS) in human,  and neurodegeneration in the pale tremor mouse (Chow et al., 2009; 
Chow et al., 2007). 
Despite considerable attention on Sac domain-containing proteins, a lack of structural 
information of this unique Sac phosphatase domain has left large gaps in our knowledge of this 
protein family. For example, each Sac phosphatase prefers a specific subgroup of PIs as 
substrates, but how the substrate specificity is determined by the otherwise homologous 
phosphatase region is unresolved.  Mutations have been mapped to Sac3/Fig4 in patients with 
CMT 4J and ALS, but how the function of the enzyme is impaired in disease mutants is still not 
understood.  Hence, we performed structural studies on the Sac phosphatase. Here we report the 
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first crystal structure of a Sac phosphatase, the yeast Sac1. The structure reveals a strikingly 
different configuration of the catalytic motif compared to protein tyrosine phosphatases and a 
large positively charged groove at the catalytic site which is surrounded by flexible loops 
enriched with hydrophobic and anionic residues. Our results further provide insights into the 
molecular mechanism for the enzymatic function of Sac phosphatases and suggest how 
mutations in Sac3/Fig4 affect its normal function in two human neuronal degeneration diseases 
(CMT4J and ALS). 
 
Materials and Methods 
Protein expression and purification 
The DNA sequence encoding a variety portions of the cytoplasmic Sac domain of wild 
type yeast Sac1 were PCR amplified and subcloned into a pET28 based bacterial expression 
vector in frame with an N-terminal His-sumo tag. The constructs were confirmed by DNA 
sequencing. Recombinant proteins were over expressed in E.coli. BL21 cells. The 
selenomethionine substituted proteins were expressed in M9 minimum media supplied with 
Drop-out mix synthetic minus methionine powder (USBiological) and selenomethionine powder 
was added upon induction. Recombinant proteins were purified with metal affinity beads 
(Clontech). The His-sumo tag was removed by the sumo specific protease Ulp1 during over 
night dialysis in a buffer of 20 mM hepes, pH 7.3, 20 mM NaCl, 5 mM β-mercaptoethanol. The 
cutting mixture was further purified by Hi-trap Q column followed by gel filtration. The peak 
corresponding to Sac1 was pooled and concentrated to 10 mg/ml in a buffer containing 20 mM 
Hepes, pH 7.3, 20 mM NaCl, 10 mM DTT.  
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Crystallization and preliminary X-ray crystallographic analysis 
 Crystallization trials were set up with a PHENIX liquid handling system (Art Robbins 
Instruments). The construct containing residues 1-503 of ySac1 yielded crystals and thus was 
pursued for further structural analysis. Sac1 crystals used for native data set were grown by 
hanging drop vapor diffusion at 4 0C by mixing protein (10 mg/ml) with reservoir solution 
containing 1.5 M NaCl, 0.1 M Na Citrate pH 7.5, 0.45 M Na Citrate in 1:1 ratio (v/v). Crystals 
were quite sensitive to pH and obtained in the pH range of 5.5-5.9. SeMet-Sac1 crystals were 
grown under similar conditions. Crystals were transferred into the same solution supplemented 
with 20% glycerol before cooling to 100K in a nitrogen stream. The crystal diffracted up to 1.97 
Å at the Cornell synchrotron light source, MacCHESS beam line A1. The crystal belongs to 
space group I222 with a=86.16 Å; b=94.7 Å 3; c=155.44 Å; α=β=γ=90 with the calculated 
Matthews coefficient Vm= 2.88 and with 57.3% of solvent in the crystal and one protein 
molecule in an asymmetric unit (Matthews, 1968). All the X-ray diffraction data were processed 
by using hkl2000 (Otwinowski and Minor, 1997). 
 
Structure determination and refinement 
 A complete three wavelength data set was collected at wavelengths around the selenium 
K edge. However, due to crystal decay during data collection, only the data collected at the peak 
wavelength (0.9794 Å) was used for phasing. The initial phase was calculated by single 
wavelength anomalous diffraction method (SAD) using the program HKL2MAP (Pape and 
Schneider, 2004). Since there are only a total of 4 methionine sites (including the NH2-terminal 
starting codon) in the 503-residue Sac1 domain, the anomalous signal contributed by selenium 
atoms was relatively weak and the initial electron density is not of quality expected for a 2.2 Å 
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resolution anomalous data set. The ab initio protein model was built manually in Xtalview 
(McRee, 1999) with the aid of automatic modeling building by using program ARP/wARP 7.0 
(Perrakis et al., 1999) in the CCP4 program suite (Collaborative Computational Project, 1994). 
The model was completed by iterative model building with COOT (Emsley and Cowtan, 2004) 
refinement with CNS (Brunger et al., 1998).  The amino acids beyond 456 were not visible in 
electron density maps and presumed to be disordered.  The final Sac1 structure consists of 1-456 
amino acids with excellent stereochemistry and good crystallographic statistics (Table A1.1). 
 
Homology structure modeling 
For Sac3 homology modeling, the Sac1 crystal structure was used as the template for 
modeling. Secondary structure prediction on the Sac3 sequence was done using the PSIPRED 
program (McGuffin et al., 2000). The CLUSATLW2 program (Labarga et al., 2007) was used to 
get the best sequence alignment between Sac3 and Sac1 using secondary structures as constraints. 
The Sac3 homology model was built using the computational Modeler 9V4 program (Sali et al., 
2008). The Sac3 structure was further refined and validated using Ramachandran plot analysis 
indicating no residues in disallowed regions. 
 
Yeast in vivo experiments and PI analysis 
SAC1 was cloned into pGOGFP N-terminal GFP vector (Odorizzi et al., 1998) with BglII 
and Sal1. Point mutants were constructed from the pGOGFP-SAC1 template by site directed 
mutagenesis and confirmed by sequencing. The resultant constructs were transformed into sac1Δ 
yeast cells (strain MFY62) (Foti et al., 2001).  For the cold sensitive growth assay, transformants 
were grown to midlog (OD600=0.5), adjusted to 1OD/ml, serially diluted 1:10 3 times,  spotted 
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onto selection plates, and left at 15°C for 6 days. For Western blot, 5 OD600 of midlog cells were 
harvested, precipitated in 10% Trichloroacetic acid, washed 2x in Acetone, and bead beated in 
sample buffer. 1 OD600 equivalent of the samples were run on an 8% SDS PAGE and 
immunoblotted against GFP (Santa Cruz Biotechnology sc-9996) and G6PDH (Sigma A-0251). 
Intracellular PI level analysis was performed as previously described (Botelho et al., 2008). 
Briefly, cells transformed with control empty vector or vector harboring WT or mutant Sac1 
were grown to log phase. Cells (5 OD600) were harvested, washed in media lacking inositol, and 
labeled with myo-[2-3H] inositol for 1 hour. Lipids were deacylated, glycerophospholipids were 
extracted, and 107 cpm of samples were separated by HPLC. 
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Results 
Structure Determination and Overall Structure 
The cytosolic portion of yeast Sac1 (residues 1-503) was expressed as an N-terminal His-
sumo-tagged fusion protein. Crystals were obtained by using hang drop vapor diffusion method 
with the reservoir solution containing 0.55 M Na Citrate (pH 7.0) and 1.5 M NaCl. The crystals 
formed in space group I222 with unit cell dimensions of a=86.16 Å; b=94.73 Å; c=155.44 Å and 
one molecule in the asymmetric unit. The structure was solved by selenomethionine single 
wavelength anomalous diffraction method (SAD) using the program HKL2MAP (Pape and 
Schneider, 2004). The final structure was refined against a 1.97 Å resolution data to a 
crystallographic Rwork = 20.1% and Rfree = 24.2% (Table A1.1).  
The crystal structure of the Sac domain of yeast Sac1p represents the first atomic 
structure of the approximate 500-residue Sac domain family. Figure A1.2 displays the ribbon 
diagram of the Sac phosphatase domain of yeast Sac1p. The overall structure has a dimension of 
about 65 x 35 x 70 Å, which can be divided into two domains, an N-terminal domain (residue 1-
182 shown in blue and referred as the SacN domain thereafter) and a roughly 320-residue C-
terminal catalytic domain (shown in yellow), which contains the CX5R(T/S) catalytic motif.  It is 
also worth noting that in the Sac1 structure, there is a peptide stretch of about 40 residues at the 
COOH-terminus lacking any electron density, suggesting a flexible nature of this region. 
 
The SacN domain of Sac1 has a unique fold 
The SacN domain is comprised of three layers of β sheets and one long and three short α 
helices. The first layer of β sheet contains anti-parallel β1 to β5. The second layer consists of β6 
and half of the long and twisted β7 to β8. The first and second β sheet layers stack on each other  
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Table A1.1 Data collection, phasing and structural refinement statistics 
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Figure A1.1. Domain Structures of members of the Sac phosphoinositide phosphatase 
family. Both in human and yeast, there are five proteins contain the Sac phosphatase module. 
(TM: transmembrane motif; RBD: RNA binding domain) 
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through extensive hydrophobic interactions. The third layer contains the other half of β7 and β8 
and a short strand β9. This layer directly contacts with the catalytic domain. The α1 helix and its 
preceding loop between β8 and β9 are partially aligned with the region that was previously 
predicted to have a leucine zipper motif in mammalian Sac1 (Blagoveshchenskaya and Mayinger, 
2009). The SacN domain of Sac1 has a novel fold and structural homology search by DALI 
server (Holm and Sander, 1995) did not reveal any significant hits.  The SacN domain is closely 
opposed to the catalytic domain, occluding a surface area of about 1300 Å2 on each domain.  The 
function of the SacN domain is still unknown.  A likely role of this domain is to control the 
enzymatic function through the interactions with other unknown factors.  
 
The Catalytic Domain of Sac1 
The catalytic domain of Sac1 consists of a nine-stranded and partially split β sheet that is 
flanked by five alpha helixes with two on one side, and three on the other. The β sheet starts with 
four long anti-parallel strands (β10 to β13) and then splits with three short parallel strands (β14, 
β15, and β18) in one branch and two anti-parallel strands (β16 and β17) in the other (Figure 
A1.2C). The P-loop (shown in red in Figure A1.2A, A1.2B), which contains the catalytic 
CX5R(T/S) motif (residue 392-399), extends from the end of β18, across the entire connecting 
loop, to the first turn of α8.  
Interestingly, the P loop is surrounded by five flexible loops (labeled from L1 to L5 and 
colored in green in Figure A1.2A, A1.2B, and Figure A1.3). Three longer loops (L1, L2, and L5), 
side chains of which are partially invisible in our crystal structure, protrude out from the catalytic 
surface and form part of the edge of a large groove (see below). Although the primary sequences 
in these loop region are not as conserved as other regions across Sac domain family members,  
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Figure A1.2. Overall crystal structure of Sac1. 
(A) Ribbon diagram of the Sac phosphoinositide phosphatase. The SacN domain is colored blue 
and the catalytic domain yellow. The secondary structure elements (strand β1-β18 and helices 
α1-α9) are labeled. The catalytic CX5R(T/S) motif (P-loop) is colored  red and labeled. Five 
protruding loops (L1 to L5) surrounding the catalytic site are colored green. 
(B) a 900 rotated view of (A).  
(C) Schematic diagram of the secondary structure topologies of Sac1.  
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these loops are enriched with positively charged and hydrophobic residues (Figure A1.3), the 
physicochemical nature of which is ideal to support interfacial membrane binding (Cho and 
Stahelin, 2005). These structural properties suggest that the catalytic site may be protected by the 
surrounding loops and upon activation, the surrounding loops, particularly the three long 
protruding loops, may directly interact with or insert into the lipid bilayer.  
 
Structure comparison of Sac1 with other phosphatases 
Comparison of the structure of the catalytic domain of Sac1 with other CX5R(T/S)-based 
phosphatases reveals that the topology of the catalytic core of Sac1 is conserved with other PTPs, 
including two lipid phosphatases MTMR2 and PTEN. They all share a common architecture of a 
central β sheet consisting of four parallel β strands flanked by antiparallel ones. This sheet is 
sandwiched by a variable number of  α helices on each side (Barford et al., 1994; Stuckey et al., 
1994). We further searched the Protein Data Bank for structural similarities to the catalytic 
domain of Sac1 using the Dali server (Holm and Sander, 1995). The structure found to have the 
highest Z-score (7.4) is human PRL-1 (PDB ID: 1XM2) (Jeong et al., 2005). The overall 
structure of the two catalytic domains can be superimposed on that of PRL-1 with a rmsd of 3.5 
Å over 128 Cα residues (Figure A1.4A). Despite the limited similarity of the catalytic core 
topology, the catalytic domain of Sac1 is unique with its large and split central β sheet compared 
to other PTPs, including the low molecular weight phosphotyrosyl phosphatase and canonical 
PTP1B (Figure A1.4A and A1.4B, and Figure A1.2C). Furthermore, structural comparison with 
the dual specific phosphatase, PTEN, reveals the difference of the interactions between the 
catalytic domain and other regulatory domains. When the catalytic domain of Sac1 is 
superimposed with   
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Figure A1.3. Sequence alignment of the Sac domain region of all Sac phosphatases in 
human and yeast.  
The sequences corresponding to the Sac domain region were aligned by ClustalW 2 (Labarga et 
al., 2007) and colored by ALSCRIPT (Barton, 1993). The conserved residues are shaded yellow 
and identical residues are shaded red. Secondary elements are drawn under the alignment. The 
catalytic site is marked by triangles. Regions that correspond to the five protruding loops 
(colored green in Figure A1.3A and B) are indicated with green boxes. Entrez database accession 
numbers are as follow: Sac1_sc: gi: 486379; Inp51_sc, gi: 6322189; Fig4_sc, gi: 6324005; 
Inp52_sc, gi: 6324224; Inp53_sc, gi: 6324683; Sac3_hs, gi: 7662034; Sac2_hs, gi: 7662414; 
Sac1_hs, gi: 190014578; Sj1_hs, gi: 223460134; Sj2_hs, gi: 26190608; 
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Figure A1.4. Superimposition of the Sac1 phosphatase domain with human PRL-1 
phosphatase and HPTP-B.  
(A) Stereo view of the two overlayed structures of the catalytic domain of Sac1 (yellow) and 
human PRL-1 (green, PDB ID: 1xm2).  
(B) Stereo view of the structural superimposition of Sac1 (yellow) and HPTP-B, a human B-
form low molecular weight PTP (green, PDB ID: 1XWW). The catalytic P-loops are colored in 
red for Sac1 and blue for both PRL-1 and HPTP-B.  
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Figure A1.5. Structural comparison of Sac1 with PTEN.  
Sac1 is colored in yellow and PTEN is in green. These two structures are superimposed based in 
structural homology on the catalytic domain. The catalytic P-loops of Sac1 and PTEN are 
colored in red and blue, respectively. Note that the SacN domain of Sac1 is located on the 
opposite side of the central β sheet compared to the C2 domain of PTEN
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that of PTEN (Lee et al., 1999), the SacN domain of Sac1 ends up on the opposite side of the 
central β sheet in contrast to the C2 domain in PTEN (Figure A1.5).  
Another major difference is the unique conformation of the catalytic P-loop of the Sac 
phosphatase (Figure A1.6A). Among all PTPs, the P-loops in PTPs are strictly superimposable, 
and a consecutive seven main-chain amide groups in this loop all face inward for the binding of a 
phosphate group of the substrate (Barford et al., 1998). The conformation of the P-loop is fairly 
stable, as evidenced by the fact that Cα tracing superimposition of P-loops from different PTPs 
(in the presence or absence of binding ligands) yields a minor standard deviation of less than 1 Å 
(Tabernero et al., 2008).  However, this conserved P-loop configuration is disrupted in Sac1. 
Moreover, within the CX5R(T/S) motif, the distance between the γ-thiol group of C392 and the 
guanidinium group of R398 is 14 Å apart in Sac1, while the corresponding distance is only about 
5 Å in other PTPs, including MTMR2 and PTEN (Figure A1.6B and A1.6C). Conformational 
deviation of the P-loop, resulting from the exposure of the enzyme to oxidants has been reported 
(Salmeen et al., 2003; van Montfort et al., 2003; Yang et al., 2007). In PTP1B, formation of 
cyclic sulphenamide of the catalytic cysteine causes a significant change in conformation.  
However, oxidation is not likely the cause of the conformational variation in Sac1 since high 
amount of reducing reagent, DTT is present in Sac1 protein stock and crystallization solutions. 
Furthermore, the electron density map around the P-loop does not reveal any extra density 
supporting the presence of oxidized forms of the thiol group of the catalytic C392 (Figure A1.7). 
Structural comparison of the catalytic domain of Sac1 with reduced [PDB ID: 1AAX; (Puius et 
al., 1997)] and oxidized [in the cyclic sulphenamide state; PDB ID: 1OEM; (Salmeen et al., 
2003)] forms of PTP1B reveals that the P-loop conformation of Sac1 is strikingly different from 
that of either form of PTP1B (Figure A1.8A and A1.8B). Particularly, the catalytic C392 and the  
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Figure A1.6. Structural comparison of the catalytic site P-loop between Sac1, MTMR2, and 
PTEN.  
(A) The P-loop configuration in Sac1. This loop, which comprises the CX5R(T/S) motif, is 
colored in red and residues in this loop are shown as sticks. This figure is generated in the same 
orientation as in Figure A1.3B.  
(B) The P-loop of MTMR2, and PTEN (C). The WPD loop in PTEN is indicated by an arrow. 
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Figure A1.7. Electron density map (2fo-fc) of the P-loop and residues in close vicinity with 
the catalytic C392.  
The map is contoured at 1σlevel. The electron density for the thiol group of the catalytic residue, 
C392 is well defined. 
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Figure A1.8. Structural comparison of Sac1 with canonical PTP1Bs at both reduced and 
oxidized state.  
Stereo view of the superimposition of the catalytic region of Sac1 (red) with reduced form of 
PTP1B (green, PDB ID: 1AAX) and oxidized (cyclic sulphenamide state) PTP-1B (cyan, PDB 
ID: 1OEM). Note that the conformation of the catalytic P-loop of Sac1 is strikingly different 
from that of both reduced and oxidized forms of PTP1B. The side chains of the catalytic C392 
and the conserved R398 residues in Sac1 are located on the opposite side of the P-loop; while in 
both reduced and oxidized PTP1Bs, these two residues are on the same side relative to the P-loop. 
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conserved R398 residues in Sac1 are located on the opposite side of the P-loop; while in both 
reduced and oxidized PTP1Bs, these two residues are on the same side. Thus this unique P-loop 
conformation of Sac1 may implicate an unusual mechanism for its catalytic function.  
 
Surface characteristics of Sac1 
Interestingly, the Sac domain is an electrostatically bipolar protein with one surface 
negatively charged (Figure A1.9A) and the opposite surface enriched with positive charges 
(Figure A1.9B). The bipolar charge distribution has been observed in other membrane interacting 
protein modules, such as PH domains (DiNitto and Lambright, 2006; Ferguson et al., 1994; 
Ferguson et al., 1995). The positively charged face of the Sac domain is likely to interface with 
the lipid bilayer which is concentrated with negatively charged phospholipids. In agreement with 
this notion, the catalytic CX5R(T/S) motif is localized on this positively charged surface.  
The other striking surface feature of the Sac domain is the presence of a deep canyon-like 
groove on the positively charged surface (Figure A1.9B and A1.9C). This groove is formed by 
both the SacN domain and the catalytic domain and travels a distance about 40 Å long at an 
average depth of more than 10 Å. There is a highly conserved positively charged residue, R256 
(labeled in Figure A1.9B and marked by a blue dot in Figure A1.3) aligned at the bottom of the 
groove. This arginine residue, together with some other positively charged residues, contributes 
to the electrostatic surface potential property in the groove. 
 
Mutagenesis of catalytic site residues 
Previous studies have revealed several interesting Sac1 mutant alleles. The catalytic 
cysteine to serine mutation (C392S) has been shown to be catalytically dead and fails to   
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Figure A1.9. Surface representative of Sac1 phosphatase.  
The surfaces were colored based on electrostatic potential with positively charged regions in blue 
(+3 kcal/electron) and negatively charged surface in red (-3 kcal/electron).  
(A) is rotated 1800 about the perpendicular axis relative to (B).  
(B) has the same orientation as in Figure A1.2B. The position of R256 is pinpointed by a red 
circle. (C) is rotated about ~900 around the horizontal axis of (B) and then slightly tilted left for a 
view of the deep cleft. The catalytic CX5R(T/S) motif is highlighted with an oval shape. Note 
that the catalytic site is located at the bottom of the positively charged groove.  
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complement the sac1Δ phenotype in yeast (Rohde et al., 2003). The yeast D394N and A445V 
mutants (the product of the sac1-8 and sac1-10 alleles, respectively) have been shown to confer 
phenotypes consistent with the loss of phosphatase activity as reported previously (Kearns et al., 
1997; Liu et al., 2008; Nemoto et al., 2000). The L304P mutation has some puzzling effects in 
that it has normal in vivo functions when the cells were grown on YPD medium, but displayed 
sac1 mutant phenotypes including elevated PI(4)P levels when grown on synthetic minimal 
medium (Hughes et al., 2000b). Interestingly, all these mutations are either located within or 
adjacent to the P-loop as revealed by the Sac1 structure (Figure A1.10A). The carboxyl group of 
D394 is 2.10 Å away from the amide group of L304 and forms a hydrogen bond with the main 
chain amide proton of L304. This hydrogen bond would then be disrupted in the L304P mutant 
due to the lack of an amide proton in the proline residue, and thus may cause conformational 
changes of the P-loop that may affect the catalytic activity in the end. 
In order to gain insight into the role of other conserved residues near the catalytic site, we 
generated several GFP-tagged Sac1 mutants in the vicinity of the catalytic site and introduced 
them into sac1Δ yeast cells. Sac1Δ yeast cells are viable when grown at permissive temperature, 
but with elevated PI(4)P level (6-8 fold greater than wild type cells) and fail to grow at 15 0C 
(Foti et al., 2001). These defects can be rescued by the re-introduction of functional Sac1. Based 
on these observations, the ability of our mutants to rescue the growth defects of sac1Δ cells at 15 
0C and the intracellular PI levels were analyzed by HPLC (Figure A1.10B and A1.10C). 
Immunoblotting experiments showed that GFP-tagged wild-type and mutant forms of Sac1 were 
expressed as stable proteins at a roughly similar level (Figure A1.10D). R256 in Sac1 is 
conserved among the Sac family members except for the catalytically inactive yeast sjl1 (Figure 
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A1.3). This conserved arginine contributes significantly to the positive electrostatic potentials at 
the catalytic  
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Figure A1.10. In vivo characterization of Sac1 mutants.  
(A) A close view of the catalytic P-loop of Sac1. Reported Sac1 mutant alleles are labeled in 
italic. Residues tested in this study are highlighted with red squares.  
(B) Quantitative analysis of PI(4)P is shown from sac1Δ cells transformed with empty vector 
control, N-term GFP tagged WT Sac1, and Sac1 mutants. The error bars represent ± SEM of 
three independent experiments.   
(C) In vivo growth rescue assay of sac1 cold sensitivity. Sac1Δ cells were transformed with 
indicated Sac1 constructs or vector control. The cells were spotted onto plates with three serial of 
dilutions from left to right, and grown at restrictive temperature at 15 °C for 6 days.  
(D) Western blots of samples prepared from the transformed cell show that the exogenously 
introduced Sac1 wild type or mutants are expressed as stable proteins and at a comparable level 
(G6PDH is shown as a loading control). 
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site. In sac1Δ cells transformed with the R256Q mutant, the 3H incorporated PI(4)P represents 
~5% of total newly synthesized PI, which is nearly double that of cells transformed with wild 
type Sac1 (Figure A1.10B). In agreement with this result, the R256Q mutant can only partially 
rescue the growth defect of sac1Δ cell at 15 0C (Figure A1.10C). We also tested several P-loop 
residues. As reported previously, the catalytically dead C392S or D394N mutants completely fail 
to rescue the growth phenotype and the PI(4)P level is about 6-8 fold greater than that of sac1Δ 
cells transformed with wild type Sac1. Similar to MTMR2, the Sac domain does not have the 
conserved aspartic acid residue (D92 in PTEN, Figure A1.9C) on its corresponding WPD loop. It 
has been suggested that in MTMR2, D422 within the P-loop may serve as the general acid and 
base during catalysis (Begley et al., 2003). This aspartic acid residue (D397 in yeast Sac1) is also 
conserved in Sac family phosphatases (Figure A1.3) and the D397N mutation has similar 
phenotypes as catalytically dead mutants. The only conserved basic residue within the catalytic 
P-loop, R398, seems also critical for the phosphatase function, as the R398Q mutant also has 
similar effects as catalytic dead mutants. Residues N229 is conserved among Sac phosphatases 
and is in the vicinity to the catalytic cysteine (C392), however, N229A has no apparent effect on 
the in vivo function of Sac1. Mutation of another conserved P-loop reside C395S also behaves 
like wild type Sac1 (Figure A1.10B and A1.10C).  
Collectively, these observations suggest that selective substitutions of some anionic 
residues near the catalytic site impair the normal function of Sac1, which may be due to direct 
impact on phospholipid binding. Both of the aspartic residues at the catalytic site are critical for 
the catalytic function by either serving as the general acid or maintaining proper P-loop 
conformation. 
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Missense disease mutations in human Sac3/Fig4  
 Several missense mutations of the human Sac3 are responsible for the genetic 
neurological disorders CMT4J and ALS. To understand how these single amino acid 
substitutions can affect the function of the protein, we computationally modeled the structure of 
the Sac phosphatase domain of human Sac3 based on the crystal structure of Sac1 (Figure A1.11). 
We then mapped five known missense mutations to the modeled structure of the Sac domain of 
Sac3. The I41T is a recessive mutation found in patients with CMT4J. This residue localizes at 
the C-terminal end of β3 in the SacN domain and is about 40 Å away from the catalytic site. The 
hydrophobic side chain of this isoleucine is buried in a hydrophobic core between the first two 
layers of β sheets in the SacN domain. Thus, the I41T substitution may not directly affect the 
catalytic activity of the Sac3, but likely may affect the local folding or the stability of the protein. 
In agreement with this prediction, yeast Fig4 carrying with a corresponding I59T mutation was 
able to produce normal levels of PI(3,5)P2 and corrected the vacuolar enlargement phenotype 
when this mutant was expressed in fig4Δ cells (Chow et al., 2007). Two other mutations, D48G 
and D53Y, which have been predicted to be responsible for a subset of ALS disease, are located 
at two ends of the β4 strand (Figure A1.11 inset). These two mutations are likely to affect protein 
folding or stability since both of these residues are surface exposed and located in flexible loop 
regions. Interestingly, these two residues, together with I41, are clustered in a surface area on the 
top of the SacN domain. This finding indicates that the SacN domain may be involved in protein-
protein interaction through a surface area on the first layer of the β sheet. Human disease 
mutations in Sac3 may displace the binding with other proteins, which may cause defective 
regulation on its enzymatic activity. The last two mutations, R388G and I411V, are located in the 
catalytic domain. The R388G is in the close vicinity of the catalytic P loop, thus it may have a 
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direct impact on its enzymatic function. The I441V is away from the catalytic P-loop and on the 
opposite side of the catalytic domain. Although I441 forms part of a hydrophobic core, 
substitution by a hydrophobic valine residue at this position may not be deleterious. Consistent 
with this prediction, the I441V variant has an activity close to the wild-type (Chow et al., 2009).   
 
Discussion 
The structure of the Sac domain of yeast Sac1, the first atomic structure of the Sac family 
phosphoinositide phosphatase, reveals that the previous predicted Sac domain contains two 
modules, the SacN and the catalytic sub-domains. Sequence and structure homology analysis 
suggests that the SacN domain has a unique sequence and a novel structural fold, both of which 
are only conserved in the Sac phosphatase family. Interestingly, several disease-related 
mutations found in Sac3/Fig4 form a cluster on the SacN domain, indicating that the SacN 
domain may mediate the interactions with other unknown factors. Recent results also show that 
mammalian Sac1 orthologs contain a leucine zipper motif within the SacN domain region and 
that this motif is required for Sac1 oligomerization. The predicted leucine zipper region is not 
conserved in yeast Sac1. However, this region partially overlaps with the α1 helix in the SacN 
domain (Figure A1.3). It has been further shown that the leucine zipper-dependent 
oligomerization of Sac1 is required for its shuttling to the Golgi complex (Blagoveshchenskaya 
et al., 2008; Blagoveshchenskaya and Mayinger, 2009). These results suggest that the regulatory 
function of the SacN domain might also be mediated by Sac1 oligomerization and translocation.  
The CX5R(T/S) catalytic motif of Sac1 is located between the C-terminus of a β-strand 
and the first turn of an α -helix. Despite the sequence variability of the X5 segment, the 
conformation of the P loop is strictly superimposable among different PTPs. Strikingly, seven  
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Figure A1.11. Homology structural modeling and missense disease mutations in human 
Sac3. The modeled Sac domain of Sac3 has a similar two domain structure: the SacN domain 
(blue) and the catalytic domain (yellow). The catalytic P-loop is colored red. Genetic mutations 
that have been implicated in CMT4J or ALS are labeled and illustrated with sticks. The inset is a 
zoomed view of a region with a clustering of three mutations in the SacN domain. 
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successive main-chain amide groups in this loop all face inward, together with the guanidinium 
group of the CX5R(T/S) arginine, to coordinate the phosphate group of the substrate in place for 
nucleophilic attack by the Sγ-atom of the catalytic cysteine (Figure A1.6B and A1.6C). 
Surprisingly, the conformation of the P-loop of the catalytic domain of Sac1 is different from all 
known PTP structures. These dissimilarities between Sac and other phosphatases suggest that the 
Sac domain family phosphatases utilize an unusual mechanism for phosphoinositide 
dephosphorylation. However, it may also be possible that the structure we crystallized is in an 
inactive conformation; it requires a conformational change that flips the P-loop into the 
consensus P-loop confirmation for its full activity.  A complex structure of Sac1 with its 
substrate analogues would resolve this ambiguity. We have intensively tried the co-
crystallization of wild type or catalytically dead C392S mutant Sac domain with inositol head 
groups [Ins(1,4)P2 and Ins(1,3)P2], but without success so far. Further structural studies are 
warranted for the delineation of the catalytic mechanisms and substrate specificity determinants 
of Sac phosphatases. 
 Since the substrates of lipid phosphatases are embedded in membrane bilayers, Sac1 must 
bind to the membrane-water interface in order to hydrolyze its substrates on membranes. Unlike 
enzymatic reactions that occur in solution, interfacial enzymatic reactions have their own unique 
kinetic features. The enzyme first needs to be adsorbed to the lipid interface for activation. Once 
the enzyme is tightly bound to the membrane surface, it may catalyze the reaction with high 
processivity in a so called “scooting” mode (Jain et al., 1986). Under the “scooting” model, the 
enzyme hydrolyzes many phosphoinositide lipids without dissociating from the membrane 
surface. The crystal structure of Sac1 reveals that the catalytic P-loop is surrounded by five 
flexible loops. Interestingly, some of these loops are enriched with cationic and hydrophobic  
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Figure A1.12. Functional model of Sac1 at the membrane interface.  
The Sac domain of Sac1 is shown by molecular surfaces colored cyan (the SacN sub-domain) 
and yellow (the catalytic sub-domain). The catalytic site P-loop is colored red. The polarized 
charge distribution controls the membrane docking of the Sac domain by orienting the catalytic 
site to its membrane embedded substrates. Several loops surrounding the catalytic site may 
directly interact or insert into the lipid bilayer and may facilitate the hydrolysis of 
phosphoinositides processively. The long flexible linker between the catalytic domain and the 
membrane anchors allows Sac1 to hydrolyze its substrates either in a trans or cis mode.  
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residues, the physicochemical nature of which is ideal to support interfacial membrane binding 
(Cho and Stahelin, 2005; Gelb et al., 1999). The structure further reveals a deep long groove on 
the catalytic surface of Sac1 (Figure A1.9B and A1.9C). This groove has its ends both open, 
which makes it possible for the enzyme to load its substrates from one end of the groove to the 
catalytic site for hydrolysis and to release the products through the other opening of the groove 
while the Sac domain remains “scooting” on the membrane. Thus Sac1 may function in an 
efficient processive manner at the membrane-water interface.  
Sac1 is a type II membrane protein that localizes to both the ER and Golgi apparatus 
(Nemoto et al., 2000; Whitters et al., 1993). A question that remains is whether its substrate is 
localized on the same membrane where Sac1 resides (cis) or on a different membrane (trans). 
Studies in yeast have demonstrated that PI(4)P is concentrated on the Golgi and the plasma 
membrane. Inactivation of Sac1p leads to a specific increase in the cellular level of PI(4)P and 
the bulk of accumulated PI(4)P is generated by the phosphoinositol-4 kinase Stt4 at the plasma 
membrane (Foti et al., 2001; Tahirovic et al., 2005). These findings suggest that Sac1 has the 
ability to hydrolyze its substrate in trans. Thus Sac1, and hence the ER, must be in close 
proximity to the plasma membrane. Indeed, ER membranes in close proximity to the PM (< 100 
Å) are often seen in ER images of both yeast and mammalian cells. In the Sac domain structure, 
there is a peptide stretch of 50 residues (residues 453-503) at the C-terminus lacking any electron 
density, suggesting a flexible nature of this region. Given an additional nearly 20-residue long 
spacer (residues 504-522, between the Sac domain and the first transmembrane motif), 
presumably also adopts a linear unfolded state, the Sac domain could extend far away from the 
membrane (A completely extended peptide of about 70 residues can reach a distance of 20 nm). 
This structural feature of Sac1 certainly allows it to overcome the space restriction to act in trans 
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on the pool of PI(4)P generated by Stt4 at the plasma membrane, although we cannot rule out 
Sac1 may also function in a cis mode. 
The structural properties of Sac1 lead us to propose a membrane interaction model for 
this phosphoinositide phosphatase (Figure A1.12). In this model, the cationic surface mediates 
the membrane association. On this surface, the catalytic P-loop is surrounded by several flexible 
loops that are enriched with cationic and hydrophobic residues. Once the Sac domain gets 
adsorbed to membrane bilayer, the deep open groove at the catalytic site would allow Sac1 to 
hydrolyze phosphoinositides in a processive manner. The long linker region between the 
catalytic domain and the first transmembrane motif allows the endoplasmic reticulum anchored 
Sac1 to reach its substrates embedded in the plasma membrane.  
In conclusion, the structure of the Sac domain of yeast Sac1 provides the first 
representative structure of the Sac phosphatase family. The structure reveals a large positively 
charged groove at the catalytic site and a strikingly different configuration of the catalytic P-loop 
of the Sac domain. These findings suggest a novel catalytic mechanism for Sac1. The structure 
also provides a three dimensional framework for the understanding of disease mechanisms of the 
missense mutations found in human Sac3. Further structural and functional studies of enzyme 
substrate complexes and of other Sac family members will lead to a full understanding of the 
structural determinants for substrate recognition and specificity. 
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